US20080160525A1 - Method and device for detecting the presence of a single target nucleic acid in a sample - Google Patents

Method and device for detecting the presence of a single target nucleic acid in a sample Download PDF

Info

Publication number
US20080160525A1
US20080160525A1 US11/837,559 US83755907A US2008160525A1 US 20080160525 A1 US20080160525 A1 US 20080160525A1 US 83755907 A US83755907 A US 83755907A US 2008160525 A1 US2008160525 A1 US 2008160525A1
Authority
US
United States
Prior art keywords
recited
sample
microfluidic device
porous sample
porous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/837,559
Inventor
James F. Brown
Jonathan E. Silver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Applied Biosystems LLC
Genomic Nanosystems Corp
Original Assignee
US Department of Health and Human Services
Cytonix LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25276672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20080160525(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by US Department of Health and Human Services, Cytonix LLC filed Critical US Department of Health and Human Services
Priority to US11/837,559 priority Critical patent/US20080160525A1/en
Publication of US20080160525A1 publication Critical patent/US20080160525A1/en
Assigned to CYTONIX CORPORATION reassignment CYTONIX CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BROWN, JAMES F.
Assigned to THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES reassignment THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SILVER, JONATHAN E.
Assigned to GENOMIC NANOSYSTEMS, LLC reassignment GENOMIC NANOSYSTEMS, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CYTONIX CORPORATION
Assigned to APPLIED BIOSYSTEMS, LLC reassignment APPLIED BIOSYSTEMS, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GENOMIC NANOSYSTEMS, LLC
Assigned to GENOMIC NANOSYSTEMS CORPORATION reassignment GENOMIC NANOSYSTEMS CORPORATION MERGER (SEE DOCUMENT FOR DETAILS). Assignors: GENOMIC NANOSYSTEMS, LLC
Assigned to APPLIED BIOSYSTEMS, LLC reassignment APPLIED BIOSYSTEMS, LLC CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NOS.; CONVEYING PARTY INTEREST; CONVEYING PARTY NAME/ADDRESS PER MERGER RECORDED 6/9/2010, REEL 024508, FRAME 0142. PREVIOUSLY RECORDED ON REEL 023950 FRAME 0123. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Assignors: GENOMIC NANOSYSTEMS CORPORATION
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • B01L3/50851Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates specially adapted for heating or cooling samples
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5088Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above confining liquids at a location by surface tension, e.g. virtual wells on plates, wires
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00279Features relating to reactor vessels
    • B01J2219/00306Reactor vessels in a multiple arrangement
    • B01J2219/00313Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315Microtiter plates
    • B01J2219/00317Microwell devices, i.e. having large numbers of wells
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614Delimitation of the attachment areas
    • B01J2219/00621Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00632Introduction of reactive groups to the surface
    • B01J2219/00637Introduction of reactive groups to the surface by coating it with another layer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00639Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
    • B01J2219/00644Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium the porous medium being present in discrete locations, e.g. gel pads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00659Two-dimensional arrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00677Ex-situ synthesis followed by deposition on the substrate
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00722Nucleotides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0642Filling fluids into wells by specific techniques
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/10Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/16Reagents, handling or storing thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0636Integrated biosensor, microarrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0819Microarrays; Biochips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0409Moving fluids with specific forces or mechanical means specific forces centrifugal forces
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/805Optical property
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809Multifield plates or multicontainer arrays
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2575Volumetric liquid transfer

Definitions

  • the present invention relates to the in vitro amplification of a segment of nucleic acid, methods to analyze concentrations of specific nucleic acids in sample fluids, and methods for detecting amplification of a target nucleic acid sequence.
  • the present invention also relates to miniaturized analytical assemblies and methods of filling miniaturized analytical assemblies.
  • PCR polymerase chain reaction
  • LCR ligase chain reaction
  • SDA strand displacement amplification
  • 3 SR self-sustained sequence replication
  • PCR although a relatively new technology, has found extensive application in various fields including the diagnosis of genetic disorders, the detection of nucleic acid sequences of pathogenic organisms in clinical samples, the genetic identification of forensic samples, and the analysis of mutations in activated oncogenes.
  • PCR amplification is being used to carry out a variety of tasks in molecular cloning and analysis of DNA.
  • These tasks include the generation of specific sequences of DNA for cloning or use as probes, the detection of segments of DNA for genetic mapping, the detection and analysis of expressed sequences by amplification of particular segments of cDNA, the generation of libraries of cDNA from small amounts of mRNA, the generation of large amounts of DNA for sequencing, the analysis of mutations, and for chromosome crawling.
  • PCR, other amplification methods, and related technologies are likely to find increasing application in many other aspects of molecular biology.
  • Nucleolytic degradation allows the two fluors to separate in solution which reduces quenching and increases the intensity of emitted light of a certain wavelength. Because these assays involve fluorescence measurements that can be performed without opening the amplification vessel, the risk of carryover contamination is greatly reduced. Furthermore, the assays are not labor intensive and are easily automated.
  • the TaqMan and related assays have provided new ways of quantitating target nucleic acids. Early methods for quantitation relied on setting up amplification reactions with known numbers of target nucleic acid molecules and comparing the amount of product generated from these control reactions to that generated from an unknown sample, as reviewed in the publication by Sninsky et al. The application of quantitative polymerase chain reaction to therapeutic monitoring , AIDS 7 (SUPPL. 2), PP. S29-S33 (1993).
  • Newer quantitative PCR methods use the number of cycles needed to reach a threshold amount of PCR product as a measure of the initial concentration of target nucleic acid, with DNA dyes such as ethidium bromide or SYBRTM Green I, or “TaqMan” or related fluorescence assays used to follow the amount of PCR product accumulated in real time. Measurements using ethidium bromide are disclosed in the publication of Higuchi et al., Simultaneous Amplification and Detection of Specific DNA Sequences , BIO/TECHNOLOGY, Vol. 10, pp. 413-417 (1992).
  • An alternative method of quantitation is to determine the smallest amount of sample that yields PCR product, relying on the fact that PCR can detect a single template molecule. Knowing the average volume of sample or sample dilution that contains a single target molecule, one can calculate the concentration of such molecules in the starting sample.
  • to accumulate detectable amounts of product from a single starting template molecule usually requires that two or more sequential PCRs have to be performed, often using nested sets of primers, and this accentuates problems with carryover contamination.
  • PCRs normally saturate at about 10 11 product molecules/microliter (molecules/ ⁇ l) due in part to rapid reannealing of product strands. To reach this concentration of product after 30 cycles in a 10 ⁇ l PCR requires at least 10 3 starting template molecules (10 3 ⁇ 2 30 /10 ⁇ l ⁇ 10 11 / ⁇ l).
  • miniaturization might also facilitate the performance of multiple different amplification reactions on the same sample. In many situations it would be desirable to test for the presence of multiple target nucleic acid sequences in a starting sample.
  • Amplification of different nucleic acid sequences and/or detection of different sequence variants usually requires separate amplification reactions with different sets of primers and/or probes.
  • primer/probe sets were positioned in an array format so that each small region of a reaction substrate performed a different amplification/detection reaction, it is possible that multiple reactions could be carried out in parallel, economizing on time, reagents, and volume of clinical specimen.
  • methods and apparatus for performing nucleic acid amplification on a miniaturized scale have the sensitivity to determine the existence of a single target nucleic acid molecule.
  • the invention also provides analytical assemblies having sample retaining means which form, isolate and retain fluid samples having volumes of from about one microliter to about one picoliter or less.
  • the invention also provides a method of forming fluid samples having sample volumes of from about one microliter to about one picoliter or less, and retaining the samples under conditions for thermocycling.
  • the invention also provides an analytical assembly having means to determine simultaneously the presence in a sample of multiple different nucleic acid target molecules.
  • PCR conditions are provided wherein a single target nucleic acid molecule is confined and amplified in a volume small enough to produce a detectable product through fluorescence microscopy.
  • samples of a few nanoliters or less can be isolated, enclosed and retained under thermocycling conditions, and a plurality of such samples can be collectively analyzed to determine the existence and initial concentration of target nucleic acid molecules and/or sequences.
  • sample retaining chambers having volumes of about 10 picoliters or less can be achieved.
  • methods of forming small fluid samples, isolating them and protecting them from evaporation are provided wherein different affinities of a sample retaining means and a communicating channel are used to retain sample in the means while a second fluid displaces sample from the channel.
  • the resultant isolated samples are then subject to PCR thermal cycling.
  • methods are provided for determining the existence and/or initial concentration of a target nucleic acid molecule in samples of about 1 microliter or less. According to some embodiments of the invention, methods are provided for a clinical diagnosis PCR analysis which can quickly and inexpensively detect a single target nucleic acid molecule.
  • sample chambers of about, 1 microliter or less that have a greater affinity for a sample to be retained than for a displacing fluid.
  • the displacing fluid displaces sample from around the chambers and isolates the sample portion retained in the chambers.
  • nucleic acid samples are isolated, retained and amplified in microcapillary devices having volumes of about 100 nanoliters or less, including microcapillary tubes, planar microcapillaries and linear microcapillaries.
  • the devices may be provided with absolute, selective or partial, barrier means.
  • a porous or microporous material retains samples of about 100 nanoliters or less, and an assembly is provided which includes a cover for sealing sample within the porous or microporous material.
  • PCR methods and apparatus wherein the sensitivity of a “TaqMan” fluorescence assay can be used to enable detection of single starting nucleic acid molecule in reaction volumes of about 100 nl or less.
  • assemblies for retaining PCR reaction volumes of about 10 nl or less are provided, wherein a single target molecule is sufficient to generate a fluorescence-detectable concentration of PCR product.
  • methods are provided for carrying out, PCR in minute volumes, for example, 10 nl or less, which allows detection of PCR products generated from a single target molecule using the “TaqMan” or other fluorescence energy transfer system.
  • methods of detecting and quantifying DNA segments by carrying out polymerase chain reaction in a plurality of discrete nanoliter-sized samples are provided.
  • the present invention also provides methods for determining the number of template molecules in a sample by conducting replicate polymerase chain reactions on a set of terminally diluted or serially smaller samples and counting the number of positive polymerase chain reactions yielding specific product.
  • the present invention is useful in detecting single starting molecules and for quantifying the concentration of a nucleic acid molecule in a sample through PCR.
  • the present invention also provides methods of detecting and quantifying a plurality of target DNA sequences.
  • the present invention also provides methods and assemblies for separating and/or analyzing multiple minute portions of a sample of fluid medium that could be useful for other applications.
  • Applications of the apparatus of the invention include the separation of biological samples into multiple minute portions for the individual analysis of each portion, and can be used in the fields of fertility, immunology, cytology, gas analysis, and pharmaceutical screening.
  • FIG. 1 is an exploded view of an analytical assembly according to an embodiment of the present invention, shown in partial cutaway;
  • FIG. 2 is an exploded view of an analytical assembly according to an embodiment of the present invention, shown in partial cutaway, comprising sample chambers in the form of wells formed into patterned layers on the inner surfaces of both a top plate and a bottom plate;
  • FIG. 3 is a cross-sectional view through a longitudinal central portion of ail analytical assembly according an embodiment of the present invention.
  • FIG. 4 is a perspective view of a bottom portion of an analytical assembly according to an embodiment of the present invention, the bottom portion comprising sample retaining means in the form of patches of fluid retaining material formed on a patterned layer coated on the inner surface of a bottom plate;
  • FIG. 5 is a cross-sectional view through a longitudinal central portion of an analytical assembly according an embodiment of the present invention.
  • FIG. 6A is a perspective view of a bottom portion of an analytical assembly according to another embodiment of the present invention.
  • FIG. 6B is an enlarged view of portion VIA shown in FIG. 6A ;
  • FIG. 7 is a top plan view of a microcapillary analytical assembly according to an embodiment of the present invention.
  • FIG. 8 is a histogram showing the maximum values of the fluorescein:rhodamine intensity ratio in over 100 capillary reactions of terminally diluted genomic DNA carried out in an assembly according to the present invention and according to a method according to the invention.
  • FIGS. 9-14 are plots of the fluorescein:rhodamine ratio along a few representative microcapillaries containing samples subject to PCR in accordance with the present invention.
  • methods of manipulating a sample of fluid medium comprise loading a sample of fluid medium into sample retaining means of an analytical assembly and displacing excess sample from areas adjacent to the portion retained by the sample retaining means.
  • sample fluid is displaced from regions adjacent to the retained sample, without displacing the retained sample.
  • a displacing fluid is used to isolate a retained sample, and the displacing fluid may be curable to form a retaining chamber entrapping the fluid sample retained by the sample retaining means.
  • the assemblies of the present, invention provide samples or sample portions enclosed in a protective environment which protects the sample or portion from evaporation and contamination.
  • sample is protected from evaporation at temperatures of about 95° C. or more, for example, at temperatures achieved during thermal cycling under conditions for PCR.
  • the isolated, entrapped or enclosed sample or portion is preferably protected from contamination and evaporation throughout an amplification protocol, for example, a PCR thermal cycling protocol.
  • an analytical assembly comprises a plurality of sample chambers each confined in at least one dimension by opposing barriers separated by a first dimension of about 500 microns or less, preferably by 100 microns or less, and in some embodiments by about 20 microns.
  • Means are provided for sealing the plurality of sample chambers to prevent evaporation and contamination of fluid sample confined within the plurality of sample chambers.
  • Means are provided for restraining reaction product formed from reactions of a chemical substance restrained within the plurality of sample chambers.
  • means may be provided for minimizing diffusion and substantially preventing convection of amplification reaction product formed from reactions of the fluid sample restrained within the plurality of sample chambers.
  • At least one of the means for restraining and the means for minimizing diffusion and substantially preventing convection may preferably comprise a patterned layer which at least partially defines the plurality of sample chambers.
  • the fluid sample contains at least one target, nucleic acid molecule to be amplified and constituents for enabling amplification of the target nucleic acid molecule.
  • the fluid sample is divided into a plurality of sample portions and the plurality of sample chambers are loaded which respective portions of the fluid sample.
  • the sample portions are in fluid communication with each other, rather than being completely isolated from each other, and separated by barrier means which may be in the shape of crosses, lines, semicircles, circles having at least one opening along the arc thereof, or other geometric shapes.
  • the barrier means may define sample retaining portions or chambers of the assembly.
  • means for minimizing diffusion and substantially preventing convection are provided, and may comprise the herein described barrier means.
  • the barrier means includes physical structures which may extend between the aforementioned opposing barriers which are separated by 500 microns.
  • the barrier means may form a wall or walls between the opposing barriers.
  • the barrier means may comprise flow restriction means.
  • Flow restriction means may be, for example, semi-circular walls extending from one of the opposing barriers toward the other, and having the concave side of the semi-circle facing the direction of fluid flow during loading, and the semicircular arc may have at least hole or interruption therein through which air may escape during fluid sample loading.
  • the first dimension, the means for restraining, and, if provided, the means for minimizing diffusion and substantially preventing convection are such that the reaction product of a single target nucleic acid molecule amplified within at least one sample chamber can attain a concentration of reaction product molecules sufficient to be detected by a homogeneous detection assay, for example a concentration of about 10 11 product molecules per microliter ( ⁇ l).
  • a homogeneous detection assay for example a concentration of about 10 11 product molecules per microliter ( ⁇ l).
  • at least one of the plurality of portions is initially free of the target nucleic acid molecule, and at least one of the plurality of portions initially contains at least one target nucleic acid molecule.
  • an analytical assembly comprising a substrate and a cover in registry with one another and attached to one another and having facing surfaces spaced a substantially uniform distance apart from one another.
  • the facing surface of the substrate comprises a first material having a first affinity to a sample of fluid to be isolated, for example, an aqueous PCR solution sample.
  • a flow-through channel is disposed between the first material and the cover, and at least one sample retaining means is bounded on at least one side by the first material.
  • the first material may comprises for example, a patterned layer of moderately hydrophobic material, that is, a material having a surface energy of from about 30 dynes/cm to about 50 dynes/cm.
  • the first material may be deposited on the inner surface of the substrate.
  • affinity is to be understood to mean a sample-holding capacity or sample-holding capability.
  • the affinity of the sample retaining means may be caused by surface energy of the material contacting or restraining a sample fluid, or it may be caused by electrostatic force, flow restriction means, temperature differences or by other means.
  • the “affinity” of a flow-through channel may be defined by the dimensions of the channel, or by the material comprising one or more bounding surface of the channel, or by a combination of dimensions and bounding surface properties.
  • the sample retaining means may have different affinities to retain a sample fluid and a displacing fluid.
  • the flow-through channel may exhibit different affinities to retain a sample fluid and a displacing.
  • the first material preferably does not comprise an extremely hydrophobic material; for example, the first material preferably does not comprise a material having a surface energy of less than about 20 dynes/cm.
  • Extremely hydrophobic materials do not tend to be wetted by aqueous samples or by many displacing fluids such as mineral oil, two-part adhesives, UV-curable and cyanoacrylate adhesives, and thus such displacing fluids would tend not to completely surround, isolate and restrain a sample (e.g. a gaseous sample) held by the sample retaining means.
  • the sample retaining means is in communication with the flow-through channel such that sample entering the flow-through channel can reach and be retained by the sample retaining means.
  • the cover and first material should be of such properties and/or special relationship to allow a sample fluid and a displacing fluid to enter the flow-through channel, whether by capillary action, pressure, or other force.
  • the sample retaining means has a second affinity to the sample of fluid medium, and the second affinity is greater than the first affinity.
  • the second affinity may be a property induced in the first material by chemicals optical, electronic, or electromagnetic means, for example.
  • An exemplary chemical means to permanently induce an affinity may be, for example, an O 2 plasma exposure to a portion of a silicone surface to effectively change the affinity of the surface to retain an aqueous sample at the portion treated.
  • Embedding ions in a surface may also be used to permanently induce an increased or decreased affinity at a location on a surface.
  • An affinity may be temporarily induced according to some embodiments of the invention, for example, where a surface charge on a sample retaining or repelling surface is induced to increase the effective surface tension of that surface.
  • a temporary affinity may be reshaped, moved or relocated during or after a sample portion is retained, for the purpose of enlarging or joining sample portions in the assembly.
  • the difference of affinities enables the retaining means to collect a portion of sample from the flaw-through channel and to retain the portion while a second fluid medium: is introduced to the flow-through channel; isolates sample retained by the sample retaining means; and displaces non-retained sample from adjacent to the sample retaining means.
  • the flow-through channel is adjacent to the sample retaining means.
  • An entrance opening is provided for introducing sample into the flow-through channel.
  • an analytical assembly is also provided which contains isolated sample entrapped by a substantially immiscible displacing fluid.
  • Methods according to embodiments of the invention involve causing the displacing fluid to flow through the flow-through channel and displace sample from the flow-through channel without displacing sample from the sample retaining means.
  • Such methods are accomplished according to embodiments of the invention by providing a sample retaining means having a greater affinity for the sample than for the displacing fluid.
  • the flow-through channel has a much lower affinity for the sample than does the sample retaining means.
  • the sample of fluid medium is a gaseous sample and the sample retaining means is extremely hydrophobic, for example, having a surface energy of from about 30 dynes/cm to about 10 dynes/cm. Because of the extreme hydrophobicity of the retaining means, displacing fluids tend to be repelled from the retaining means, and thus avoid displacing gaseous sample from the retaining means. Displacing fluids can thus entrap, retain and isolate a sample within an assembly of the invention.
  • an organic sample is trapped in a high surface energy displacing fluid.
  • Both the sample to be isolated and the displacing fluid may be introduced into the flow-through channel by being drawn in under the influence of capillary forces. Pressurized loading techniques may also be used, but if displacing fluid is forced into the device under pressure, the pressure should not be so high as to displace sample from the sample retaining means.
  • Other means of loading sample fluid and/or displacing fluid may be used according to the invention and include electrokinetic or electrostatic loading techniques, temperature differentials, centrifugal force, vacuum or suction loading, magnetic attraction loading of magnetic fluids, and electrophoretic or columbic force loading.
  • An exemplary magnetic attraction loading technique involves drawing a fluid containing magnetic particles dispersed therein into the device under the influence of a magnetic field and using mineral oil containing dispersed iron particles as a displacing fluid and drawing the mineral oil into a flow-through channel with a magnetic field.
  • the sample is loaded with magnetic particles and attracted toward and held by a sample retaining means adjacent to or including a source of a magnetic field or a material which is attracted to a magnet, for example, an iron-containing material.
  • the displacing fluid is substantially immiscible with the sample of fluid medium to be isolated.
  • the displacing fluid may comprise a flowable, curable fluid such as a curable adhesive selected from the group consisting of: ultra-violet-curable and other light-curable adhesives; heat, two-part, or moisture activated adhesives; and cyanoacrylate adhesives.
  • a curable adhesive selected from the group consisting of: ultra-violet-curable and other light-curable adhesives; heat, two-part, or moisture activated adhesives; and cyanoacrylate adhesives.
  • Exemplary displacing fluids include Norland optical adhesives available from Norland Products, Inc., New Brunswick, N.J., cyanoacrylate adhesives disclosed in U.S. Pat. Nos.
  • the displacing fluid may be transparent, have a refractive index similar to glass, have low or no fluorescence, have a low viscosity, and/or be curable.
  • Some methods according to embodiments of the invention may comprise isolating a sample into a plurality of discrete retained sample portions, and processing and/or analyzing the portions to determine concentrations of components and other characteristics of the sample.
  • assemblies are provided having a plurality of sample retaining means. Evaluating multiple portions of a sample can then be used to determine characteristics of the entire sample.
  • Manipulating may comprise cloning a segment of DNA, for example, where the sample of fluid medium comprises a polymerase chain reaction solution, and at least one segment of DNA to be amplified.
  • Methods of PCR according to the invention comprise exposing isolated sample retained by the sample retaining means to a temperature profile which causes polymerase chain reaction amplification of a target nucleic acid molecule segment within the sample.
  • isolated and minute PCR samples can be retained under conditions which protect the sample during temperature profiling to dehybridize double stranded polynucleotides, anneal primers to the dehybridized molecules, and to polymerize and thus amplify the polynucleotide.
  • PCR methods are carried out in assemblies according to the invention, and the methods include manipulating a PCR sample which contains an effective amount of a probe or system of probes having fluorescent properties or chemical properties that change upon hybridization to a nucleic acid target.
  • a normally quenched double labeled fluorescent probe is degraded upon hybridization to target DNA during PCR and the degradation results in increased emitted light of a certain wavelength.
  • methods according to embodiments of the invention can be used to determine whether a segment of DNA has been amplified and thereby calculate the concentration of a target DNA segment that existed in the original sample before PCR.
  • the measured fluorescence of a certain wavelength may in some cases be used according to the invention to quantify the amount of a DNA segment, which had been retained by the sample retaining means prior to exposing a retained sample to a PCR thermal cycling profile or protocol.
  • Other detection methods may be used to determine PCR product and/or reactant concentrations or to make other quantitative or qualitative evaluations of many types of samples. These other detection methods include agglutination, turbidity, phosphorescence detection techniques, light scattering, light absorbance, fluorescence energy transfer, fluorescence quenching or dequenching, time-delayed fluorescence, chemiluminescence and calorimetric evaluation techniques.
  • methods of cloning a segment of DNA wherein a sample containing a DNA segment to be amplified is divided into a plurality of sample portions and the portions are simultaneously subjected to PCR.
  • sample portions of as small as about 10 nanoliters or less, for example 10 picoliters or less, single molecules of a target DNA segment to be amplified can be detected according to the invention.
  • the sample from which the portions are derived may comprise a polymerase chain reaction solution, at least one segment of DNA to be amplified, and a sufficient amount of primer to carry out a polymerase chain reaction for multiple cycles, and the method may comprise exposing the sample portions retained by the plurality of sample retaining means to a temperature profile which causes polymerase chain reaction and amplification of a target DNA segment within the portions.
  • the presence of a single strand of a target DNA segment can be detected in a portion retained by at least one of a plurality of sample retaining means.
  • Methods according to some embodiments of the present invention comprise manipulating a sample of fluid medium by loading the sample into an analytical assembly having a porous sample retaining means.
  • Porous sample retaining means according to the invention comprise a porous structure having an exposed porous surface and a plurality of pores having open upper ends at the exposed porous surface.
  • the exposed porous surface is moderately hydrophobic yet receptive to adhesive bonding.
  • the pores of the sample retaining means may have substantially the same volume and have closed lower ends which may be defined by a substrate onto which the porous structure may be disposed.
  • the ratio of pore diameter to depth is from about 2:1 to about 10:1, for example, 4:1, for embodiments wherein a porous material is attached to a substrate.
  • the ratio of exposed porous surface area that is, the area of the surface not taken up by the openings, to the area of pore openings is from about 4:1 to about 1:1.5, for example, a ratio of about 1:1.
  • the pores have a first affinity to a sample such that when the sample is disposed upon the exposed porous surface, the sample is drawn into the plurality of pores.
  • the assembly used according to these methods of the invention further comprises means to displace sample from the exposed porous surface without displacing the sample from the pores.
  • the means to displace may comprise a displacing fluid or a displacing device such as a coverslip pressed against the exposed surface.
  • the assembly may also include means for sealing the sample within the pores to prevent evaporation and contamination of the sample during heat treatment and analysis of the sample in the pores.
  • Loading sample into the pores of a porous sample retaining means comprises contacting the sample to the exposed porous surface and retaining the sample in the plurality of pores. Due to the affinity the pores exhibit to the sample, particularly to aqueous PCR samples, the sample is drawn into the pores by capillary force and retained therein.
  • the methods also include displacing sample from the exposed porous surface without displacing sample from within the pores.
  • the methods may also include sealing the open ends of the pores with the sample disposed therein.
  • both the top and the bottom of the pores may be open for loading and then sealed.
  • analytical assemblies are provided for carrying out methods of manipulating a sample of fluid medium with a porous sample retaining means.
  • the porous sample retaining means in such assemblies may comprise a microchannel, array, a metal, glass, ceramic, cellulosic or polymeric screen or sieve, or a material, having a plurality of pores formed therein, such as a substantially flat plastic disk having a plurality of pores ablated, molded, etched or drilled therein.
  • the pores may be treated or coated with a material to provide an affinity to a sample.
  • the exposed porous surface may be treated or coated with a material to render the exposed surface moderately hydrophobic.
  • the sample retaining pores have a volume of from about 1 microliter to about 100 nanoliters or less, preferably about 10 nanoliters or less, and may have pore volumes of about 1 picoliter or less for some applications. According to one embodiment, the pores have volumes of about 10 picoliters.
  • a sealing means such as a microscope slide coverslip, tape, film or a device including other components, a silicon film or device, a device having an array of reactants, or other means is disposed on the exposed porous surface and displaces sample from the exposed porous surface, without displacing sample from within the pores. After displacing sample from the exposed porous surface, the displacing means may become the sealing means if subsequently held, adhered or attached to the porous surface, which would then no longer be exposed.
  • the sealing means comprises a material having a second affinity for the sample which is less than the first affinity, for example, the sealing means comprises a relatively hydrophobic material which contacts the exposed porous surface, and the pores are defined by a relatively hydrophilic porous material.
  • the means for displacing sample and the means for sealing may be a single cover having a hydrophobic surface which contacts the porous surface.
  • the sealing means may be glued to the previously exposed porous surface, glued to a substrate on which the porous retaining means is disposed, or clamped or otherwise attached to the porous retaining means or a substrate therefor, as for example, with clips or springs.
  • a surface of the cover, substrate or porous sample retaining means may provide adhesive or glue properties.
  • a target nucleic acid molecule or segment is amplified in at least one of the pores of a porous sample retaining means.
  • the sample to be retained by the retaining means may comprise a polymerase chain reaction solution, and at least one target segment of nucleic acid molecule to be amplified.
  • the method further comprises exposing the sample sealed within the pores to a temperature profile which causes polymerase chain reaction amplification of the target segment within at least one of the pores.
  • the sample further comprises an effective amount of a fluorescent probe which fluoresces upon degradation caused by the successful amplification of the target segment in the sample.
  • Such methods may further comprise measuring the fluorescence emitted from degraded probe after the polymerase chain reaction and determining whether the target segment was amplified in at least one of the pores.
  • the fluorescence measurement may be of the amount of fluorescence, the lifetime of fluorescence, or another fluorescence property.
  • the methods of the present invention using a porous sample retaining means may further comprise using measured fluorescence to quantify the amount of target nucleic acid segment which had been retained in at least one of the pores prior to exposing retained sample portions to a thermal cycling protocol. Due to the extremely small volume of sample chambers which can be achieved with a porous sample retaining means, the presence of a single strand of the target segment can be detected in the pores.
  • the methods may also comprise determining the initial concentration of the target segment which had been in the sample prior to amplification.
  • a sample of fluid medium is loaded into an analytical assembly comprising a microcapillary device, for example, a microcapillary tube having an inner diameter of about 500 ⁇ m or less, preferably about 100 ⁇ m or less.
  • Loading may comprise filling the microcapillary tube with a sample by capillary action.
  • Microcapillary devices provided with a sample retaining means for example, a hydrophobic or hydrophilic surface or an electromagnetic or electrostatic force, may have an inner dimension or inner diameter of about 500 ⁇ m or less.
  • Tubular or linear microcapillaries not provided with sample retaining means may preferably have an inner dimension of about 100 ⁇ m or less.
  • Planar microcapillaries not provided with sample retaining means for example, comprising the space between two facing plates, may preferably have an inner dimension of about 20 ⁇ m or less.
  • a first fluid may initially be disposed into the microcapillary device, for example, a microcapillary tube.
  • the first fluid may preferably be substantially immiscible, and more preferably, completely immiscible with a sample fluid.
  • Loading then comprises disposing a portion of a sample fluid into the microcapillary tube adjacent the first fluid, and subsequently disposing a second fluid into the microcapillary tube adjacent the sample.
  • the second fluid is also preferably substantially immiscible, and more preferably completely immiscible, with the sample.
  • the sample is disposed between and restrained by the first and second fluids.
  • the first and second fluids may be the same fluid, and can be, for example, mineral oil or a gas or a curable monomer formulation, if the sample is an aqueous fluid.
  • the microcapillary device may contain more than one isolated sample portion, which may be separated by one of the first and second fluids. Each portion may be about 100 nl or less, preferably 10 nl or less.
  • Some methods of the invention which employ microcapillary sample retaining means may also comprise sealing both ends of the microcapillary tube with the sample therein.
  • the sample may fill the entire capillary tube and be sealed therein, or the sample may be sealed in the tube sandwiched between first and second fluids.
  • Means may be employed to load numerous sample portions, such as an ink jet or fluidic control apparatus.
  • microcapillary analytical assemblies are also provided and can be used to isolate and retain a sample of fluid medium comprising about 100 nanoliters or less of a fluid medium, preferably about 60 nanoliters or less.
  • Assemblies are also provided which comprise a plurality of such microcapillary tubes, each tube having a sample of fluid medium disposed therein.
  • a plurality of tubes may be attached to a pair of microscope slide coverslips, or to a tape or pair of tapes, or otherwise held together.
  • the microcapillary sample retaining devices of the present invention may be used to carry out nucleic acid amplification methods, according to embodiments of the invention.
  • the fluid sample may comprise a polymerase chain reaction solution which may include reagents, enzymes, buffer, bovine serum albumin and other well known ingredients commonly used to perform a polymerase chain reaction.
  • Methods according to the invention which employ the inventive microcapillary devices may further comprise exposing the sample sealed within the microcapillary tube, or within a plurality of tubes, to a temperature profile which causes amplification of the target segment within the sealed sample.
  • the PCR sample in the microcapillary tube may further comprise an effective amount of a fluorescent probe which fluoresces upon degradation of the probe caused by the successful amplification of the target segment.
  • the fluorescence emitted from the hybridized probe can be measured to determine whether the target segment was amplified.
  • fluorescence or other detection properties are promptly analyzed after PCR thermal cycling, for example, within about 5 hours, more preferably within about 1 hour after PCR thermal cycling is complete.
  • Prompt analysis of the fluorescence emitted maximizes the concentration of measured degraded probe along regions of the microcapillary tube, before the degraded probe diffuses along the tube and becomes less detectable.
  • the amplification is carried out as rapidly as possible, for example, in less than one hour.
  • assemblies according to embodiments of the invention can take many forms but can generally be classified into three types, (1) assemblies having flow-through channels and sample retaining means in communication with the flow-through channel, (2) assemblies having porous sample retaining means and means for sealing sample within sample retaining pores, and (3) assemblies comprising at least one microcapillary tube.
  • assemblies are provided for manipulating samples of fluid medium, for example, methods for isolating small sample volumes, such as sample volumes of 100 nanoliters or less.
  • Some assemblies according to the invention comprise a substrate and a cover in registry with and attached to one another and having facing surfaces spaced a substantially uniform distance apart from one another.
  • the facing surface of the substrate comprises a first material having a first affinity to a sample of fluid medium to be contained in the assembly.
  • the first material is preferably a moderately hydrophobic material.
  • the first material preferably defines at least a portion of a flow-through channel which is disposed between the substrate and the cover.
  • the flow-through channel is in fluid communication with a sample retaining means, and the retaining means is bounded on at least one side thereof by the first material.
  • the sample retaining means has a second affinity to the same sample of fluid medium.
  • the second affinity to the sample fluid is greater than the first affinity thereto, preferably much greater, enabling the sample retaining means to retain or collect a portion of a sample of fluid medium which flows through the flow-through channel and to retain the portion while a second fluid medium flows through and displaces sample from the flow-through channel.
  • the result can be a very small isolated portion of the sample being retained by the sample retaining means and entrapped, encased or otherwise surrounded by the second fluid medium in the flow-through channel.
  • the substrate may be a first plate having a patterned layer of the first material formed thereon.
  • the cover may be a second plate attached to and substantially parallel to the first plate, with the first and second plates having facing substantially parallel planar surfaces.
  • the first and second plates may each be rigid or flexible, flat or contoured, a sheet, a film, a microscope slide, a microscope slide coverslip, a glass plate, a tape, a device including other components, a silicon device, a silicon film, or the like.
  • the plate has a substantially planar surface on a side adjacent or defining the sample retaining means.
  • the patterned layer is preferably located between the planar surfaces and at least partially forms a boundary for the sample retaining means.
  • the sample retaining means is a chamber formed from an opening in, a cavity or recess in, or a hole through the patterned layer
  • the closed end of the chamber may be defined by the substrate surface on which the patterned layer is disposed or by the patterned layer, and the patterned layer may define the sidewalls of the sample chamber.
  • the sample retaining means is a recessed sample chamber at least partially defined by the patterned layer
  • the chamber may comprise a sidewall, a closed lower end, and an upper end which may be open or closed.
  • the sample chamber has a communication with the flow-through channel.
  • the sample chamber also extends into and is partially defined by a patterned layer formed on the facing surface of the assembly cover, in which case the sample chamber may have a closed upper end and the communication to the chamber may be formed in the chamber sidewall, for example, an annular gap in an otherwise continuous sidewall.
  • the cover is substantially planar and the sample chamber does not extend into the cover or a layer disposed on the cover, in which case the chamber has an open upper end in communication with the flow-through channel.
  • the closed lower end of the sample chamber may comprise the first plate.
  • the sample retaining means may comprise a third material at the lower end of the sample chamber.
  • the third material may in some cases be a hydrophilic material deposited on the first plate and defining the lower end of the chamber.
  • the third material may be very hydrophobic.
  • hydrophilic materials may be used at the lower end of the sample chamber.
  • a sample chamber comprising a recess in a substrate or substrate coating may preferably have hydrophilic material at a lower end thereof and hydrophobic material forming the sidewall.
  • the hydrophilic lower end provides an affinity to an aqueous PCR sample which is sufficient to retain the sample while a displacing fluid carries away sample adjacent the sample chamber.
  • the hydrophobic sidewalls prevent sample from being displaced from the sample chamber.
  • Preferred sample chambers according some embodiments of the invention for nucleic acid amplification methods to detect single target nucleic acid molecules, have volumes of from about 1 microliter to about 1 picoliter or less.
  • Screen printing and photolithography are preferred methods of forming a patterned layer on the substrate.
  • Screen printing methods can provide a patterned layer on a 1, inch by 3 inch microscope slide wherein the layer contains over one thousand isolated and spaced sample chambers each having a volume of about 1 nanoliter.
  • Such a patterned layer could enable over one thousand PCR chambers of about 1, nanoliter each, all on the surface of a 1′′ ⁇ 3′′ microscope slide.
  • Photolithographic methods can provide from about 10,000 to over 100,000 sample chambers of about 100 picoliters each on a 1′′ ⁇ 3′′ substrate.
  • the first material or patterned layer material is moderately hydrophobic.
  • the term “moderately hydrophobic” refers to a material or layer that exhibits a contact angle to water of from greater than about 30° to less than about 85°.
  • a hydrophobic patterned layer is disposed on the facing surfaces of both the substrate and the cover, the average contact angle of the two patterned layers is preferably more than about 30° to less than about 85°, and more preferably each of the two layers is moderately hydrophobic.
  • Patterned layers exhibiting higher contact angles to water may be employed on the substrate surface if the cover comprises a hydrophilic facing surface.
  • the patterned layer or first material is of such a nature that displacing fluid can bond thereto when the second fluid or displacing fluid is a polymerizable fluid.
  • a curable or polymerizable displacing fluid may not be capable of bonding thereto and thus may not sufficiently seal an entrapped sample fluid posing contamination and evaporation risks.
  • the substrate and cover comprise first and second facing planar surfaces with a first layer on the first surface and a second layer on the second surface.
  • sample chambers are formed in the first layer and the second layer is substantially smooth.
  • the second layer also has sample chambers formed therein, preferably mirroring the sample chambers formed in the first layer.
  • the second layer may comprise a moderately hydrophobic material.
  • the interior surface(s) of the substrate and/or cover may be altered by chemical or other means to form a pattern of retaining means having altered surface energy or structure.
  • a sample chamber comprises a hole or recess formed in a first patterned layer, and a hole or recess formed in a second patterned layer, the sidewall comprises both the first and second patterned layers, a flow-through channel is disposed between the first and second patterned layers, and the communication to the flow-through channel interrupts the sidewall.
  • the first and second layers may comprise the same material.
  • the second patterned layer may have a substantially smooth surface facing the first patterned layer, and the second layer may have a substantially uniform layer thickness.
  • the sample chamber may have an open upper end in fluid communication with the flow-through channel and the sidewall may completely comprise the first patterned layer.
  • the patterned layer may be the retaining means, for example, hydrophobic or hydrophilic spots on the substrate or cover.
  • the patterned layer may comprise the retaining means and may comprise a microporous material such as an epoxy material which is highly filled with micron-sized beads.
  • the flow-through channel may have an entrance opening and an exit vent. Assemblies designed for forced pressure loading may not require an exit vent.
  • the channel may have a substantially uniform cross-sectioned area throughout. In other embodiments, the cross-sectional area of the flow through channel increases or decreases in a direction from the entrance opening to said exit vent. The changing cross-sectional area of the flow-through channel can influence the travel of the sample and/or displacing fluid through the flow-through channel due to increasing or decreasing resistance of the fluid flow.
  • fluid flow toward the exit vent is subject to decreased flow resistance compared to embodiments wherein the cross-sectional area is the same throughout the flow-through channel.
  • One method of forming a flow-through channel with an increasing or decreasing cross-sectional area is to space the cover or top plate further from the substrate or bottom plate at the entrance end of the assembly than at the exit end.
  • Another method of forming an increasing or decreasing flow-through channel cross-sectional area is to form the patterned layer thicker at one end of the device than at the opposite end of the device, and to have the thickness of the layer gradually increase or decrease in thickness.
  • the retaining means may have different sizes and shapes.
  • a hydrophilic pattern is provided to form sample retaining means and the pattern may be induced by electrets or by internal or external electrodes to provide a charged surface having higher surface energy and wettability than a flow-through channel in communication with the retaining means.
  • an analytical assembly is provided with a plurality of sample retaining means separated from one another.
  • the plurality of sample retaining means comprise sample chambers formed in a patterned layer disposed between the substrate and cover or first and second plates.
  • the sample retaining means may comprise chambers each having a sidewall, an upper end, a closed lower end, and a communication with a flow-through channel.
  • Filled assemblies are also provided according to embodiments of the invention, and may comprise a sample fluid retained by the sample retaining means, and a different, second fluid retained in the flow-through channel.
  • the second fluid is substantially immiscible with the sample fluid.
  • the sample fluid may comprise a polymerase chain reaction solution and at least one segment of DNA to be amplified.
  • the second fluid is referred to as a displacing fluid and may comprise a curable fluid, particularly curable adhesives, and preferably fluid adhesives selected from the group consisting of light-curable, heat-curable, two-part-curable, moisture-curable and cyanoacrylate adhesives.
  • UV-curable adhesives are used and cured, UV-blocking spots may be provided on the cover and/or substrate, aligned with the sample retaining means, to protect the retained sample from harmful light.
  • the sample retaining means may comprise a fibrous or porous material which absorbs a sample of fluid medium through capillary forces.
  • the fibrous or porous material may be formed on a patterned layer of a first material deposited on one of the surfaces.
  • the first material may comprise a moderately hydrophobic material.
  • a second material layer may be included on one of the facing surfaces and may comprise a moderately hydrophobic material.
  • the fibrous or porous material may be a cellulosic material, a filter paper material, absorbent textured material, absorbent sintered materials, absorbent pastes, microporous membranes, fiberglass, and the like.
  • the fibrous or porous material is a porous membrane having a maximum pore diameter size of about 1 micron.
  • the fibrous or porous material may fill the gap between the substrate and cover or may be disposed on just one of the interior substrate or cover surfaces.
  • the fibrous or porous material has a wicking rate for a sample which can be measured in millimeters per second, and sample flowing through the flow-through channel advances through the channel at an advancing rate which can be measured in millimeters per second.
  • the wicking rate exceeds the advancing rate, thus minimizing the possibility of an aqueous sample entrapping or encircling the sample retaining means before air in the retaining means can escape and be carried away by the advancing fluid.
  • sample tends to be absorbed too slowly by the retaining means and the advancing fluid in the channel tends to surround the retaining means and entrap air before the air has a chance to escape.
  • the size and shape of the porous retaining means also influences whether air will be trapped in the sample retaining means. For larger sample retaining means, there is a greater chance that air may be entrapped in the sample retaining means than for smaller sample retaining means. Therefore, it is preferable to use higher wicking rates for larger fibrous or porous sample retaining means than for smaller retaining means. For example, if the retaining means has a wicking rate of 1 mm/sec and the advancing rate is also 1 mm/sec, a substantially flat sample retaining means having a diameter of about 1 mm tends to be wicked by sample without entrapping air, whereas a retaining means having a diameter of about 2 mm may not be completely wicked with sample but instead is more likely to entrap air. Retaining means that are elongated in the direction of sample flow may be preferred for large samples.
  • sample retaining means which exhibit, an affinity to retain a sample through application of a generated force.
  • the sample retaining means may be provided with means to generate, for example, an electrostatic force.
  • Indium oxide or other conductive coating materials can be strategically placed on or in the substrate, cover or patterned material to form a region or spot which can be charged to form an electrostatic attractive force. If a curable displacing fluid is then used to displace sample from around the charged region or spot, generation of the force is no longer needed after the displacing fluid displaces sample and/or cures.
  • the generated force may be a temperature gradient or temperature altering means which provides a temperature to the sample retaining means which affects the affinity of the retaining means to a sample, and produces a different affinity for the sample at the retaining means than at surrounding regions of the assembly such as in the flow-through channel.
  • the sample retaining means is not a sample well or recess but rather a sample chamber formed between a patch of a second material and a cover or patch of a third material.
  • the second and third materials may be the same, and preferably both the second and third materials have a greater affinity for a sample of fluid medium than a first material layer which at least partially defines the flow-through channel.
  • the second and third materials preferably have a greater affinity for an aqueous PCR sample than the affinity the first material exhibits to the same PCR sample.
  • the patch or spot of the second and/or third material is disposed on the first material.
  • the substrate is a first, plate having a patterned layer formed thereon, and the cover is a second plate attached to and substantially parallel to the first plate.
  • the first and second plates have facing substantially parallel planar surfaces, and the patterned layer is located between the planar surfaces and at least partially bounds the sample retaining means.
  • the sample retaining means comprises a sample retaining patch disposed on the patterned layer and is spaced a first distance from the facing surface of the second plate.
  • the flow-through channel has a bottom surface which is spaced from the facing surface of the second plate by a second distance, and the second distance is greater than the first distance.
  • the sample retaining means comprises a plurality of sample retaining patches disposed on the patterned layer, spaced from one another, and spaced a first distance from the facing surface of the second plate.
  • the substrate comprises a flexible material, for example, a polymeric film such as polypropylene film, polyethylene film, polycarbonate film, polyethyleneterephthalate film, silicone film, teflon film, celluloid film, or other film such as a metal or ceramic film.
  • a flexible material when used, it may instead be molded or formed if not in the form of a tape.
  • the cover may also comprise a flexible material such as a polymeric film, such that the entire assembly is substantially flexible.
  • a flexible tape can be constructed and cut to size depending upon the number of sample retaining means desired to be utilized.
  • An entrance opening and an exit vent can be used to load and displace sample fluid, and to load displacing fluid.
  • the entrance opening and/or exit vent may be in the form of a gap formed between the substrate and cover at an end or gaps formed at opposite ends of a piece of tape and in communication with a flow-through channel and a supply of sample to be apportioned.
  • a combination which includes a miniaturized assembly for containing a sample of fluid medium, a means for displacing a portion of a sample of fluid medium, and a sealing means, which may be packaged together as a kit or available separately.
  • the miniaturized assembly comprises a substrate having a surface and a sample retaining means disposed on the surface.
  • the sample retaining means comprises a porous structure having a porous surface and a plurality of pores having open ends at the surface. The pores may each have substantially the same volume and closed lower ends.
  • the pores have a first affinity to a sample of fluid medium such that a sample of fluid medium disposed upon the porous surface is drawn into and retained by the plurality of pores.
  • the pores preferably have an affinity to retain a sample of aqueous medium, particularly an aqueous PCR sample.
  • the means to displace a sample of fluid medium from the porous surface without displacing the sample from within said pores may comprise a cover or coverslip, for example, a standard microscope slide coverslip.
  • the cover or coverslip has a hydrophobic surface, which may be adhesive, and which contacts the porous surface and is not wet by aqueous samples.
  • the cover or coverslip may be permanently attached to the substrate after displacing sample from the porous surface, or the cover or coverslip may be removed and replaced with a sealing device.
  • the sealing device is preferably transparent so that fluorescence emitted from sample retained by the sample retaining means can be observed and/or measured.
  • the means for displacing fluid and the means for sealing are the same device, for example, a single covering device such as a single coated microscope coverslip.
  • the porous sample retaining means may be a metal plastic, glass or ceramic sieve or screen, or other materials having a plurality of pores formed therein, such as a substantially flat plastic disk having a plurality of pores etched, ablated, molded, drilled, poked or otherwise formed therein.
  • the volume of the pores may be from about 1 microliter to about 1 picoliter or less.
  • the volume of the pores is about 100 nanoliters or less, and for some applications may be 1 nanoliter or less.
  • an analytical assembly comprising a microcapillary tube having opposite ends, an inner diameter of about 100 microns or less, and at least one amplifiable nucleic acid molecule segment entrapped inside the tube.
  • Microcapillary tubes having inner diameters of about 500 ⁇ m or less may also be used if a sample restraining means is included in the tube, for example, glass beads, gels, absorbent particles, barrier means or electrophoretic means. Tube lengths of from about 1 mm to about 100 mm are preferred.
  • Capillary action is preferably used to introduce a sample fluid in the microcapillary tube, and after the sample is disposed in the tube, the tube is sealed at both ends thereof to entrap the sample inside.
  • the sample may be divided into a plurality of portions separated by, for example, mineral oil. The entrapped sample or sample portions is/are thereby protected from contamination and from evaporation.
  • the sample of fluid medium disposed in the tube may have a volume of about 100 nanoliters or less, more preferably about 10 nanoliters or less, and for some applications, a volume of about 1 nanoliter or less.
  • a first fluid is disposed in the tube on a side of the sample and adjacent to the sample, and the first fluid is preferably substantially immiscible with the sample.
  • a second fluid may be disposed in the tube on the opposite side of the sample and adjacent to the sample, and the second fluid is also preferably substantially immiscible with the sample, such that the sample is disposed between, and restrained by, the first and second fluids.
  • the sample is an aqueous medium and the first and second fluids are both mineral oil or polymerizable fluid.
  • the sample preferably comprises about 100 nanoliters or less of a fluid medium. Multiple isolated sample segments may be introduced by ink jet or other sample dispensing means.
  • the microcapillary assemblies according to embodiments of the invention may comprise a plurality of sealed microcapillary tubes having inner diameters of 100 microns or less, with each tube containing at least one portion of a sample of fluid medium.
  • Microcapillary tubes having inner diameters of about 500 ⁇ m or less may also be used if a restraining means such as a mineral oil is used to separate minute sample portions from each other. Tube lengths of from about 1 mm to about 100 mm are preferred.
  • the tubes may each contain substantially immiscible fluids on opposite sides of the respective portion(s) of sample within each tube, such that the sample portion(s) in each tube is/are disposed between, and restrained by, the substantially immiscible fluid.
  • the substantially immiscible fluids are preferably essentially immiscible with the sample.
  • the sample comprises a polymerase chain reaction solution including primer, and at least one segment of a nucleic acid molecule to be amplified.
  • the tube or tubes used in the assembly may be self sealing or sealed at either or both ends thereof with a curable fluid, preferably a curable adhesive.
  • curable adhesives include those selected from the group consisting of light-curable, heat-curable, two-part-curable, moisture-curable and cyanoacrylate adhesives.
  • UV-curable adhesives are used and cured, UV-blocking spots may be provided on the cover and/or substrate, aligned with the sample retaining means, to protect the retained sample from harmful light.
  • a method for loading a fluid sample into an assembly for isolating and retaining a small portion of the sample.
  • Assemblies for carrying out such methods comprise a sample retaining means, for example, sample chambers, for retaining the small portion of the sample.
  • the method of loading a fluid into an assembly may comprise providing a first fluid to be retained and providing a displacing fluid.
  • An assembly is provided comprising a substrate and a cover having facing surfaces spaced from one another, wherein the facing surface of at least one of the substrate and the cover comprises a first material.
  • the assembly has a flow-through channel between the substrate and the cover, and a first fluid retaining means bounded on at least one side thereof by the first material.
  • the channel is in communication with the flow-through channel.
  • the first fluid retaining means has a first affinity to the first fluid and a second affinity to the displacing fluid
  • the flow-through channel has a third affinity to the first fluid and a fourth affinity to the displacing fluid.
  • the first, second, third and fourth affinities are such that the first fluid retaining means retains at least a portion of the first fluid loaded into the assembly while displacing fluid displaces first fluid from the flow-through channel.
  • the displacing fluid preferably can displace the first fluid from the flow-through channel without substantially displacing first fluid from the first fluid retaining means.
  • the method further comprises causing the first fluid to be loaded into the flow-through channel and be retained by the first fluid retaining means, and causing the displacing fluid to enter the flow-through channel and displace first fluid from the flow-through channel without substantially displacing first fluid from the first fluid retaining means.
  • the first affinity is greater than the second affinity.
  • the fourth affinity is greater than the third affinity.
  • the flow-through channel comprises at least one bounding surface and has dimensions, and the third and fourth affinities are provided by the dimensions of the flow-through channel and the respective affinities of the at least one bounding surface to the first fluid and to the displacing fluid.
  • a method comprising providing an assembly including a substrate and a cover in registry with and attached or affixed to one another and having facing surfaces spaced a substantially uniform distance apart from one another.
  • the facing surface of the substrate comprises a first material having a first affinity to a sample of fluid medium to be contained in the assembly.
  • a flow-through channel is disposed between the substrate and the cover, and the sample retaining means is bounded on at least one side thereof by the first material.
  • the first material may be, for example, a surface of a glass plate or slide, or a patterned layer such as a hydrophobic material, layer deposited on the facing surface of the substrate.
  • the sample retaining means is in communication with the flow-through channel and has a second affinity to the sample of fluid medium, wherein the second affinity is greater than the first affinity.
  • the different affinities enable the sample retaining means to collect a portion of a sample of fluid medium which flows through the flow-through channel and to retain the portion while a second fluid medium flows through and displaces the sample from the flow-through channel.
  • the method of loading also comprises causing the sample to flow through the flow-through channel and to be retained by the sample retaining means, and causing a displacing fluid to flow through the flow-through channel and displace the sample of fluid medium from the flow-through channel without displacing sample from the sample retaining means, wherein the sample retaining means has a greater affinity for the sample than for the displacing fluid.
  • the displacing fluid thereby covers, entraps, encircles, and/or surrounds, and isolates the sample retained by the sample retaining means on at least one side of the retained sample.
  • the displacing fluid is preferably substantially immiscible with the sample of fluid medium, and more preferably, is essentially or completely immiscible with the sample.
  • the sample comprises an aqueous medium.
  • the displacing fluid may comprise a curable fluid, preferably a curable adhesive.
  • the flow-through channel has an entrance opening for introducing sample to the channel, and an exit vent for the escape of displaced air, sample or excess displacing fluid from the channel, and the method further comprises introducing the displacing fluid to the channel through the entrance opening and causing sample in the channel to be displaced by the displacing fluid.
  • the displacing fluid may cause excess sample to exit the assembly through the exit vent, particularly in embodiments wherein the displacing fluid is forced into the assembly by other than capillary forces, for example, by pressure loading.
  • the exit vent may comprise a porous or absorbent material such as paper, or other materials that are wettable by the sample.
  • the method further comprises sealing the entrance opening and exit vent after the displacing fluid displaces sample from the channel.
  • the displacing fluid cures to seal the entrance opening and the exit vent.
  • the displacing fluid cures adjacent to the sample retaining means to seal the sample within the sample retaining means.
  • the sample retaining means retains about 1 microliter to about 1 picoliter of sample or less, preferably about 10 nanoliters of sample or less, and for some embodiments, about 1, nanoliter or less.
  • amplification targeting reagents can be loaded separately or together with respective different samples to be amplified.
  • different amplification targeting reagents are preloaded into different sample retaining means within a single assembly, for example, an assembly having two parallel but separated flow-through channels having respective sample retaining means in communication with one of the channels.
  • each sample retaining means contains a specific primer, pair of primers, and/or probe and at least one of the sample retaining means contains a primer or probe that differs from the primer or probe of a second retaining means.
  • a sample possibly containing more than one different target sequence to be amplified is then introduced and retained by the sample retaining means.
  • the existence and quantitation of two or more different target sequences can be determined, for example by using a fluorescence energy transfer assay.
  • the device is permanently sealed with a curable adhesive and a homogeneous assay is performed. The sealed assay does not require physical separation of components of the assembly to determine whether specific target sequences have been amplified.
  • FIG. 1 shows an exploded view of an analytical assembly according to an embodiment of the present invention, shown in partial cutaway.
  • the assembly comprises a substrate 20 and a cover 22 .
  • the substrate and cover comprise substantially rigid plates such as microscope slides, but may comprise more flexible materials such as microscope slide coverslips.
  • the substrate includes a bottom plate 23 having an inner surface 24 , and a patterned layer 26 of a first material disposed on the inner surface.
  • the first material may be a patterned layer comprising a hydrophobic material, and provides the substrate 20 with a facing surface 28 which faces the cover 22 .
  • Within the patterned layer 26 of the first material are formed a plurality of wells or holes therethrough defining sample chambers 30 .
  • Each sample chamber 30 has a closed lower end 32 , defined by the inner surface 24 of the bottom plate 23 .
  • Each sample chamber also has a sidewall which extends from the closed lower end 32 up to the facing surface 28 of the substrate. In some embodiments, the sample chamber extends up through the flow-through channel.
  • the cover 22 comprises a top plate 34 and a facing surface 36 which may comprise the same material as the top plate or a patterned layer 38 of a second material disposed on the inner surface of the top plate.
  • the second material may be the same as the first material, and in some embodiments is preferably moderately hydrophobic, that is, it preferably has a surface energy of from about 30 dynes/cm to about 50 dynes/cm.
  • Exemplary materials for the second material include silanes, methacrylates, epoxies, acrylates, cellulosics, urethanes, silicones, and materials having good adhesion to the displacing fluid, for example, materials having good adhesion to displacing fluids comprising curable adhesives.
  • the patterned layer 38 may be smooth and of uniform thickness or it may have a plurality of sample chambers formed therein complementary to the chambers formed in patterned layer 26 .
  • the substrate 20 and cover 22 When assembled, the substrate 20 and cover 22 are attached together, with the facing surface 36 of the cover being spaced from the facing surface 28 of the substrate.
  • the space between the facing surfaces 36 and 28 defines a flow-through channel through which sample fluid and displacing fluid may travel.
  • the facing surfaces 36 and 28 are maintained spaced apart by spacer strips 40 , which may comprise transfer adhesive strips, films or adhesive layers applied to edge regions of the substrate.
  • spacer strips 40 may comprise transfer adhesive strips, films or adhesive layers applied to edge regions of the substrate.
  • the spacer may also provide means to hold the substrate and cover together. Other means of holding the substrate and cover together may be used and include clips and clamps. According to some embodiments, hydrophobic spacer materials are preferred.
  • the spacer strips are disposed along the longitudinal edges of facing surface 28 but are not included on the lateral, edges of the facing surface 28 .
  • a gap is provided at the lateral edges of the assembled device and can be employed as an entrance opening and/or an exit vent.
  • a sample of fluid medium for example, an aqueous PCR sample
  • a sample of fluid medium can be introduced to the flow-through channel by entering a gap at a lateral edge of the assembly.
  • the sample flows through and fills the flow-through channel and the sample chambers, which are in fluid communication with the flow-through channel.
  • a displacing fluid is caused to enter the flow-through channel through a gap at a lateral edge of the assembly, and the displacing fluid flows through and fills the channel displacing sample from within the channel but without displacing sample from the sample chambers.
  • the result is a plurality of discrete, isolated portions of the sample, held by the sample chambers.
  • sample chambers having dimensions of a few microns in diameter and a few microns in depth can be provided, and result in sample chamber volumes of about 10 picoliters or less.
  • sample chambers having diameters of about 0.5 millimeter and depths of about 0.05 millimeter, sample volumes of about 10 nanoliters can be achieved.
  • the flow-through channel may have a depth of about 0.1, to about 500 microns, preferably from about 10 to about 100 microns.
  • FIG. 2 is an exploded view of an analytical assembly according to an embodiment of the present invention, shown in partial cutaway.
  • the assembly comprises a substrate 50 and a cover 52 .
  • the substrate and cover comprise substantially rigid plates such as microscope slides, but may comprise more flexible materials such as microscope slide coverslips.
  • the substrate includes a bottom plate 53 having an inner surface 54 , and a patterned layer 56 of a first material disposed on the inner surface.
  • the first material may be a patterned layer comprising a hydrophobic material, and provides the substrate 50 with a facing surface 58 which faces the cover 52 .
  • Within the patterned layer 56 of the first material are formed a plurality of wells or holes therethrough defining bottom portions 60 of sample chambers.
  • Each sample chamber bottom portion 60 has a closed lower end 62 , defined by the inner surface 54 of the bottom plate 53 .
  • Each sample chamber also has a sidewall which extends from the closed lower end 62 up to the facing surface 58 of the substrate.
  • the cover 52 comprises a top plate 64 and a facing surface 66 which comprises a patterned layer 68 of a second material.
  • the second material may be the same as the first material, and in some embodiments is preferably moderately hydrophobic, that is, it preferably has a surface energy of from about 30 dynes/cm to about 50 dynes/cm.
  • the patterned layer 68 may be smooth and of uniform thickness or, as shown in FIG. 2 , the patterned layer 68 may have a plurality of upper portions 69 of sample chambers formed therein which are complementary to the bottom portions 60 formed in patterned layer 56 .
  • the substrate 50 and cover 52 When assembled, the substrate 50 and cover 52 are attached together, with the facing surface 66 of the cover being spaced from the facing surface 58 of the substrate.
  • the space between the facing surfaces 66 and 58 defines one or more flow-through channels through which sample fluid and displacing fluid may travel.
  • Entrance openings 70 in the form of holes through the cover 52 are provided for the sample fluid and displacing fluid to enter the flow-through channel.
  • Two entrance openings 70 are provided as the assembly depicted in FIG. 2 comprises two flow-through channels.
  • An exit vent (not shown) is provided for each flow-through channel and may comprise a hole formed through the substrate or cover and in communication with the flow-through channel.
  • spacer strips 72 which may comprise transfer adhesive strips or patterned layer applied to edge regions of the substrate.
  • the spacer may also provide means to hold the substrate and cover together. Other means of holding the substrate and cover together may be used and include clips and clamps. According to some embodiments, hydrophobic spacer materials are preferred.
  • a centrally located entrance opening in the top plate can be provided and a sample fluid and/or displacing fluid can be loaded into the assembly by capillary force, centrifugal force, or other loading techniques.
  • spacer strips 72 are disposed along the entire peripheral edge of facing surface 58 .
  • a spacer strip 74 may also be included to divide the assembly into different portions. As shown in FIG. 2 , spacer strip 74 divides the assembly into first and second halves, 76 and 78 , respectively.
  • the lower and upper portions of the sample chambers complement one another to form a plurality a sample chambers, each having a closed lower end, a closed upper end, and a communication to a flow-through channel, the communication of each chamber being formed in the sidewall of the chamber.
  • a sample of fluid medium for example, an aqueous PCR sample, can be introduced to the flow-through channels through entrance openings 70 .
  • the sample flows through and fills the flow-through channels and both the lower and upper portions of the sample chambers, which are in fluid communication with the respective flow-through channels.
  • a displacing fluid is caused to enter the flow-through channels through the entrance openings 70 , and the displacing fluid flows through and fills the channels displacing sample from within the channels but without displacing sample from the sample chambers.
  • the result is a plurality of discrete, isolated portions of the sample, held by the sample chambers.
  • two different sample fluids are used, one in each half ( 76 , 78 ) of the assembly.
  • FIG. 3 is a cross-sectional view through a longitudinal central portion of an analytical assembly according to another embodiment of the present invention.
  • the assembly of FIG. 3 comprises a substrate 90 and a cover 92 .
  • the substrate and cover comprise substantially rigid plates such as microscope slides, but may comprise more flexible materials such as films or microscope slide coverslips.
  • the substrate includes a bottom plate 93 having an inner surface 94 , and a patterned layer 96 of a first material disposed on the inner surface.
  • the first material may be a patterned layer comprising a hydrophobic material, and provides the substrate 90 with a facing surface 98 which faces the cover 92 .
  • Each sample chamber bottom portion 100 has a closed lower end 102 , defined by the inner surface 94 of the bottom plate 93 .
  • Each sample chamber also has a sidewall which extends from the closed lower end 102 up to the facing surface 98 of the substrate.
  • the cover 92 comprises a top plate 104 and a facing surface 106 which comprises a patterned layer 108 of a second material.
  • the second material may be the same as the first material, and in some embodiments is preferably moderately hydrophobic, that is, it preferably has a surface energy of from about 20 dynes/cm to about 30 dynes/cm.
  • the patterned layer 108 may be smooth and of uniform thickness or, as shown in FIG. 3 , the patterned layer 108 may have a plurality of upper portions 109 of sample chambers formed therein which are complementary to the bottom portions 100 formed in patterned layer 96 .
  • the substrate 90 and cover 92 are attached together, with the facing surface 106 of the cover being spaced from the facing surface 98 of the substrate.
  • the space between the facing surfaces 106 and 98 defines one or more flow-through channels 110 through which sample fluid and displacing fluid may travel.
  • An entrance opening 112 in communication with the flow-through channel 110 in the form of a gap formed at a lateral end of the assembly, is provided for the sample fluid and displacing fluid to enter the flow-through channel 110 .
  • An exit vent 114 is provided for sample to exit the channel 110 as the sample is displaced from the channel by the displacing fluid.
  • the entrance opening and exit vent may instead be in the form of holes formed through the substrate and/or cover.
  • spacer strips 116 may comprise transfer adhesive strips or a patterned layer applied to edge regions of the substrate.
  • spacer strips 116 may also provide means to hold the substrate and cover together. Other means of holding the substrate and cover together may be used and include clips and clamps.
  • the spacer strips are disposed along the longitudinal edges between the facing surfaces but are not included on the lateral edges of the of facing surfaces. Thus, gaps used as the entrance opening and exit vent are provided at the lateral edges of the device.
  • the lower portions 100 and upper portions 109 of the sample chambers complement one another to form a plurality a sample chambers 118 , each having a closed lower end, a closed upper end, and a communication to a flow-through channel, the communication of each chamber being formed in the sidewall of the chamber.
  • a sample of fluid medium for example, an aqueous PCR sample, can be introduced to the flow-through channel 110 through entrance openings 112 . The sample flows through and fills the flow-through channel and both the lower and upper portions of the sample chambers.
  • a displacing fluid is caused to enter the flow-through channel through the entrance openings, and the displacing fluid flows through and fills the channel displacing sample from within the channel but not displacing sample from the sample chambers.
  • the result is a plurality of discrete, isolated portions of the sample, held or retained by the sample chambers.
  • the sample fluid retained in the sample chambers may form a cylinder extending from the closed lower, through and interrupting the flow-through channel, and up to the closed upper end.
  • FIG. 4 is a perspective view of a bottom portion of an analytical assembly according to an embodiment of the present invention, with the cover removed.
  • the bottom portion of the assembly comprises a substrate 120 , depicted in the figure as a coated substantially rigid plate such as microscope slide.
  • the substrate includes a bottom plate 122 having an inner surface 124 , and a patterned layer 126 of a first material disposed on the inner surface.
  • the patterned layer has a substantially uniform thickness.
  • the first material may comprise a hydrophobic material, and provides the substrate 120 with a facing surface 128 which faces a cover (not shown), for example, the cover used in the embodiment of FIG. 1 .
  • a plurality of patches 130 of sample retaining material preferably capable of retaining a fluid sample volume of from about 1 microliter to about 1 picoliter or less.
  • Adhesive strips, a patterned layer of pressure sensitive adhesive, or a patterned layer of a curable adhesive, 132 may be used to attach a cover to the bottom portion.
  • the patch occupies a volume of about 100 nanoliters or less.
  • the patch may be an absorbent material which absorbs and retains sample, or the patch may be made of material which has an affinity sufficient enough to retain, for example, an aqueous PCR sample.
  • the patches of material comprise a hydrophilic material.
  • the sample retaining patches comprise a substantially non-absorbent material which has a retaining affinity for a sample
  • the patch defines a closed lower end of a sample chamber defined between the exposed surface of the patch and the facing surface of a cover.
  • a patch of porous material may fill a volume between the substrate and the cover and the sample chamber is defined by the void volume of the porous patch.
  • FIG. 5 is a cross-sectional view through a longitudinal central portion of an analytical assembly according an embodiment of the present invention wherein sample chambers comprise absorbent material patches or comprise the volume between complementary opposing patches of sample retaining materials.
  • the assembly of FIG. 5 comprises a substrate 134 and a cover 136 attached to one another.
  • the substrate and cover comprise substantially rigid plates such as microscope slides.
  • the substrate includes a bottom plate 138 having an inner surface 140 , and a patterned layer 142 of a first material disposed on the inner surface.
  • the first material may be a hydrophobic material, and provides the substrate 134 with a facing surface 144 which faces the cover 136 .
  • On the patterned layer 142 are formed a plurality of sample retaining patches 146 which define sample chambers by absorbency or surface energy or other retentive property.
  • the cover 136 comprises a top plate 148 and a patterned layer 150 of a second material defining a facing surface 152 .
  • the second material may be the same as the first material, and in some embodiments is preferably a hydrophilic material if aqueous samples are to be retained and isolated.
  • the patterned layer 150 may be smooth and of uniform thickness or, as shown in FIG. 5 , the patterned layer 150 may have a plurality of sample retaining patches 154 complementary to and mirroring patches 146 .
  • the substrate 134 and cover 136 are attached together, with the facing surface 152 of the cover being spaced from the facing surface 144 of the substrate.
  • the space between the facing surfaces 152 and 144 defines one or more flow-through channels 156 through which sample fluid and displacing fluid may travel.
  • An entrance opening 158 comprising a hole formed through the cover and in communication with the flow-through channel 156 .
  • An exit vent 160 comprising a hole through the substrate 134 is provided for sample to exit the channel 156 as the sample is displaced from the channel by the displacing fluid.
  • spacer strips 162 may comprise transfer adhesive strips applied to edge regions of the substrate.
  • the spacer may also provide means to hold the substrate and cover together. Other means of holding the substrate and cover together may be used and include clips and clamps.
  • the patches comprise an absorbent sample retaining material.
  • the patches retain sample by surface energy, and have an affinity for a sample, for example, a hydrophilic material patch which retains an aqueous sample on a surface 164 thereof.
  • the affinity may be induced by optical or electromagnetic means.
  • the sample chamber may comprise the volume 166 between the facing surfaces of each complementary pair of patches, wherein the sample chambers have no sidewalls but are defined as the volume between the two complementary patch surfaces.
  • the affinity of the two opposing patch surfaces to a retained sample is sufficient to support a column of sample between the two patches while a displacing flows through the channel adjacent the column.
  • patches of porous material extending from the substrate to the cover may interrupt the flow-through channel and the sample chamber may be defined as the void volume of a porous patch.
  • Sample flows through and fills the flow-through channel and the sample chambers, which are in fluid communication with the flow-through channel.
  • a displacing fluid can subsequently be caused to enter the flow-through channel through the entrance opening, displacing sample from within the channel but not displacing sample from the sample chambers.
  • the result is a plurality of discrete, isolated portions of the sample, held or retained or absorbed by the sample chambers.
  • FIG. 6A is a perspective view of another embodiment of the present invention, and FIG. 6B shows an enlargement of portion VIB from FIG. 6A .
  • a bottom support plate 174 supports a sample retaining means 167 comprising a plurality of pores or cavities 168 having open ends in communication with an exposed surface 170 on which a sample of fluid is applied.
  • the pores have a first affinity to a sample of fluid medium such that when the sample is disposed upon the exposed porous surface 170 the sample is drawn into and retained by the plurality of pores 168 . For example, through capillary or other force, the sample may wet and fill the pores 168 .
  • the pores 168 have substantially the same volume as one another and each has a closed lower end 169 .
  • the pores 168 each have a volume of about 1 ⁇ l or less, more preferably, about 10 nl or less, and for some applications about 1 nl or less.
  • the closed lower ends 169 of the pores are defined or bound by a layer of coating material 172 deposited on a bottom plate 174 .
  • the coating material may be a hydrophilic material if aqueous samples are to be retained in the pores.
  • a cover 171 is provided on one of the sample retaining means shown in FIG. 6A .
  • the cover 171 can be used to displace sample fluid from the porous surface 170 of the retaining means and for sealing sample within the pores 168 .
  • the cover 171 displaces sample fluid from the porous surface without displacing sample from within the pores.
  • the cover 171 comprises a hydrophobic coating 173 on the surface of the cover which contacts the exposed surface 170 of the sample retaining means.
  • the coating 173 contacts sample and can be used to squeeze excess sample off of the surface 170 .
  • a means for sealing the sample of fluid within the pores is also provided, and in the embodiment shown in FIG.
  • the means for displacing excess sample and the means for sealing sample in the pores are the same means, that is, the cover 171 .
  • the coating 173 is adhesive as well as hydrophobic, although an adhesive and/or hydrophobic coating may instead or additionally be provided in the exposed surface 170 of the sample retaining means. Sealing the sample in the pores prevents evaporation and contamination of the sealed sample.
  • the displacing means and the sealing means may be pressed against the exposed surface 170 by any of a variety of means. Clamps, clips or springs may be used to attach the sealing means to the exposed surface 170 , and/or to force the displacing means against the exposed surface.
  • displacing means for a device similar to, or the same as, that shown in FIGS. 6A and 6B .
  • a drop or bead of curable fluid for example, a curable adhesive
  • a sample retaining means having one or more sample retaining cavity, recess, hole or pore formed in the surface.
  • Gravity, pressurized gas, or mechanical means, for example can be used to force the curable fluid across the exposed surface, displacing excess sample from the surface without displacing sample from within the sample retaining cavity.
  • the curable fluid traverses the exposed surface a thin layer of the fluid is deposited on the surface and coats the top of a sample portion retained in the cavity.
  • the curable fluid forms a seal for the sample retained within the cavity such that the sample retained is isolated from other cavities and from excess sample.
  • the sealed sample is protected from contamination and evaporation.
  • the curable fluid seal is sufficient to prevent contamination and evaporation of the entrapped sample during thermal cycling conditions generally used in PCR amplification methods.
  • separate displacing means and sealing means are provided for isolating a sample portion within a sample retaining cavity.
  • a displacing means is provided for removing excess sample from an exposed surface of a device having a sample retaining cavity associated therewith.
  • the sample retaining cavity may be formed on, formed in, in contact with or adjacent to a substrate.
  • the cavity may be defined by at least one sidewall, and the sidewall may comprise a hydrophilic material.
  • the displacing means may comprise a wiping device such as a squeegy, a wiper, a blade or other scraping or rubbing device which can physically move excess sample away from the open upper end of a sample retaining cavity and preferably off of the exposed surface of the sample retaining means.
  • Preferred displacing means may comprise a wiping device made of an elastomeric material, for example, a stiff silicone rubber blade.
  • the wiping device comprises a hydrophobic material, to which aqueous sample fluids will not cling.
  • the displacing means comprises an opening or channel through which a sample retaining means snugly fits, and a wiping device is provided adjacent to the opening or channel such that the wiping device wipes excess sample from an exposed surface of the sample retaining means as the retaining means is forced through the opening or channel.
  • sealing means are applied to the sample retaining cavity immediately after the displacing means displaces excess sample from adjacent the sample retaining cavity.
  • a wiping device is used to displace excess sample fluid from an exposed surface of a sample retaining means, and the wiping device is provided with a trailing edge that pulls a bead or drop of a curable sealing fluid across the exposed surface as a leading edge of the wiping device displaces excess sample.
  • PCR was performed in 0.2 ml polypropylene ependorf tubes to set standards. Microcapillary PCR was then performed according to the present invention on the same sample material in quartz glass microcapillaries.
  • the PCR sample containing the nucleic acid sequence to be amplified was prepared and included materials from a “TaqMan” kit available from Perkin-Elmer, Applied Biosystems Division, Foster City, Calif.
  • the kit contained human DNA at 10 ng/ ⁇ l, the forward primer 5′-TCACCCACACTGTGCCCATCTACGA-3′ (SEQUENCE ID NO:1) and the reverse primer 5′-CAGCGGAACCGCTCATTGCCAATGG-3′ (SEQUENCE ID NO:2) that amplify a 295 bp segment of the human ⁇ actin gene, and a dual fluor-labeled probe comprising 5′-[6FAM]-ATGCCC-[TAMRA]-CCCCCATGCCATCCTGCGT-3′ (SEQUENCE ID NO:3) that is complementary to bases 31 , to 56 of the PCR product.
  • FAM 6-carboxyfluorescein
  • TAMRA 6-carboxytetramethyl-rhodamine
  • the PCR sample comprised Taq polymerase available from Boehringer Mannheim, Indianapolis, Ind., and anti-Taq antibody from Clonetech, Palo Alto, Calif.
  • the sample also comprised concentrations of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, about 0.01% by weight gelatin, 500 ⁇ g/ml to 5 mg/ml bovine serum albumin (BSA), 3.5 mM MgCl 2 , 0.2 mM each of dATP, dCTP, dGTP and dUTP, 0.3 ⁇ M forward and reverse primers, 0.2 mM dual-fluor-labeled probe, 0.5 manufacturer's units (u) Taq polymerase per 1.0 ⁇ l PCR mixture, 0.1 ⁇ l anti-Taq antibody per 10 ⁇ l PCR mixture, and varying amounts of template DNA.
  • Tag polymerase The specific activity of Tag polymerase was about 250,000 units per mg which, at a molecular weight of 100,000 Daltons, translates to about 10 9 molecules per ⁇ l. Since ⁇ actin is a single copy gene, it was estimated that there is one copy of ⁇ actin template per 3 pg of human genomic DNA. In some PCRs the dual-fluor-labeled probe was replaced with the fluorescent, DNA-staining dye SYBRTM Green I (product # S-7567) available from Molecular Probes, Eugene, Oreg., used a 10 ⁇ 4 dilution from the stock supplied by the manufacturer.
  • SYBRTM Green I product # S-7567
  • the conventional PCRs (CONTROL 1) performed in the 0.2 ml polypropylene tubes were thermocycled in a model 9600 thermocycler from Perkin Elmer using 92° C. for 15 seconds, 54° C. for 15 seconds, and 72° C. for 15 seconds, for 40 cycles.
  • Microcapillary PCR was performed according to the present invention in quartz glass microcapillaries from Polymicro Technologies (Phoenix, Ariz.). These capillaries had inner diameters ranging from 20 ⁇ m to 75 ⁇ m and outer diameters of 250 ⁇ m to 375 ⁇ l.
  • the capillaries come with either a polyimide or Teflon external coating to make them flexible. Because the polyimide coating is opaque and fluorescent, it had to be removed before use. The coating was removed by flaming a segment of polyimide capillary with a Bunson burner for several seconds and then gently wiping off the burned coating. Flaming and wiping was repeated as necessary until the capillary was clear. The resulting bare capillaries were very fragile.
  • the Teflon coated microcapillaries were easier to work with since the optically clear and non-fluorescent Teflon coating did not need to be removed. Both types of capillaries gave equivalent results in PCR.
  • microcapillary tubes EXAMPLE 1
  • EXAMPLE 1 Hundreds of microcapillary tubes (EXAMPLE 1) were filled by touching an open end to a drop of the PCR sample which wicked in by capillary action.
  • the microcapillaries were then sealed and supported by gluing the two ends thereof to two respective coverslips, leaving an unsupported segment in the middle, thus minimizing thermal mass.
  • a UV-curable fluid glue was used to seal the end of the tube and to glue the tube ends to coverslips.
  • Assemblies comprising a plurality of microcapillaries were formed by sealing the ends of each tube in the assembly to the same pair of coverslips.
  • the glue was available as optical adhesive #81 from Norland Products, New Brunswick, N.J.
  • the glue was cured by exposure to 366 nm UV light.
  • a source of 366 nm wavelength light is UV lamp model UVL-21, available from UVP Inc., San Gabriel, Calif. The lamp was held about 1 cm from the sample for 30 seconds.
  • the PCR mixture was shielded from UV light by laying a small piece of opaque paper over the center section of the capillary during UV exposure.
  • FIG. 7 is a top plan view of an exemplary microcapillary device used in accordance with Example 1 of the present invention.
  • an assembly 176 is provided having four microcapillary tubes 178 having inner diameters of about 100 microns each, and two support tubes 180 having outer diameters of about 1.5 mm.
  • the ends of the tubes 178 and 180 were adhered to two respective plates or bases 182 with UV-curable adhesive 184 .
  • One end of each tube microcapillary and support tube shared a respective plate 182 .
  • the plates comprised standard 1′′ ⁇ 1′′ microscope cover slips and the tubes were each about 4 cm long. All the tubes were arranged substantially parallel to one another with the microcapillary tubes 178 each being positioned between the two larger diameter support tubes.
  • the sample holding assembly 176 was attached with SCOTCH tape to the sample holder of a Rapidcycler air oven available from Idaho Technologies, Idaho Falls, Id., and cycled through a protocol comprising cycles of 92° C. for 5 seconds, 54° C. for 5 seconds, and 72° C. for 15 seconds, for 40 cycles.
  • the cycling protocol took about 30 minutes in the Rapidcycler.
  • fluorescence of the samples was measured with a Zeiss Axiovert 410 laser scanning microscope using a 20 ⁇ 0.5NA objective, 15 mW external argon laser approximately 5% of the power of which was focused to a spot size of 1 ⁇ m 2 , and band pass filters of 515-565 nm for fluorescein and SYBRTM Green, and >590 nm for rhodamine (power loss and spot size estimates provided from the manufacturer). Average pixel intensity was measured in regions of about 20 ⁇ m ⁇ 50 ⁇ m overlying the capillary image. Fluorescence intensity was examined visually along the 2.5 cm lengths of capillaries by manually translating the stage; quantitative measurements were made every 2-5 mm or more often if variability in the fluorescence signal was observed.
  • PCRs were performed in 20 ⁇ l volumes in ependorf tubes in a model 9600 Thermocycler (Perkin Elmer, Norwalk, Conn.), the ⁇ actin primers amplified an approximately 300 bp segment from human DNA as expected.
  • PCRs performed in the presence of the TaqMan probe were transferred to capillary tubes and analyzed by fluorescence microscopy. Typical values for average pixel intensity were about 130 (relative fluorescence units) for fluorescein and about 60 for rhodamine, with values of background emission from empty capillaries of about 20 at both wavelengths.
  • F/R fluorescein:rhodamine intensity ratio varied from about 1.0:1.0 to about 2.0:1.0 in samples containing PCR product.
  • the rhodamine emission was about the same (about 60), while the fluorescein emission was reduced to about 30, giving a F/R intensity ratio of about 0.5.
  • the absolute values of fluorescein and rhodamine emission varied between experiments and with small changes in machine settings (laser power, attenuation, brightness, contrast) whereas the F/R intensity ratio was fairly constant. Therefore, the F/R intensity ratio was used as a measure of whether the ⁇ actin product had been amplified.
  • the yield of PCR product in conventional reactions in polypropylene tubes was estimated by ethidium bromide staining of product in agarose gels, and by adding a known amount of 32 P-dCTP to a PCR and counting radioactivity in the purified PCR product. Both methods gave an estimate of about 10 11 product molecules/ ⁇ l of PCR. This corresponds to a product concentration of about 0.16 ⁇ M which implies that about half of the PCR primers were converted to product.
  • the F/R intensity ratio was therefore used as a surrogate measure of amplification. This ratio was about 0.5 in negative control reactions (no template, no enzyme, or no reverse primer) and was usually greater than 1 in samples where product was expected. In capillaries containing terminal dilutions of genomic DNA template, the ratio sometimes varied with position along the capillary, which was attributed to localized accumulation of degraded probe, discussed in more detail below. In cases where the intensity ratio varied, the maximum value of the F/R intensity ratio in the capillary was used as the measure of whether the target sequence had been amplified.
  • FIG. 8 A histogram of the maximum values of the F/R intensity ratio in over 100 capillary reactions of terminally diluted genomic DNA is shown in FIG. 8 , along with the corresponding values for negative control reactions.
  • the negative controls had a mean ratio of 0.5 with a range of 0.4 to 0.9.
  • the experimental samples had a bimodal distribution with one arm of the distribution paralleling that of the negative control samples. This suggests that the experimental samples consisted of positive and negative samples. Since the nadir of the experimental sample distribution occurred at about an F/R intensity ratio of 1, we chose this value as a “cut-off” to distinguish positive from negative samples. This “cut-off” is consistent with the F/R values of 1 to 2 in PCRs carried out in conventional volumes in ependorf tubes.
  • the sensitivity of the detection system was estimated by mixing exonuclease-digested probe with undegraded probe.
  • An F/R ratio of ⁇ 1 was obtained when ⁇ 0.02 ⁇ M degraded probe was mixed with 0.2 ⁇ M undegraded probe. This corresponds to about 10 molecules of degraded probe in a 10 nl volume.
  • the confocal feature of the microscope it was determined that the signal decreased rapidly when the depth of field dropped below 20 ⁇ m.
  • an estimate of the lower limit of detection for this system is about 10 5 molecules of degraded probe in a volume of 20 ⁇ m ⁇ 20 ⁇ m ⁇ 20 ⁇ m, that is, about 10 picoliters (pl).
  • BSA bovine serum albumin
  • Capillaries containing more than one haploid genome equivalent generally had F/R intensity ratios greater than 1.
  • the fluorescent dye SYBRTM Green I was substituted for the TaqMan probe. Because the fluorescence of SYBRTM Green I increases many fold in the presence of double stranded DNA, it can be used to detect double stranded PCR product, although it does not distinguish spurious product such as “primer dimer” from desired product.
  • the SYBRTM Green I fluorescence assay has to be performed at elevated temperature to reduce background fluorescence from non-specific annealing of primers.
  • segments of capillaries were placed, after PCR, in about 1 ml of mineral oil in a special 35 mm petri dish, the bottom of which was made of optically clear, conducting glass coated with a thin layer of indium tin oxide available from Bioptechs, of Butler, Pa.
  • the temperature in the oil was raised to about 70° C. Because only a portion of the bottom of the petri dish was flat and accessible in the microscope, the capillaries had to be cut after PCR into approximately 1 cm segments in order to be imaged.
  • PCR product derived from single template molecules could be detected.
  • the fluorescence intensity was 155-194 in 7 capillary segments derived from a PCR containing 30 haploid genome equivalents per cm of capillary length, compared to a fluorescence intensity of 40-57 in 7 capillary segments containing no template DNA.
  • the variability in fluorescence at 2-3 mm intervals along these capillaries was about 20%.
  • a device substantially similar to that depicted in FIG. 3 having a substrate and a cover comprising microscope slide coverslips, and provided with first and second patterned layers comprising cured Norland 68 UV-curable adhesive coated respectively thereon by screen printing, was filled by capillary action with a Beta-actin polymerase chain reaction solution.
  • the substrate and coverslip were spaced apart and held together with adhesive strips and the first and second patterned layers had complementary sample chamber portions formed therein having radii of about 1 mm.
  • a displacing fluid comprising uncured Norland 81 UV-curable adhesive was then loaded into the flow-through channel by capillary action and displaced the polymerase chain reaction solution from the flow-through channel but not from the sample chambers.
  • the device was then exposed to UV light to cure the displacing fluid, and the sample portions were shielded from the light with a transparency laid on top of the device and having inked spots aligned with the sample chambers.
  • the device was then thermocycled and analyzed by fluorescence microscopy as described in connection with Example 1.
  • Six of six sample chambers estimated to contain an average of 3 copies of genomic DNA template had F/R intensity ratios greater than 1 and four of six sample chambers estimated to contain an average of 0.3 template copies had F/R intensity ratios of greater than 1.
  • the results presented above provide strong evidence that the TaqMan assay can easily detect as little as 1 template molecule when the volume of the reaction is on the order of 10 nl.
  • the reaction volume is about 20 nl per 1 cm length of capillary.
  • good correlation has been found according to the invention between the number of capillaries giving positive reactions and the number of capillaries calculated to contain 1 or more template molecules.
  • the inference of single molecule sensitivity is further supported by the observation of peaks of elevated F/R emission along the length or capillaries estimated to contain 1 or 2 template molecules. Presumably these peaks results from localized accumulation of PCR product and corresponding degraded probe.
  • the viscosity of water decreases about 3-fold as temperature increases from 25° C. (298° K.) to 92° C. (365° K.); thus, D would increase about 3.25-fold over this temperature range.
  • the root mean square distance traveled by a molecule with diffusion constant D in time t is (2Dt) 1/2 or about 2-5 mm in 2 hours for molecules the size of completely degraded probe at temperatures between 25° C. and 92° C.
  • the PCR product based on its molecular weight, should have a diffusion constant of about 0.45 ⁇ 10 ⁇ 6 cm 2 /sec and should diffuse about 3 times less far than degraded probe in the same time.
  • the width of peaks might be slightly larger than predicted by diffusion, due to the tendency of PCR to saturate in regions where the concentration of PCR product is high. So long as all of the amplified molecules are replicated each cycle, the progeny from a single starting template will have the same average displacement (i.e., root mean square displacement) as a collection of independent molecules, that is, they will appear to diffuse with a root mean square displacement that is proportional to the square root of the time. However, as PCR begins to saturate, molecules near the center of the distribution where concentration is high have a lower probability of being replicated than molecules near the “edge” of the distribution where concentration is low. This unequal probability of replication tends to make the distribution broader.
  • a 5 mm segment (characteristic diffusion distance for degraded probe) in a 0.8 mm inner diameter capillary contains about 2.5 ⁇ l. After spreading in 1/50th of this volume (about 50 nl), the fluorescent signal obtained from single starting molecules in 50 ⁇ m inner diameter capillaries was sometimes not above the background (see Table 2, average F/R intensity at 24 and 48 hours and number of capillaries in which maximum F/R>1). Thus, PCR would have to be significantly more efficient than achieved to detect single molecules in volumes greater than 1 ⁇ l.
  • the data also shows that single DNA molecules or segments can be detected with the “TaqMan” system when PCRs are confined to volumes of 100 nanoliters or less, preferably 60 nanoliters or less, by using capillaries with small diameters and relying on the fortuitously slow rate of diffusion.
  • Many PCR reactions with single molecule sensitivity can be performed simultaneously in small spaces by confining PCR's to small regions in 3 dimensions as described in other embodiments of the present invention.
  • the devices of the invention can be used to measure the number of template molecules in a sample simply by counting the number of positive reactions in replicate PCRs containing terminal dilutions of sample.
  • devices according to the present invention and methods for using the devices have significant potential for clinical uses of PCR.
  • An assay based on presence versus absence of PCR product in replicate reactions may be more robust with respect to small changes in amplification efficiency than quantitative competitive assays or time-to-reach-threshold level assays that require assumptions about relative or absolute amplification rates.

Abstract

A method comprises loading a sample portion into a first porous structure, subjecting the sample portion to an amplification step, and determining whether the sample portion contains at least one molecule of a target nucleic acid. If the sample portion contains a single molecule of the target nucleic acid, the sample portion would attain a detectable concentration of the target nucleic acid after a single round of amplification. Also, a microfluidic device comprising a porous sample structure and a sample portion positioned in the porous sample structure. Also, a microfluidic device comprising a porous sample structure and an amplification targeting reagent positioned in the porous sample structure.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation application of U.S. patent application Ser. No. 10/798,857 (the entirety of which is incorporated herein by reference), filed on Mar. 11, 2004, which is a divisional application of U.S. patent application Ser. No. 10/131,854, filed on Apr. 25, 2002, which is a divisional application of U.S. patent application Ser. No. 09/563,714, filed on May 2, 2000 (now U.S. Pat. No. 6,391,559), which is a divisional application of U.S. patent application Ser. No. 08/838,262, filed Apr. 17, 1997 (now U.S. Pat. No. 6,143,496).
  • This application is also a continuation application of U.S. patent application Ser. No. 10/131,854 (the entirety of which is incorporated herein by reference), filed on Apr. 25, 2002, which is a divisional application of U.S. patent application Ser. No. 09/563,714, filed on May 2, 2000 (now U.S. Pat. No. 6,391,559), which is a divisional application of U.S. patent application Ser. No. 08/838,262, filed Apr. 17, 1997 (now U.S. Pat. No. 6,143,496).
  • FIELD OF THE INVENTION
  • The present invention relates to the in vitro amplification of a segment of nucleic acid, methods to analyze concentrations of specific nucleic acids in sample fluids, and methods for detecting amplification of a target nucleic acid sequence. The present invention also relates to miniaturized analytical assemblies and methods of filling miniaturized analytical assemblies.
  • BACKGROUND OF THE INVENTION
  • Nucleic acid amplification techniques such as polymerase chain reaction (PCR), ligase chain reaction (LCR), strand displacement amplification (SDA), and self-sustained sequence replication (3 SR) have had a major impact on molecular biology research. In particular, PCR, although a relatively new technology, has found extensive application in various fields including the diagnosis of genetic disorders, the detection of nucleic acid sequences of pathogenic organisms in clinical samples, the genetic identification of forensic samples, and the analysis of mutations in activated oncogenes. In addition, PCR amplification is being used to carry out a variety of tasks in molecular cloning and analysis of DNA. These tasks include the generation of specific sequences of DNA for cloning or use as probes, the detection of segments of DNA for genetic mapping, the detection and analysis of expressed sequences by amplification of particular segments of cDNA, the generation of libraries of cDNA from small amounts of mRNA, the generation of large amounts of DNA for sequencing, the analysis of mutations, and for chromosome crawling. During the next few years, PCR, other amplification methods, and related technologies are likely to find increasing application in many other aspects of molecular biology.
  • Unfortunately, problems exist in the application of PCR to clinical diagnostics. Development has been slow due in part to: labor intensive methods for detecting PCR product; susceptibility of PCR to carryover contamination—false positives due to contamination of a sample with molecules amplified in a previous PCR; and difficulty using PCR to quantitate the number of target nucleic acid molecules in a sample. A need exists for a simple method of quantitative analysis of target nucleic acid molecules in a sample.
  • Recently, significant progress has been made in overcoming some of the problems of clinical diagnostic nucleic acid amplification through the development of automatable assays for amplified product that do not require that the reaction vessel be opened, thereby minimizing the risk of carryover contamination. Most of these assays rely on changes in fluorescent light emission consequent to hybridization of a fluorescent probe or probes to amplified nucleic acid. One such assay involves the hybridization of two probes to adjacent positions on the target nucleic acid. The probes are labeled with different fluors with the property that energy transfer from one fluor stimulates emissions from the other when they are brought together by hybridization to adjacent sites on the target molecule.
  • Another assay, which is commercially available, is the “TaqMan” fluorescence energy transfer assay and kit, available from Perkin Elmer, Applied Biosystems Division, Foster City, Calif. This type of assay is disclosed in the publication of Holland et al., Detection of specific polymerase chain reaction product by utilizing the 5′→3′ exonuclease activity of Thermus aquaticus DNA polymerase, Proc. Natl. Acad. Sci. USA, Vol. 88, pp. 7276-7280, August 1991, and in the publication of Livak et al., Oligonucleotides with Fluorescent Dyes at opposite Ends Provide a Quenched Probe System Useful for Detecting PCR Product and Nucleic Acid Hybridization, PCR Methods and Applic., 4, pp. 357-362 (1995). The “TaqMan” or 5′ exonuclease assay uses a single nucleic acid probe complementary to the amplified DNA and labeled with two fluors, one of which quenches the other. If PCR product is made, the probe becomes susceptible to degradation via an exonuclease activity of Taq polymerase that is specific for DNA hybridized to template (“TaqMan” activity). Nucleolytic degradation allows the two fluors to separate in solution which reduces quenching and increases the intensity of emitted light of a certain wavelength. Because these assays involve fluorescence measurements that can be performed without opening the amplification vessel, the risk of carryover contamination is greatly reduced. Furthermore, the assays are not labor intensive and are easily automated.
  • The TaqMan and related assays have provided new ways of quantitating target nucleic acids. Early methods for quantitation relied on setting up amplification reactions with known numbers of target nucleic acid molecules and comparing the amount of product generated from these control reactions to that generated from an unknown sample, as reviewed in the publication by Sninsky et al. The application of quantitative polymerase chain reaction to therapeutic monitoring, AIDS 7 (SUPPL. 2), PP. S29-S33 (1993). Later versions of this method used an “internal control”, i.e., a target nucleic acid added to the amplification reaction that should amplify at the same rate as the unknown but which could be distinguished from it by virtue of a small sequence difference, for example, a small insertion or deletion or a change that led to the gain or loss of a restriction site or reactivity with a special hybridization probe, as disclosed in the publication by Becker-Andre, et al., Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY), Nucleic Acids Res., Vol. 17, No. 22, pp. 9437-9446 (1989), and in the publication of Gilliland et al., Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction, Proc. Natl. Acad. Sci. USA, Vol. 87, pp. 2725-2729 (1990). These methods have the disadvantage that slight differences in amplification efficiency between the control and experimental nucleic acids can lead to large differences in the amounts of their products after the million-fold amplification characteristic of PCR and related technologies, and it is difficult to determine relative amplification rates accurately.
  • Newer quantitative PCR methods use the number of cycles needed to reach a threshold amount of PCR product as a measure of the initial concentration of target nucleic acid, with DNA dyes such as ethidium bromide or SYBR™ Green I, or “TaqMan” or related fluorescence assays used to follow the amount of PCR product accumulated in real time. Measurements using ethidium bromide are disclosed in the publication of Higuchi et al., Simultaneous Amplification and Detection of Specific DNA Sequences, BIO/TECHNOLOGY, Vol. 10, pp. 413-417 (1992). “TagMan” assays used to follow the amount of PCR product accumulated in real time are disclosed in the publication of Heid et al., Real Time Quantitative PCR, Genome Research, Vol. 6, pp. 986-994 (1996), and in the publication of Gibson et al., A Novel Method for Real Time Quantitative RT-PCR, Genome Research, Vol. 6, pp. 995-1001 (1996). However, these assays also require assumptions about relative amplification efficiency in different samples during the exponential phase of PCR.
  • An alternative method of quantitation is to determine the smallest amount of sample that yields PCR product, relying on the fact that PCR can detect a single template molecule. Knowing the average volume of sample or sample dilution that contains a single target molecule, one can calculate the concentration of such molecules in the starting sample. However, to accumulate detectable amounts of product from a single starting template molecule usually requires that two or more sequential PCRs have to be performed, often using nested sets of primers, and this accentuates problems with carryover contamination.
  • Careful consideration of the factors affecting sensitivity to detect single starting molecules suggests that decreasing the volume of the amplification reaction might improve sensitivity. For example, the “TaqMan” assay requires near saturating amounts of PCR product to detect enhanced fluorescence. PCRs normally saturate at about 1011 product molecules/microliter (molecules/μl) due in part to rapid reannealing of product strands. To reach this concentration of product after 30 cycles in a 10 μl PCR requires at least 103 starting template molecules (103×230/10 μl≈1011/μl). Somewhat less than this number of starting molecules can be detected by increasing the number of cycles, and in special circumstances even single starting molecules may be detectable as described in the publication of Gerard et al., A Rapid and Quantitative Assay to Estimate Gene Transfer into Retrovirally Transduced Hematopoietic Stem/Progenitor Cells Using a 96-Well Format PCR and Fluorescent Detection System Universal for MMLV-Based Proviruses, Human Gene Therapy, Vol. 7, pp. 343-354 (1996). However, this strategy usually fails before getting to the limit of detecting single starting molecules due to the appearance of artifactual amplicons derived from the primers (so called “primer-dimers”) which interfere with amplification of the desired product.
  • If the volume of the PCR were reduced 1000-fold to ˜10 nanoliters (nl), then a single round of 30 cycles of PCR might suffice to generate the saturating concentration of product needed for detection by the TaqMan assay, i.e. 1×230 per 10 nanoliters≈1011 per microliter. Attempts have been made to miniaturize PCR assemblies but no one has developed a cost-effective PCR assembly which can carry out PCR in a nanoliter-sized sample. Part of the problem with miniaturization is that evaporation occurs very rapidly with small sample volumes, and this problem is made worse by the need to heat samples to ˜90° C. during thermocycling.
  • In addition to potential advantages stemming from ability to detect single target nucleic acid molecules, miniaturization might also facilitate the performance of multiple different amplification reactions on the same sample. In many situations it would be desirable to test for the presence of multiple target nucleic acid sequences in a starting sample. For example, it may be desirable to test for the presence of multiple different viruses such as HIV-1, HIV-2, HTLV-1, HBV and HCV in a clinical specimen; or it may be desirable to screen for the presence of any of several different sequence variants in microbial nucleic acid associated with resistance to various therapeutic drugs; or it may be desirable to screen DNA or RNA from a single individual for sequence variants associated with different mutations in the same or different genes, or for sequence variants that serve as “markers” for the inheritance of different chromosomal segments from a parent. Amplification of different nucleic acid sequences and/or detection of different sequence variants usually requires separate amplification reactions with different sets of primers and/or probes. If different primer/probe sets were positioned in an array format so that each small region of a reaction substrate performed a different amplification/detection reaction, it is possible that multiple reactions could be carried out in parallel, economizing on time, reagents, and volume of clinical specimen.
  • A need therefore exists for a device that can form and retain a sample volume of about 10 nanoliters or less and enable amplification to be performed without significant evaporation. A need also exists for a reliable means of detecting a single starting target nucleic acid molecule to facilitate quantification of target nucleic acid molecules. A need also exists for performing multiple different amplification and detection reactions in parallel on a single specimen and for economizing usage of reagents in the process.
  • SUMMARY OF THE INVENTION
  • According to the present invention, methods and apparatus for performing nucleic acid amplification on a miniaturized scale are provided that have the sensitivity to determine the existence of a single target nucleic acid molecule. The invention also provides analytical assemblies having sample retaining means which form, isolate and retain fluid samples having volumes of from about one microliter to about one picoliter or less. The invention also provides a method of forming fluid samples having sample volumes of from about one microliter to about one picoliter or less, and retaining the samples under conditions for thermocycling. The invention also provides an analytical assembly having means to determine simultaneously the presence in a sample of multiple different nucleic acid target molecules.
  • According to embodiments of the invention, PCR conditions are provided wherein a single target nucleic acid molecule is confined and amplified in a volume small enough to produce a detectable product through fluorescence microscopy. According to embodiments of the invention, samples of a few nanoliters or less can be isolated, enclosed and retained under thermocycling conditions, and a plurality of such samples can be collectively analyzed to determine the existence and initial concentration of target nucleic acid molecules and/or sequences. According to some embodiments of the invention, sample retaining chambers having volumes of about 10 picoliters or less can be achieved.
  • According to embodiments of the invention, methods of forming small fluid samples, isolating them and protecting them from evaporation are provided wherein different affinities of a sample retaining means and a communicating channel are used to retain sample in the means while a second fluid displaces sample from the channel. According to some embodiments of the invention, the resultant isolated samples are then subject to PCR thermal cycling.
  • According to embodiments of the invention, methods are provided for determining the existence and/or initial concentration of a target nucleic acid molecule in samples of about 1 microliter or less. According to some embodiments of the invention, methods are provided for a clinical diagnosis PCR analysis which can quickly and inexpensively detect a single target nucleic acid molecule.
  • According to some embodiments of the invention, sample chambers of about, 1 microliter or less are provided that have a greater affinity for a sample to be retained than for a displacing fluid. The displacing fluid displaces sample from around the chambers and isolates the sample portion retained in the chambers.
  • According to embodiments of the invention, nucleic acid samples are isolated, retained and amplified in microcapillary devices having volumes of about 100 nanoliters or less, including microcapillary tubes, planar microcapillaries and linear microcapillaries. The devices may be provided with absolute, selective or partial, barrier means.
  • According to embodiments of the invention, a porous or microporous material retains samples of about 100 nanoliters or less, and an assembly is provided which includes a cover for sealing sample within the porous or microporous material.
  • According to embodiments of the present invention, PCR methods and apparatus are provided wherein the sensitivity of a “TaqMan” fluorescence assay can be used to enable detection of single starting nucleic acid molecule in reaction volumes of about 100 nl or less. According to the present invention, assemblies for retaining PCR reaction volumes of about 10 nl or less are provided, wherein a single target molecule is sufficient to generate a fluorescence-detectable concentration of PCR product.
  • According to the invention, methods are provided for carrying out, PCR in minute volumes, for example, 10 nl or less, which allows detection of PCR products generated from a single target molecule using the “TaqMan” or other fluorescence energy transfer system.
  • According to embodiments of the present invention, methods of detecting and quantifying DNA segments by carrying out polymerase chain reaction in a plurality of discrete nanoliter-sized samples are provided. The present invention also provides methods for determining the number of template molecules in a sample by conducting replicate polymerase chain reactions on a set of terminally diluted or serially smaller samples and counting the number of positive polymerase chain reactions yielding specific product. The present invention is useful in detecting single starting molecules and for quantifying the concentration of a nucleic acid molecule in a sample through PCR. The present invention also provides methods of detecting and quantifying a plurality of target DNA sequences.
  • The present invention also provides methods and assemblies for separating and/or analyzing multiple minute portions of a sample of fluid medium that could be useful for other applications. Applications of the apparatus of the invention include the separation of biological samples into multiple minute portions for the individual analysis of each portion, and can be used in the fields of fertility, immunology, cytology, gas analysis, and pharmaceutical screening.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will be described in connection with various embodiments exemplified in the accompanying drawings, wherein:
  • FIG. 1 is an exploded view of an analytical assembly according to an embodiment of the present invention, shown in partial cutaway;
  • FIG. 2 is an exploded view of an analytical assembly according to an embodiment of the present invention, shown in partial cutaway, comprising sample chambers in the form of wells formed into patterned layers on the inner surfaces of both a top plate and a bottom plate;
  • FIG. 3 is a cross-sectional view through a longitudinal central portion of ail analytical assembly according an embodiment of the present invention;
  • FIG. 4 is a perspective view of a bottom portion of an analytical assembly according to an embodiment of the present invention, the bottom portion comprising sample retaining means in the form of patches of fluid retaining material formed on a patterned layer coated on the inner surface of a bottom plate;
  • FIG. 5 is a cross-sectional view through a longitudinal central portion of an analytical assembly according an embodiment of the present invention;
  • FIG. 6A is a perspective view of a bottom portion of an analytical assembly according to another embodiment of the present invention;
  • FIG. 6B is an enlarged view of portion VIA shown in FIG. 6A;
  • FIG. 7 is a top plan view of a microcapillary analytical assembly according to an embodiment of the present invention;
  • FIG. 8 is a histogram showing the maximum values of the fluorescein:rhodamine intensity ratio in over 100 capillary reactions of terminally diluted genomic DNA carried out in an assembly according to the present invention and according to a method according to the invention; and
  • FIGS. 9-14 are plots of the fluorescein:rhodamine ratio along a few representative microcapillaries containing samples subject to PCR in accordance with the present invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • According to embodiments of the present invention, methods of manipulating a sample of fluid medium are provided. The methods comprise loading a sample of fluid medium into sample retaining means of an analytical assembly and displacing excess sample from areas adjacent to the portion retained by the sample retaining means. According to embodiments of the invention, sample fluid is displaced from regions adjacent to the retained sample, without displacing the retained sample. In some embodiments, a displacing fluid is used to isolate a retained sample, and the displacing fluid may be curable to form a retaining chamber entrapping the fluid sample retained by the sample retaining means.
  • The assemblies of the present, invention provide samples or sample portions enclosed in a protective environment which protects the sample or portion from evaporation and contamination. Preferably, sample is protected from evaporation at temperatures of about 95° C. or more, for example, at temperatures achieved during thermal cycling under conditions for PCR. The isolated, entrapped or enclosed sample or portion is preferably protected from contamination and evaporation throughout an amplification protocol, for example, a PCR thermal cycling protocol.
  • According to some embodiments of the invention, an analytical assembly is provided and comprises a plurality of sample chambers each confined in at least one dimension by opposing barriers separated by a first dimension of about 500 microns or less, preferably by 100 microns or less, and in some embodiments by about 20 microns. Means are provided for sealing the plurality of sample chambers to prevent evaporation and contamination of fluid sample confined within the plurality of sample chambers. Means are provided for restraining reaction product formed from reactions of a chemical substance restrained within the plurality of sample chambers. According to some embodiments, means may be provided for minimizing diffusion and substantially preventing convection of amplification reaction product formed from reactions of the fluid sample restrained within the plurality of sample chambers. If provided, at least one of the means for restraining and the means for minimizing diffusion and substantially preventing convection may preferably comprise a patterned layer which at least partially defines the plurality of sample chambers. Preferably, the fluid sample contains at least one target, nucleic acid molecule to be amplified and constituents for enabling amplification of the target nucleic acid molecule. The fluid sample is divided into a plurality of sample portions and the plurality of sample chambers are loaded which respective portions of the fluid sample. According to some embodiments of the invention, the sample portions are in fluid communication with each other, rather than being completely isolated from each other, and separated by barrier means which may be in the shape of crosses, lines, semicircles, circles having at least one opening along the arc thereof, or other geometric shapes. According to embodiments of the invention, the barrier means may define sample retaining portions or chambers of the assembly. According to some embodiments, means for minimizing diffusion and substantially preventing convection are provided, and may comprise the herein described barrier means. According to some embodiments, the barrier means includes physical structures which may extend between the aforementioned opposing barriers which are separated by 500 microns. The barrier means may form a wall or walls between the opposing barriers. The barrier means may comprise flow restriction means. Flow restriction means may be, for example, semi-circular walls extending from one of the opposing barriers toward the other, and having the concave side of the semi-circle facing the direction of fluid flow during loading, and the semicircular arc may have at least hole or interruption therein through which air may escape during fluid sample loading. According to embodiments of the invention, the first dimension, the means for restraining, and, if provided, the means for minimizing diffusion and substantially preventing convection are such that the reaction product of a single target nucleic acid molecule amplified within at least one sample chamber can attain a concentration of reaction product molecules sufficient to be detected by a homogeneous detection assay, for example a concentration of about 1011 product molecules per microliter (μl). Preferably, at least one of the plurality of portions is initially free of the target nucleic acid molecule, and at least one of the plurality of portions initially contains at least one target nucleic acid molecule.
  • According to some embodiments of the invention, an analytical assembly is provided comprising a substrate and a cover in registry with one another and attached to one another and having facing surfaces spaced a substantially uniform distance apart from one another. The facing surface of the substrate comprises a first material having a first affinity to a sample of fluid to be isolated, for example, an aqueous PCR solution sample. A flow-through channel is disposed between the first material and the cover, and at least one sample retaining means is bounded on at least one side by the first material. The first material may comprises for example, a patterned layer of moderately hydrophobic material, that is, a material having a surface energy of from about 30 dynes/cm to about 50 dynes/cm. The first material may be deposited on the inner surface of the substrate.
  • Herein, the term “affinity” is to be understood to mean a sample-holding capacity or sample-holding capability. The affinity of the sample retaining means may be caused by surface energy of the material contacting or restraining a sample fluid, or it may be caused by electrostatic force, flow restriction means, temperature differences or by other means. The “affinity” of a flow-through channel may be defined by the dimensions of the channel, or by the material comprising one or more bounding surface of the channel, or by a combination of dimensions and bounding surface properties. The sample retaining means may have different affinities to retain a sample fluid and a displacing fluid. The flow-through channel may exhibit different affinities to retain a sample fluid and a displacing.
  • According to embodiments of the invention, the first material preferably does not comprise an extremely hydrophobic material; for example, the first material preferably does not comprise a material having a surface energy of less than about 20 dynes/cm. Extremely hydrophobic materials do not tend to be wetted by aqueous samples or by many displacing fluids such as mineral oil, two-part adhesives, UV-curable and cyanoacrylate adhesives, and thus such displacing fluids would tend not to completely surround, isolate and restrain a sample (e.g. a gaseous sample) held by the sample retaining means.
  • The sample retaining means is in communication with the flow-through channel such that sample entering the flow-through channel can reach and be retained by the sample retaining means. The cover and first material should be of such properties and/or special relationship to allow a sample fluid and a displacing fluid to enter the flow-through channel, whether by capillary action, pressure, or other force. The sample retaining means has a second affinity to the sample of fluid medium, and the second affinity is greater than the first affinity. The second affinity may be a property induced in the first material by chemicals optical, electronic, or electromagnetic means, for example. An exemplary chemical means to permanently induce an affinity may be, for example, an O2 plasma exposure to a portion of a silicone surface to effectively change the affinity of the surface to retain an aqueous sample at the portion treated. Embedding ions in a surface may also be used to permanently induce an increased or decreased affinity at a location on a surface. An affinity may be temporarily induced according to some embodiments of the invention, for example, where a surface charge on a sample retaining or repelling surface is induced to increase the effective surface tension of that surface. According to some embodiments of the invention, a temporary affinity may be reshaped, moved or relocated during or after a sample portion is retained, for the purpose of enlarging or joining sample portions in the assembly. According to embodiments of the invention, the difference of affinities enables the retaining means to collect a portion of sample from the flaw-through channel and to retain the portion while a second fluid medium: is introduced to the flow-through channel; isolates sample retained by the sample retaining means; and displaces non-retained sample from adjacent to the sample retaining means.
  • According to embodiments of the invention, the flow-through channel is adjacent to the sample retaining means. An entrance opening is provided for introducing sample into the flow-through channel. According to embodiments of the invention, an analytical assembly is also provided which contains isolated sample entrapped by a substantially immiscible displacing fluid.
  • Methods according to embodiments of the invention involve causing the displacing fluid to flow through the flow-through channel and displace sample from the flow-through channel without displacing sample from the sample retaining means. Such methods are accomplished according to embodiments of the invention by providing a sample retaining means having a greater affinity for the sample than for the displacing fluid. Preferably, the flow-through channel has a much lower affinity for the sample than does the sample retaining means.
  • According to some embodiments of the invention, the sample of fluid medium is a gaseous sample and the sample retaining means is extremely hydrophobic, for example, having a surface energy of from about 30 dynes/cm to about 10 dynes/cm. Because of the extreme hydrophobicity of the retaining means, displacing fluids tend to be repelled from the retaining means, and thus avoid displacing gaseous sample from the retaining means. Displacing fluids can thus entrap, retain and isolate a sample within an assembly of the invention.
  • According to some embodiments, an organic sample is trapped in a high surface energy displacing fluid.
  • Both the sample to be isolated and the displacing fluid may be introduced into the flow-through channel by being drawn in under the influence of capillary forces. Pressurized loading techniques may also be used, but if displacing fluid is forced into the device under pressure, the pressure should not be so high as to displace sample from the sample retaining means. Other means of loading sample fluid and/or displacing fluid may be used according to the invention and include electrokinetic or electrostatic loading techniques, temperature differentials, centrifugal force, vacuum or suction loading, magnetic attraction loading of magnetic fluids, and electrophoretic or columbic force loading. An exemplary magnetic attraction loading technique involves drawing a fluid containing magnetic particles dispersed therein into the device under the influence of a magnetic field and using mineral oil containing dispersed iron particles as a displacing fluid and drawing the mineral oil into a flow-through channel with a magnetic field. According to some embodiments, the sample is loaded with magnetic particles and attracted toward and held by a sample retaining means adjacent to or including a source of a magnetic field or a material which is attracted to a magnet, for example, an iron-containing material.
  • Preferably, the displacing fluid is substantially immiscible with the sample of fluid medium to be isolated. According to embodiments of the invention wherein a displacing fluid is used, the displacing fluid may comprise a flowable, curable fluid such as a curable adhesive selected from the group consisting of: ultra-violet-curable and other light-curable adhesives; heat, two-part, or moisture activated adhesives; and cyanoacrylate adhesives. Exemplary displacing fluids include Norland optical adhesives available from Norland Products, Inc., New Brunswick, N.J., cyanoacrylate adhesives disclosed in U.S. Pat. Nos. 5,328,944 and 4,866,198, available from Loctite Corporation, Newington, Conn., resins, monomers, mineral, oil, silicone oil, fluorinated oils, and other fluids which are preferably substantially non-miscible with water. According to some embodiments the displacing fluid may be transparent, have a refractive index similar to glass, have low or no fluorescence, have a low viscosity, and/or be curable.
  • Some methods according to embodiments of the invention, including methods of nucleic acid molecule amplification, including PCR, may comprise isolating a sample into a plurality of discrete retained sample portions, and processing and/or analyzing the portions to determine concentrations of components and other characteristics of the sample. To carry out methods of the invention wherein a plurality of sample portions are formed and isolated, assemblies are provided having a plurality of sample retaining means. Evaluating multiple portions of a sample can then be used to determine characteristics of the entire sample.
  • While the resolution and accuracy of many analytical techniques can be improved according to the invention by forming and analyzing a plurality of portions of a sample, embodiments of methods of the present invention more generally involve manipulating a fluid sample. Manipulating may comprise cloning a segment of DNA, for example, where the sample of fluid medium comprises a polymerase chain reaction solution, and at least one segment of DNA to be amplified. Methods of PCR according to the invention comprise exposing isolated sample retained by the sample retaining means to a temperature profile which causes polymerase chain reaction amplification of a target nucleic acid molecule segment within the sample. According to embodiments of the invention, isolated and minute PCR samples can be retained under conditions which protect the sample during temperature profiling to dehybridize double stranded polynucleotides, anneal primers to the dehybridized molecules, and to polymerize and thus amplify the polynucleotide.
  • According to embodiments of the invention, PCR methods are carried out in assemblies according to the invention, and the methods include manipulating a PCR sample which contains an effective amount of a probe or system of probes having fluorescent properties or chemical properties that change upon hybridization to a nucleic acid target. According to embodiments of the invention, a normally quenched double labeled fluorescent probe is degraded upon hybridization to target DNA during PCR and the degradation results in increased emitted light of a certain wavelength. By measuring the amount of fluorescence and thus the amount of degraded probe, methods according to embodiments of the invention can be used to determine whether a segment of DNA has been amplified and thereby calculate the concentration of a target DNA segment that existed in the original sample before PCR. The measured fluorescence of a certain wavelength may in some cases be used according to the invention to quantify the amount of a DNA segment, which had been retained by the sample retaining means prior to exposing a retained sample to a PCR thermal cycling profile or protocol.
  • Other detection methods may be used to determine PCR product and/or reactant concentrations or to make other quantitative or qualitative evaluations of many types of samples. These other detection methods include agglutination, turbidity, phosphorescence detection techniques, light scattering, light absorbance, fluorescence energy transfer, fluorescence quenching or dequenching, time-delayed fluorescence, chemiluminescence and calorimetric evaluation techniques.
  • According to some preferred embodiments of the invention, methods of cloning a segment of DNA are provided wherein a sample containing a DNA segment to be amplified is divided into a plurality of sample portions and the portions are simultaneously subjected to PCR. By providing sample portions of as small as about 10 nanoliters or less, for example 10 picoliters or less, single molecules of a target DNA segment to be amplified can be detected according to the invention. For PCR methods according to the invention which enable amplification of a plurality of sample portions simultaneously, the sample from which the portions are derived may comprise a polymerase chain reaction solution, at least one segment of DNA to be amplified, and a sufficient amount of primer to carry out a polymerase chain reaction for multiple cycles, and the method may comprise exposing the sample portions retained by the plurality of sample retaining means to a temperature profile which causes polymerase chain reaction and amplification of a target DNA segment within the portions. According to embodiments of the invention, the presence of a single strand of a target DNA segment can be detected in a portion retained by at least one of a plurality of sample retaining means.
  • Methods according to some embodiments of the present invention comprise manipulating a sample of fluid medium by loading the sample into an analytical assembly having a porous sample retaining means. Porous sample retaining means according to the invention comprise a porous structure having an exposed porous surface and a plurality of pores having open upper ends at the exposed porous surface. Preferably, the exposed porous surface is moderately hydrophobic yet receptive to adhesive bonding. The pores of the sample retaining means may have substantially the same volume and have closed lower ends which may be defined by a substrate onto which the porous structure may be disposed.
  • Preferably, the ratio of pore diameter to depth is from about 2:1 to about 10:1, for example, 4:1, for embodiments wherein a porous material is attached to a substrate. According to embodiments of the invention, the ratio of exposed porous surface area, that is, the area of the surface not taken up by the openings, to the area of pore openings is from about 4:1 to about 1:1.5, for example, a ratio of about 1:1.
  • The pores have a first affinity to a sample such that when the sample is disposed upon the exposed porous surface, the sample is drawn into the plurality of pores. The assembly used according to these methods of the invention further comprises means to displace sample from the exposed porous surface without displacing the sample from the pores. The means to displace may comprise a displacing fluid or a displacing device such as a coverslip pressed against the exposed surface. The assembly may also include means for sealing the sample within the pores to prevent evaporation and contamination of the sample during heat treatment and analysis of the sample in the pores.
  • Loading sample into the pores of a porous sample retaining means comprises contacting the sample to the exposed porous surface and retaining the sample in the plurality of pores. Due to the affinity the pores exhibit to the sample, particularly to aqueous PCR samples, the sample is drawn into the pores by capillary force and retained therein. The methods also include displacing sample from the exposed porous surface without displacing sample from within the pores. The methods may also include sealing the open ends of the pores with the sample disposed therein.
  • According to some embodiments of the invention, both the top and the bottom of the pores may be open for loading and then sealed.
  • According to embodiments of the invention, analytical assemblies are provided for carrying out methods of manipulating a sample of fluid medium with a porous sample retaining means. The porous sample retaining means in such assemblies may comprise a microchannel, array, a metal, glass, ceramic, cellulosic or polymeric screen or sieve, or a material, having a plurality of pores formed therein, such as a substantially flat plastic disk having a plurality of pores ablated, molded, etched or drilled therein. The pores may be treated or coated with a material to provide an affinity to a sample. The exposed porous surface may be treated or coated with a material to render the exposed surface moderately hydrophobic.
  • According to some embodiments, the sample retaining pores have a volume of from about 1 microliter to about 100 nanoliters or less, preferably about 10 nanoliters or less, and may have pore volumes of about 1 picoliter or less for some applications. According to one embodiment, the pores have volumes of about 10 picoliters.
  • After sample is loaded into the pores of the porous sample retaining means, remaining sample which is not retained by the pores but rather which remains on the exposed porous surface is removed or displaced. According to embodiments of the invention, a sealing means such as a microscope slide coverslip, tape, film or a device including other components, a silicon film or device, a device having an array of reactants, or other means is disposed on the exposed porous surface and displaces sample from the exposed porous surface, without displacing sample from within the pores. After displacing sample from the exposed porous surface, the displacing means may become the sealing means if subsequently held, adhered or attached to the porous surface, which would then no longer be exposed. Preferably, the sealing means comprises a material having a second affinity for the sample which is less than the first affinity, for example, the sealing means comprises a relatively hydrophobic material which contacts the exposed porous surface, and the pores are defined by a relatively hydrophilic porous material.
  • According to embodiments of the invention using the aforementioned porous sample retaining means, the means for displacing sample and the means for sealing may be a single cover having a hydrophobic surface which contacts the porous surface. The sealing means may be glued to the previously exposed porous surface, glued to a substrate on which the porous retaining means is disposed, or clamped or otherwise attached to the porous retaining means or a substrate therefor, as for example, with clips or springs. A surface of the cover, substrate or porous sample retaining means may provide adhesive or glue properties.
  • According to methods of some embodiments of the invention, a target nucleic acid molecule or segment is amplified in at least one of the pores of a porous sample retaining means. According to such embodiments, the sample to be retained by the retaining means may comprise a polymerase chain reaction solution, and at least one target segment of nucleic acid molecule to be amplified. The method further comprises exposing the sample sealed within the pores to a temperature profile which causes polymerase chain reaction amplification of the target segment within at least one of the pores. In some embodiments of the invention, the sample further comprises an effective amount of a fluorescent probe which fluoresces upon degradation caused by the successful amplification of the target segment in the sample. Such methods may further comprise measuring the fluorescence emitted from degraded probe after the polymerase chain reaction and determining whether the target segment was amplified in at least one of the pores. The fluorescence measurement may be of the amount of fluorescence, the lifetime of fluorescence, or another fluorescence property.
  • The methods of the present invention using a porous sample retaining means may further comprise using measured fluorescence to quantify the amount of target nucleic acid segment which had been retained in at least one of the pores prior to exposing retained sample portions to a thermal cycling protocol. Due to the extremely small volume of sample chambers which can be achieved with a porous sample retaining means, the presence of a single strand of the target segment can be detected in the pores. The methods may also comprise determining the initial concentration of the target segment which had been in the sample prior to amplification.
  • According to yet other embodiments of the present invention, methods of manipulating a sample of fluid medium are also provided wherein a sample of fluid medium is loaded into an analytical assembly comprising a microcapillary device, for example, a microcapillary tube having an inner diameter of about 500 μm or less, preferably about 100 μm or less. Loading may comprise filling the microcapillary tube with a sample by capillary action. Microcapillary devices provided with a sample retaining means, for example, a hydrophobic or hydrophilic surface or an electromagnetic or electrostatic force, may have an inner dimension or inner diameter of about 500 μm or less. Tubular or linear microcapillaries not provided with sample retaining means may preferably have an inner dimension of about 100 μm or less. Planar microcapillaries not provided with sample retaining means, for example, comprising the space between two facing plates, may preferably have an inner dimension of about 20 μm or less.
  • According to some embodiments, a first fluid may initially be disposed into the microcapillary device, for example, a microcapillary tube. The first fluid may preferably be substantially immiscible, and more preferably, completely immiscible with a sample fluid. Loading then comprises disposing a portion of a sample fluid into the microcapillary tube adjacent the first fluid, and subsequently disposing a second fluid into the microcapillary tube adjacent the sample. The second fluid is also preferably substantially immiscible, and more preferably completely immiscible, with the sample. The sample is disposed between and restrained by the first and second fluids. The first and second fluids may be the same fluid, and can be, for example, mineral oil or a gas or a curable monomer formulation, if the sample is an aqueous fluid. The microcapillary device may contain more than one isolated sample portion, which may be separated by one of the first and second fluids. Each portion may be about 100 nl or less, preferably 10 nl or less.
  • Some methods of the invention which employ microcapillary sample retaining means may also comprise sealing both ends of the microcapillary tube with the sample therein. The sample may fill the entire capillary tube and be sealed therein, or the sample may be sealed in the tube sandwiched between first and second fluids. Means may be employed to load numerous sample portions, such as an ink jet or fluidic control apparatus.
  • According to embodiments of the invention, microcapillary analytical assemblies are also provided and can be used to isolate and retain a sample of fluid medium comprising about 100 nanoliters or less of a fluid medium, preferably about 60 nanoliters or less. Assemblies are also provided which comprise a plurality of such microcapillary tubes, each tube having a sample of fluid medium disposed therein. A plurality of tubes may be attached to a pair of microscope slide coverslips, or to a tape or pair of tapes, or otherwise held together.
  • The microcapillary sample retaining devices of the present invention may be used to carry out nucleic acid amplification methods, according to embodiments of the invention. When used in PCR applications, the fluid sample may comprise a polymerase chain reaction solution which may include reagents, enzymes, buffer, bovine serum albumin and other well known ingredients commonly used to perform a polymerase chain reaction. Methods according to the invention which employ the inventive microcapillary devices may further comprise exposing the sample sealed within the microcapillary tube, or within a plurality of tubes, to a temperature profile which causes amplification of the target segment within the sealed sample.
  • As mentioned in connection with other methods and apparatus according to the invention, the PCR sample in the microcapillary tube may further comprise an effective amount of a fluorescent probe which fluoresces upon degradation of the probe caused by the successful amplification of the target segment. The fluorescence emitted from the hybridized probe can be measured to determine whether the target segment was amplified. By using different dilutions of starting sample or by using replicate samples in different volumes, the concentration of starting target segment can be determined.
  • According to embodiments of the present invention wherein PCR is carried out in a microcapillary assembly, fluorescence or other detection properties are promptly analyzed after PCR thermal cycling, for example, within about 5 hours, more preferably within about 1 hour after PCR thermal cycling is complete. Prompt analysis of the fluorescence emitted maximizes the concentration of measured degraded probe along regions of the microcapillary tube, before the degraded probe diffuses along the tube and becomes less detectable. Preferably the amplification is carried out as rapidly as possible, for example, in less than one hour.
  • Miniaturized assemblies according to embodiments of the invention have been briefly described above and will be discussed in greater detail below. Assemblies according to embodiments of the invention can take many forms but can generally be classified into three types, (1) assemblies having flow-through channels and sample retaining means in communication with the flow-through channel, (2) assemblies having porous sample retaining means and means for sealing sample within sample retaining pores, and (3) assemblies comprising at least one microcapillary tube.
  • According to embodiments of the invention, assemblies are provided for manipulating samples of fluid medium, for example, methods for isolating small sample volumes, such as sample volumes of 100 nanoliters or less.
  • Some assemblies according to the invention comprise a substrate and a cover in registry with and attached to one another and having facing surfaces spaced a substantially uniform distance apart from one another. The facing surface of the substrate comprises a first material having a first affinity to a sample of fluid medium to be contained in the assembly. For example, if an aqueous fluid is to be manipulated, the first material is preferably a moderately hydrophobic material. The first material preferably defines at least a portion of a flow-through channel which is disposed between the substrate and the cover. The flow-through channel is in fluid communication with a sample retaining means, and the retaining means is bounded on at least one side thereof by the first material. The sample retaining means has a second affinity to the same sample of fluid medium. Preferably, the second affinity to the sample fluid is greater than the first affinity thereto, preferably much greater, enabling the sample retaining means to retain or collect a portion of a sample of fluid medium which flows through the flow-through channel and to retain the portion while a second fluid medium flows through and displaces sample from the flow-through channel. The result can be a very small isolated portion of the sample being retained by the sample retaining means and entrapped, encased or otherwise surrounded by the second fluid medium in the flow-through channel.
  • According to embodiments of the invention wherein the assembly comprises a flow-through channel and sample retaining means, the substrate may be a first plate having a patterned layer of the first material formed thereon. The cover may be a second plate attached to and substantially parallel to the first plate, with the first and second plates having facing substantially parallel planar surfaces. The first and second plates may each be rigid or flexible, flat or contoured, a sheet, a film, a microscope slide, a microscope slide coverslip, a glass plate, a tape, a device including other components, a silicon device, a silicon film, or the like. According to some embodiments, the plate has a substantially planar surface on a side adjacent or defining the sample retaining means. The patterned layer is preferably located between the planar surfaces and at least partially forms a boundary for the sample retaining means. For example, when the sample retaining means is a chamber formed from an opening in, a cavity or recess in, or a hole through the patterned layer, the closed end of the chamber may be defined by the substrate surface on which the patterned layer is disposed or by the patterned layer, and the patterned layer may define the sidewalls of the sample chamber. According to embodiments wherein the sample retaining means is a recessed sample chamber at least partially defined by the patterned layer, the chamber may comprise a sidewall, a closed lower end, and an upper end which may be open or closed. The sample chamber has a communication with the flow-through channel. According to some embodiments of the invention, the sample chamber also extends into and is partially defined by a patterned layer formed on the facing surface of the assembly cover, in which case the sample chamber may have a closed upper end and the communication to the chamber may be formed in the chamber sidewall, for example, an annular gap in an otherwise continuous sidewall. According to other embodiments of the invention, the cover is substantially planar and the sample chamber does not extend into the cover or a layer disposed on the cover, in which case the chamber has an open upper end in communication with the flow-through channel.
  • According to embodiments of the invention wherein the substrate and cover comprise first and second plates, the closed lower end of the sample chamber may comprise the first plate. The sample retaining means may comprise a third material at the lower end of the sample chamber. The third material may in some cases be a hydrophilic material deposited on the first plate and defining the lower end of the chamber. According to some embodiments, the third material may be very hydrophobic. For aqueous samples in particular, hydrophilic materials may be used at the lower end of the sample chamber. According to some embodiments of the present invention, a sample chamber comprising a recess in a substrate or substrate coating may preferably have hydrophilic material at a lower end thereof and hydrophobic material forming the sidewall. Preferably, the hydrophilic lower end provides an affinity to an aqueous PCR sample which is sufficient to retain the sample while a displacing fluid carries away sample adjacent the sample chamber. The hydrophobic sidewalls prevent sample from being displaced from the sample chamber.
  • Preferred sample chambers according some embodiments of the invention, for nucleic acid amplification methods to detect single target nucleic acid molecules, have volumes of from about 1 microliter to about 1 picoliter or less. Printing, photolithography, etching, ablation and other methods of forming sample chambers in, for example, printed layers, can provide sample chambers of ten nanoliters or less, for example, about 100 picoliters.
  • Screen printing and photolithography are preferred methods of forming a patterned layer on the substrate. Screen printing methods can provide a patterned layer on a 1, inch by 3 inch microscope slide wherein the layer contains over one thousand isolated and spaced sample chambers each having a volume of about 1 nanoliter. Such a patterned layer could enable over one thousand PCR chambers of about 1, nanoliter each, all on the surface of a 1″×3″ microscope slide. Photolithographic methods can provide from about 10,000 to over 100,000 sample chambers of about 100 picoliters each on a 1″×3″ substrate.
  • According to embodiments of the invention, the first material or patterned layer material is moderately hydrophobic.
  • Herein, the term “moderately hydrophobic” refers to a material or layer that exhibits a contact angle to water of from greater than about 30° to less than about 85°. According to some embodiments, a hydrophobic patterned layer is disposed on the facing surfaces of both the substrate and the cover, the average contact angle of the two patterned layers is preferably more than about 30° to less than about 85°, and more preferably each of the two layers is moderately hydrophobic. Patterned layers exhibiting higher contact angles to water may be employed on the substrate surface if the cover comprises a hydrophilic facing surface. Preferably, the patterned layer or first material is of such a nature that displacing fluid can bond thereto when the second fluid or displacing fluid is a polymerizable fluid. If the patterned layer or first material comprises TEFLON, for example, a curable or polymerizable displacing fluid may not be capable of bonding thereto and thus may not sufficiently seal an entrapped sample fluid posing contamination and evaporation risks.
  • According to some embodiments of the invention, the substrate and cover comprise first and second facing planar surfaces with a first layer on the first surface and a second layer on the second surface. According to some embodiments, sample chambers are formed in the first layer and the second layer is substantially smooth. According to some other embodiments, the second layer also has sample chambers formed therein, preferably mirroring the sample chambers formed in the first layer. The second layer may comprise a moderately hydrophobic material.
  • According to some embodiments, the interior surface(s) of the substrate and/or cover may be altered by chemical or other means to form a pattern of retaining means having altered surface energy or structure.
  • According to some embodiments of the invention, a sample chamber comprises a hole or recess formed in a first patterned layer, and a hole or recess formed in a second patterned layer, the sidewall comprises both the first and second patterned layers, a flow-through channel is disposed between the first and second patterned layers, and the communication to the flow-through channel interrupts the sidewall.
  • According to embodiments comprising first and second patterned layers, the first and second layers may comprise the same material. The second patterned layer may have a substantially smooth surface facing the first patterned layer, and the second layer may have a substantially uniform layer thickness. In embodiments wherein a smooth and continuous second layer is provided on the inner surface of a cover or top plate of an assembly, the sample chamber may have an open upper end in fluid communication with the flow-through channel and the sidewall may completely comprise the first patterned layer.
  • The patterned layer may be the retaining means, for example, hydrophobic or hydrophilic spots on the substrate or cover. According to some embodiments, the patterned layer may comprise the retaining means and may comprise a microporous material such as an epoxy material which is highly filled with micron-sized beads.
  • According to embodiments of the invention wherein an assembly comprises a flow-through channel, the flow-through channel may have an entrance opening and an exit vent. Assemblies designed for forced pressure loading may not require an exit vent. In embodiments of the invention comprising a flow-through channel, the channel may have a substantially uniform cross-sectioned area throughout. In other embodiments, the cross-sectional area of the flow through channel increases or decreases in a direction from the entrance opening to said exit vent. The changing cross-sectional area of the flow-through channel can influence the travel of the sample and/or displacing fluid through the flow-through channel due to increasing or decreasing resistance of the fluid flow. For example, in embodiments wherein the flow-through channel increases in cross-sectional area from adjacent to the entrance opening in the direction of the exit vent, fluid flow toward the exit vent is subject to decreased flow resistance compared to embodiments wherein the cross-sectional area is the same throughout the flow-through channel. One method of forming a flow-through channel with an increasing or decreasing cross-sectional area is to space the cover or top plate further from the substrate or bottom plate at the entrance end of the assembly than at the exit end. Although the substrate and cover, or first and second plates, would remain substantially parallel to each other as defined by the present invention, they would not be exactly parallel. Another method of forming an increasing or decreasing flow-through channel cross-sectional area is to form the patterned layer thicker at one end of the device than at the opposite end of the device, and to have the thickness of the layer gradually increase or decrease in thickness. According to some embodiments wherein holes in a patterned layer define sample retaining means, the retaining means may have different sizes and shapes.
  • According to some embodiments of the invention, a hydrophilic pattern is provided to form sample retaining means and the pattern may be induced by electrets or by internal or external electrodes to provide a charged surface having higher surface energy and wettability than a flow-through channel in communication with the retaining means.
  • According to some preferred embodiments of the invention, an analytical assembly is provided with a plurality of sample retaining means separated from one another. In some embodiments, the plurality of sample retaining means comprise sample chambers formed in a patterned layer disposed between the substrate and cover or first and second plates. The sample retaining means may comprise chambers each having a sidewall, an upper end, a closed lower end, and a communication with a flow-through channel.
  • Filled assemblies are also provided according to embodiments of the invention, and may comprise a sample fluid retained by the sample retaining means, and a different, second fluid retained in the flow-through channel. Preferably, the second fluid is substantially immiscible with the sample fluid. The sample fluid may comprise a polymerase chain reaction solution and at least one segment of DNA to be amplified. The second fluid is referred to as a displacing fluid and may comprise a curable fluid, particularly curable adhesives, and preferably fluid adhesives selected from the group consisting of light-curable, heat-curable, two-part-curable, moisture-curable and cyanoacrylate adhesives. When UV-curable adhesives are used and cured, UV-blocking spots may be provided on the cover and/or substrate, aligned with the sample retaining means, to protect the retained sample from harmful light.
  • According to some embodiments of the invention, wherein an assembly is provided having opposing surfaces, sample retaining means between the surfaces, and a flow-through channel in communication with the retaining means, the sample retaining means may comprise a fibrous or porous material which absorbs a sample of fluid medium through capillary forces. The fibrous or porous material may be formed on a patterned layer of a first material deposited on one of the surfaces. The first material may comprise a moderately hydrophobic material. A second material layer may be included on one of the facing surfaces and may comprise a moderately hydrophobic material. The fibrous or porous material may be a cellulosic material, a filter paper material, absorbent textured material, absorbent sintered materials, absorbent pastes, microporous membranes, fiberglass, and the like. Preferably, the fibrous or porous material is a porous membrane having a maximum pore diameter size of about 1 micron. The fibrous or porous material may fill the gap between the substrate and cover or may be disposed on just one of the interior substrate or cover surfaces.
  • The fibrous or porous material has a wicking rate for a sample which can be measured in millimeters per second, and sample flowing through the flow-through channel advances through the channel at an advancing rate which can be measured in millimeters per second. Preferably, the wicking rate exceeds the advancing rate, thus minimizing the possibility of an aqueous sample entrapping or encircling the sample retaining means before air in the retaining means can escape and be carried away by the advancing fluid. In cases where the advancing rate exceeds the wicking rate, sample tends to be absorbed too slowly by the retaining means and the advancing fluid in the channel tends to surround the retaining means and entrap air before the air has a chance to escape.
  • The size and shape of the porous retaining means also influences whether air will be trapped in the sample retaining means. For larger sample retaining means, there is a greater chance that air may be entrapped in the sample retaining means than for smaller sample retaining means. Therefore, it is preferable to use higher wicking rates for larger fibrous or porous sample retaining means than for smaller retaining means. For example, if the retaining means has a wicking rate of 1 mm/sec and the advancing rate is also 1 mm/sec, a substantially flat sample retaining means having a diameter of about 1 mm tends to be wicked by sample without entrapping air, whereas a retaining means having a diameter of about 2 mm may not be completely wicked with sample but instead is more likely to entrap air. Retaining means that are elongated in the direction of sample flow may be preferred for large samples.
  • According to some embodiments of the invention, sample retaining means are provided which exhibit, an affinity to retain a sample through application of a generated force. Rather than using materials having different affinities, the sample retaining means may be provided with means to generate, for example, an electrostatic force. Indium oxide or other conductive coating materials can be strategically placed on or in the substrate, cover or patterned material to form a region or spot which can be charged to form an electrostatic attractive force. If a curable displacing fluid is then used to displace sample from around the charged region or spot, generation of the force is no longer needed after the displacing fluid displaces sample and/or cures.
  • In some embodiments wherein a generated force is used to retain sample in a region or at a spot, the generated force may be a temperature gradient or temperature altering means which provides a temperature to the sample retaining means which affects the affinity of the retaining means to a sample, and produces a different affinity for the sample at the retaining means than at surrounding regions of the assembly such as in the flow-through channel.
  • According to some embodiments of the invention having a flow-through channel, the sample retaining means is not a sample well or recess but rather a sample chamber formed between a patch of a second material and a cover or patch of a third material. The second and third materials may be the same, and preferably both the second and third materials have a greater affinity for a sample of fluid medium than a first material layer which at least partially defines the flow-through channel. For example, the second and third materials preferably have a greater affinity for an aqueous PCR sample than the affinity the first material exhibits to the same PCR sample. According to some embodiments, the patch or spot of the second and/or third material is disposed on the first material.
  • According to embodiments of the invention having a flow-through channel, the substrate is a first, plate having a patterned layer formed thereon, and the cover is a second plate attached to and substantially parallel to the first plate. The first and second plates have facing substantially parallel planar surfaces, and the patterned layer is located between the planar surfaces and at least partially bounds the sample retaining means. The sample retaining means comprises a sample retaining patch disposed on the patterned layer and is spaced a first distance from the facing surface of the second plate. Preferably, the flow-through channel has a bottom surface which is spaced from the facing surface of the second plate by a second distance, and the second distance is greater than the first distance. According to some preferred embodiments, the sample retaining means comprises a plurality of sample retaining patches disposed on the patterned layer, spaced from one another, and spaced a first distance from the facing surface of the second plate.
  • According to some embodiments of the invention, the substrate comprises a flexible material, for example, a polymeric film such as polypropylene film, polyethylene film, polycarbonate film, polyethyleneterephthalate film, silicone film, teflon film, celluloid film, or other film such as a metal or ceramic film. When a flexible material is used, it may instead be molded or formed if not in the form of a tape. The cover may also comprise a flexible material such as a polymeric film, such that the entire assembly is substantially flexible. According to such embodiments, a flexible tape can be constructed and cut to size depending upon the number of sample retaining means desired to be utilized. An entrance opening and an exit vent can be used to load and displace sample fluid, and to load displacing fluid. The entrance opening and/or exit vent may be in the form of a gap formed between the substrate and cover at an end or gaps formed at opposite ends of a piece of tape and in communication with a flow-through channel and a supply of sample to be apportioned.
  • According to embodiments of the invention, a combination is provided which includes a miniaturized assembly for containing a sample of fluid medium, a means for displacing a portion of a sample of fluid medium, and a sealing means, which may be packaged together as a kit or available separately. The miniaturized assembly comprises a substrate having a surface and a sample retaining means disposed on the surface. The sample retaining means comprises a porous structure having a porous surface and a plurality of pores having open ends at the surface. The pores may each have substantially the same volume and closed lower ends. The pores have a first affinity to a sample of fluid medium such that a sample of fluid medium disposed upon the porous surface is drawn into and retained by the plurality of pores. The pores preferably have an affinity to retain a sample of aqueous medium, particularly an aqueous PCR sample. The means to displace a sample of fluid medium from the porous surface without displacing the sample from within said pores may comprise a cover or coverslip, for example, a standard microscope slide coverslip. Preferably, the cover or coverslip has a hydrophobic surface, which may be adhesive, and which contacts the porous surface and is not wet by aqueous samples. The cover or coverslip may be permanently attached to the substrate after displacing sample from the porous surface, or the cover or coverslip may be removed and replaced with a sealing device. The sealing device according to this and other embodiments is preferably transparent so that fluorescence emitted from sample retained by the sample retaining means can be observed and/or measured. The means for displacing fluid and the means for sealing are the same device, for example, a single covering device such as a single coated microscope coverslip. The porous sample retaining means may be a metal plastic, glass or ceramic sieve or screen, or other materials having a plurality of pores formed therein, such as a substantially flat plastic disk having a plurality of pores etched, ablated, molded, drilled, poked or otherwise formed therein. The volume of the pores may be from about 1 microliter to about 1 picoliter or less. Preferably, the volume of the pores is about 100 nanoliters or less, and for some applications may be 1 nanoliter or less.
  • According to some embodiments of the invention, an analytical assembly is provided comprising a microcapillary tube having opposite ends, an inner diameter of about 100 microns or less, and at least one amplifiable nucleic acid molecule segment entrapped inside the tube. Microcapillary tubes having inner diameters of about 500 μm or less may also be used if a sample restraining means is included in the tube, for example, glass beads, gels, absorbent particles, barrier means or electrophoretic means. Tube lengths of from about 1 mm to about 100 mm are preferred.
  • Capillary action is preferably used to introduce a sample fluid in the microcapillary tube, and after the sample is disposed in the tube, the tube is sealed at both ends thereof to entrap the sample inside. The sample may be divided into a plurality of portions separated by, for example, mineral oil. The entrapped sample or sample portions is/are thereby protected from contamination and from evaporation. The sample of fluid medium disposed in the tube may have a volume of about 100 nanoliters or less, more preferably about 10 nanoliters or less, and for some applications, a volume of about 1 nanoliter or less.
  • According to some microcapillary embodiments, a first fluid is disposed in the tube on a side of the sample and adjacent to the sample, and the first fluid is preferably substantially immiscible with the sample. A second fluid may be disposed in the tube on the opposite side of the sample and adjacent to the sample, and the second fluid is also preferably substantially immiscible with the sample, such that the sample is disposed between, and restrained by, the first and second fluids. According to some embodiments, the sample is an aqueous medium and the first and second fluids are both mineral oil or polymerizable fluid. According to some embodiments, the sample preferably comprises about 100 nanoliters or less of a fluid medium. Multiple isolated sample segments may be introduced by ink jet or other sample dispensing means.
  • The microcapillary assemblies according to embodiments of the invention may comprise a plurality of sealed microcapillary tubes having inner diameters of 100 microns or less, with each tube containing at least one portion of a sample of fluid medium. Microcapillary tubes having inner diameters of about 500 μm or less may also be used if a restraining means such as a mineral oil is used to separate minute sample portions from each other. Tube lengths of from about 1 mm to about 100 mm are preferred. The tubes may each contain substantially immiscible fluids on opposite sides of the respective portion(s) of sample within each tube, such that the sample portion(s) in each tube is/are disposed between, and restrained by, the substantially immiscible fluid. The substantially immiscible fluids are preferably essentially immiscible with the sample. According to some embodiments, the sample comprises a polymerase chain reaction solution including primer, and at least one segment of a nucleic acid molecule to be amplified.
  • According to embodiments wherein microcapillary assemblies are provided, the tube or tubes used in the assembly may be self sealing or sealed at either or both ends thereof with a curable fluid, preferably a curable adhesive. Exemplary curable adhesives include those selected from the group consisting of light-curable, heat-curable, two-part-curable, moisture-curable and cyanoacrylate adhesives. When UV-curable adhesives are used and cured, UV-blocking spots may be provided on the cover and/or substrate, aligned with the sample retaining means, to protect the retained sample from harmful light.
  • According to yet other embodiments of the invention, a method is provided for loading a fluid sample into an assembly for isolating and retaining a small portion of the sample. Assemblies for carrying out such methods comprise a sample retaining means, for example, sample chambers, for retaining the small portion of the sample. The method of loading a fluid into an assembly may comprise providing a first fluid to be retained and providing a displacing fluid. An assembly is provided comprising a substrate and a cover having facing surfaces spaced from one another, wherein the facing surface of at least one of the substrate and the cover comprises a first material. The assembly has a flow-through channel between the substrate and the cover, and a first fluid retaining means bounded on at least one side thereof by the first material. The channel is in communication with the flow-through channel. The first fluid retaining means has a first affinity to the first fluid and a second affinity to the displacing fluid, and the flow-through channel has a third affinity to the first fluid and a fourth affinity to the displacing fluid. The first, second, third and fourth affinities are such that the first fluid retaining means retains at least a portion of the first fluid loaded into the assembly while displacing fluid displaces first fluid from the flow-through channel. The displacing fluid preferably can displace the first fluid from the flow-through channel without substantially displacing first fluid from the first fluid retaining means. The method further comprises causing the first fluid to be loaded into the flow-through channel and be retained by the first fluid retaining means, and causing the displacing fluid to enter the flow-through channel and displace first fluid from the flow-through channel without substantially displacing first fluid from the first fluid retaining means. According to some embodiments of the invention, the first affinity is greater than the second affinity. According to some embodiments, the fourth affinity is greater than the third affinity. According to some embodiments, the flow-through channel comprises at least one bounding surface and has dimensions, and the third and fourth affinities are provided by the dimensions of the flow-through channel and the respective affinities of the at least one bounding surface to the first fluid and to the displacing fluid.
  • According to some embodiments of the invention, a method is provided which comprises providing an assembly including a substrate and a cover in registry with and attached or affixed to one another and having facing surfaces spaced a substantially uniform distance apart from one another. The facing surface of the substrate comprises a first material having a first affinity to a sample of fluid medium to be contained in the assembly. A flow-through channel is disposed between the substrate and the cover, and the sample retaining means is bounded on at least one side thereof by the first material. The first material may be, for example, a surface of a glass plate or slide, or a patterned layer such as a hydrophobic material, layer deposited on the facing surface of the substrate. The sample retaining means is in communication with the flow-through channel and has a second affinity to the sample of fluid medium, wherein the second affinity is greater than the first affinity. The different affinities enable the sample retaining means to collect a portion of a sample of fluid medium which flows through the flow-through channel and to retain the portion while a second fluid medium flows through and displaces the sample from the flow-through channel.
  • The method of loading also comprises causing the sample to flow through the flow-through channel and to be retained by the sample retaining means, and causing a displacing fluid to flow through the flow-through channel and displace the sample of fluid medium from the flow-through channel without displacing sample from the sample retaining means, wherein the sample retaining means has a greater affinity for the sample than for the displacing fluid. The displacing fluid thereby covers, entraps, encircles, and/or surrounds, and isolates the sample retained by the sample retaining means on at least one side of the retained sample.
  • According to some methods of loading, the displacing fluid is preferably substantially immiscible with the sample of fluid medium, and more preferably, is essentially or completely immiscible with the sample. According to embodiments of the invention, the sample comprises an aqueous medium. According to embodiments of the invention, the displacing fluid may comprise a curable fluid, preferably a curable adhesive.
  • According to some methods of loading, the flow-through channel has an entrance opening for introducing sample to the channel, and an exit vent for the escape of displaced air, sample or excess displacing fluid from the channel, and the method further comprises introducing the displacing fluid to the channel through the entrance opening and causing sample in the channel to be displaced by the displacing fluid. The displacing fluid may cause excess sample to exit the assembly through the exit vent, particularly in embodiments wherein the displacing fluid is forced into the assembly by other than capillary forces, for example, by pressure loading. In some embodiments, the exit vent may comprise a porous or absorbent material such as paper, or other materials that are wettable by the sample.
  • According to some embodiments, the method further comprises sealing the entrance opening and exit vent after the displacing fluid displaces sample from the channel. In some embodiments, the displacing fluid cures to seal the entrance opening and the exit vent. Preferably, the displacing fluid cures adjacent to the sample retaining means to seal the sample within the sample retaining means. In some embodiments, the sample retaining means retains about 1 microliter to about 1 picoliter of sample or less, preferably about 10 nanoliters of sample or less, and for some embodiments, about 1, nanoliter or less.
  • According to embodiments of the invention, methods are also provided for determining the existence and/or quantitation of multiple types of nucleic acid target molecules. According to some embodiments, different amplification targeting reagents can be loaded separately or together with respective different samples to be amplified. According to some embodiments, different amplification targeting reagents are preloaded into different sample retaining means within a single assembly, for example, an assembly having two parallel but separated flow-through channels having respective sample retaining means in communication with one of the channels. According to some embodiments, each sample retaining means contains a specific primer, pair of primers, and/or probe and at least one of the sample retaining means contains a primer or probe that differs from the primer or probe of a second retaining means. A sample possibly containing more than one different target sequence to be amplified is then introduced and retained by the sample retaining means. When isolated, amplified and quantitated, the existence and quantitation of two or more different target sequences can be determined, for example by using a fluorescence energy transfer assay. According to the invention, the device is permanently sealed with a curable adhesive and a homogeneous assay is performed. The sealed assay does not require physical separation of components of the assembly to determine whether specific target sequences have been amplified.
  • The invention will now be described with reference to the drawing figures which are exemplary in nature and not intended to limit the scope of the invention in any respect.
  • FIG. 1 shows an exploded view of an analytical assembly according to an embodiment of the present invention, shown in partial cutaway. The assembly comprises a substrate 20 and a cover 22. In the embodiment depicted, the substrate and cover comprise substantially rigid plates such as microscope slides, but may comprise more flexible materials such as microscope slide coverslips. The substrate includes a bottom plate 23 having an inner surface 24, and a patterned layer 26 of a first material disposed on the inner surface. The first material may be a patterned layer comprising a hydrophobic material, and provides the substrate 20 with a facing surface 28 which faces the cover 22. Within the patterned layer 26 of the first material are formed a plurality of wells or holes therethrough defining sample chambers 30. Each sample chamber 30 has a closed lower end 32, defined by the inner surface 24 of the bottom plate 23. Each sample chamber also has a sidewall which extends from the closed lower end 32 up to the facing surface 28 of the substrate. In some embodiments, the sample chamber extends up through the flow-through channel.
  • The cover 22 comprises a top plate 34 and a facing surface 36 which may comprise the same material as the top plate or a patterned layer 38 of a second material disposed on the inner surface of the top plate. The second material may be the same as the first material, and in some embodiments is preferably moderately hydrophobic, that is, it preferably has a surface energy of from about 30 dynes/cm to about 50 dynes/cm. Exemplary materials for the second material include silanes, methacrylates, epoxies, acrylates, cellulosics, urethanes, silicones, and materials having good adhesion to the displacing fluid, for example, materials having good adhesion to displacing fluids comprising curable adhesives. The patterned layer 38 may be smooth and of uniform thickness or it may have a plurality of sample chambers formed therein complementary to the chambers formed in patterned layer 26.
  • When assembled, the substrate 20 and cover 22 are attached together, with the facing surface 36 of the cover being spaced from the facing surface 28 of the substrate. The space between the facing surfaces 36 and 28 defines a flow-through channel through which sample fluid and displacing fluid may travel. The facing surfaces 36 and 28 are maintained spaced apart by spacer strips 40, which may comprise transfer adhesive strips, films or adhesive layers applied to edge regions of the substrate. In embodiments wherein a spacer strip is used and comprises an adhesive material, the spacer may also provide means to hold the substrate and cover together. Other means of holding the substrate and cover together may be used and include clips and clamps. According to some embodiments, hydrophobic spacer materials are preferred.
  • As can be seen in FIG. 1, the spacer strips are disposed along the longitudinal edges of facing surface 28 but are not included on the lateral, edges of the facing surface 28. Thus, a gap is provided at the lateral edges of the assembled device and can be employed as an entrance opening and/or an exit vent.
  • When assembled, a sample of fluid medium, for example, an aqueous PCR sample, can be introduced to the flow-through channel by entering a gap at a lateral edge of the assembly. The sample flows through and fills the flow-through channel and the sample chambers, which are in fluid communication with the flow-through channel. Then, a displacing fluid is caused to enter the flow-through channel through a gap at a lateral edge of the assembly, and the displacing fluid flows through and fills the channel displacing sample from within the channel but without displacing sample from the sample chambers. The result is a plurality of discrete, isolated portions of the sample, held by the sample chambers.
  • According to the embodiment of FIG. 1 and other embodiments, sample chambers having dimensions of a few microns in diameter and a few microns in depth can be provided, and result in sample chamber volumes of about 10 picoliters or less. In embodiments wherein sample chambers are provided having diameters of about 0.5 millimeter and depths of about 0.05 millimeter, sample volumes of about 10 nanoliters can be achieved.
  • The flow-through channel may have a depth of about 0.1, to about 500 microns, preferably from about 10 to about 100 microns.
  • FIG. 2 is an exploded view of an analytical assembly according to an embodiment of the present invention, shown in partial cutaway. The assembly comprises a substrate 50 and a cover 52. In the embodiment depicted, the substrate and cover comprise substantially rigid plates such as microscope slides, but may comprise more flexible materials such as microscope slide coverslips. The substrate includes a bottom plate 53 having an inner surface 54, and a patterned layer 56 of a first material disposed on the inner surface. The first material may be a patterned layer comprising a hydrophobic material, and provides the substrate 50 with a facing surface 58 which faces the cover 52. Within the patterned layer 56 of the first material are formed a plurality of wells or holes therethrough defining bottom portions 60 of sample chambers. Each sample chamber bottom portion 60 has a closed lower end 62, defined by the inner surface 54 of the bottom plate 53. Each sample chamber also has a sidewall which extends from the closed lower end 62 up to the facing surface 58 of the substrate.
  • The cover 52 comprises a top plate 64 and a facing surface 66 which comprises a patterned layer 68 of a second material. The second material may be the same as the first material, and in some embodiments is preferably moderately hydrophobic, that is, it preferably has a surface energy of from about 30 dynes/cm to about 50 dynes/cm. The patterned layer 68 may be smooth and of uniform thickness or, as shown in FIG. 2, the patterned layer 68 may have a plurality of upper portions 69 of sample chambers formed therein which are complementary to the bottom portions 60 formed in patterned layer 56.
  • When assembled, the substrate 50 and cover 52 are attached together, with the facing surface 66 of the cover being spaced from the facing surface 58 of the substrate. The space between the facing surfaces 66 and 58 defines one or more flow-through channels through which sample fluid and displacing fluid may travel. Entrance openings 70 in the form of holes through the cover 52 are provided for the sample fluid and displacing fluid to enter the flow-through channel. Two entrance openings 70 are provided as the assembly depicted in FIG. 2 comprises two flow-through channels. An exit vent (not shown) is provided for each flow-through channel and may comprise a hole formed through the substrate or cover and in communication with the flow-through channel. The facing surfaces 66 and 58 are maintained spaced apart by spacer strips 72, which may comprise transfer adhesive strips or patterned layer applied to edge regions of the substrate. In embodiments wherein a spacer strip is used and comprises an adhesive material, the spacer may also provide means to hold the substrate and cover together. Other means of holding the substrate and cover together may be used and include clips and clamps. According to some embodiments, hydrophobic spacer materials are preferred.
  • According to some embodiments of the invention, for example, some embodiments similar to that of FIG. 2, a centrally located entrance opening in the top plate can be provided and a sample fluid and/or displacing fluid can be loaded into the assembly by capillary force, centrifugal force, or other loading techniques.
  • As can be seen in FIG. 2, the spacer strips 72 are disposed along the entire peripheral edge of facing surface 58. A spacer strip 74 may also be included to divide the assembly into different portions. As shown in FIG. 2, spacer strip 74 divides the assembly into first and second halves, 76 and 78, respectively.
  • When assembled, the lower and upper portions of the sample chambers complement one another to form a plurality a sample chambers, each having a closed lower end, a closed upper end, and a communication to a flow-through channel, the communication of each chamber being formed in the sidewall of the chamber. A sample of fluid medium, for example, an aqueous PCR sample, can be introduced to the flow-through channels through entrance openings 70. The sample flows through and fills the flow-through channels and both the lower and upper portions of the sample chambers, which are in fluid communication with the respective flow-through channels. Then, a displacing fluid is caused to enter the flow-through channels through the entrance openings 70, and the displacing fluid flows through and fills the channels displacing sample from within the channels but without displacing sample from the sample chambers. The result is a plurality of discrete, isolated portions of the sample, held by the sample chambers. According to some embodiments of the invention, two different sample fluids are used, one in each half (76, 78) of the assembly.
  • FIG. 3 is a cross-sectional view through a longitudinal central portion of an analytical assembly according to another embodiment of the present invention. The assembly of FIG. 3 comprises a substrate 90 and a cover 92. In the embodiment depicted, the substrate and cover comprise substantially rigid plates such as microscope slides, but may comprise more flexible materials such as films or microscope slide coverslips. The substrate includes a bottom plate 93 having an inner surface 94, and a patterned layer 96 of a first material disposed on the inner surface. The first material, may be a patterned layer comprising a hydrophobic material, and provides the substrate 90 with a facing surface 98 which faces the cover 92. Within the patterned layer 96 of the first material are formed a plurality of wells or holes therethrough defining bottom portions 100 of sample chambers. Each sample chamber bottom portion 100 has a closed lower end 102, defined by the inner surface 94 of the bottom plate 93. Each sample chamber also has a sidewall which extends from the closed lower end 102 up to the facing surface 98 of the substrate.
  • The cover 92 comprises a top plate 104 and a facing surface 106 which comprises a patterned layer 108 of a second material. The second material may be the same as the first material, and in some embodiments is preferably moderately hydrophobic, that is, it preferably has a surface energy of from about 20 dynes/cm to about 30 dynes/cm. The patterned layer 108 may be smooth and of uniform thickness or, as shown in FIG. 3, the patterned layer 108 may have a plurality of upper portions 109 of sample chambers formed therein which are complementary to the bottom portions 100 formed in patterned layer 96.
  • The substrate 90 and cover 92 are attached together, with the facing surface 106 of the cover being spaced from the facing surface 98 of the substrate. The space between the facing surfaces 106 and 98 defines one or more flow-through channels 110 through which sample fluid and displacing fluid may travel. An entrance opening 112 in communication with the flow-through channel 110, in the form of a gap formed at a lateral end of the assembly, is provided for the sample fluid and displacing fluid to enter the flow-through channel 110. An exit vent 114 is provided for sample to exit the channel 110 as the sample is displaced from the channel by the displacing fluid. The entrance opening and exit vent may instead be in the form of holes formed through the substrate and/or cover. The facing surfaces 106 and 98 are maintained spaced apart by spacer strips 116, which may comprise transfer adhesive strips or a patterned layer applied to edge regions of the substrate. In embodiments wherein a spacer strip is used and comprises an adhesive material, the spacer may also provide means to hold the substrate and cover together. Other means of holding the substrate and cover together may be used and include clips and clamps.
  • As can be seen in FIG. 3, the spacer strips are disposed along the longitudinal edges between the facing surfaces but are not included on the lateral edges of the of facing surfaces. Thus, gaps used as the entrance opening and exit vent are provided at the lateral edges of the device.
  • As can be seen in FIG. 3, the lower portions 100 and upper portions 109 of the sample chambers complement one another to form a plurality a sample chambers 118, each having a closed lower end, a closed upper end, and a communication to a flow-through channel, the communication of each chamber being formed in the sidewall of the chamber. A sample of fluid medium, for example, an aqueous PCR sample, can be introduced to the flow-through channel 110 through entrance openings 112. The sample flows through and fills the flow-through channel and both the lower and upper portions of the sample chambers. Then, a displacing fluid is caused to enter the flow-through channel through the entrance openings, and the displacing fluid flows through and fills the channel displacing sample from within the channel but not displacing sample from the sample chambers. The result is a plurality of discrete, isolated portions of the sample, held or retained by the sample chambers. The sample fluid retained in the sample chambers may form a cylinder extending from the closed lower, through and interrupting the flow-through channel, and up to the closed upper end.
  • FIG. 4 is a perspective view of a bottom portion of an analytical assembly according to an embodiment of the present invention, with the cover removed. The bottom portion of the assembly comprises a substrate 120, depicted in the figure as a coated substantially rigid plate such as microscope slide. The substrate includes a bottom plate 122 having an inner surface 124, and a patterned layer 126 of a first material disposed on the inner surface. The patterned layer has a substantially uniform thickness. The first material may comprise a hydrophobic material, and provides the substrate 120 with a facing surface 128 which faces a cover (not shown), for example, the cover used in the embodiment of FIG. 1. On the patterned layer 126 are formed a plurality of patches 130 of sample retaining material, preferably capable of retaining a fluid sample volume of from about 1 microliter to about 1 picoliter or less. Adhesive strips, a patterned layer of pressure sensitive adhesive, or a patterned layer of a curable adhesive, 132, may be used to attach a cover to the bottom portion.
  • According to some embodiments, the patch occupies a volume of about 100 nanoliters or less. The patch may be an absorbent material which absorbs and retains sample, or the patch may be made of material which has an affinity sufficient enough to retain, for example, an aqueous PCR sample. According to some embodiments, the patches of material comprise a hydrophilic material. According to embodiments of the invention wherein the sample retaining patches comprise a substantially non-absorbent material which has a retaining affinity for a sample, the patch defines a closed lower end of a sample chamber defined between the exposed surface of the patch and the facing surface of a cover. In some embodiments, a patch of porous material may fill a volume between the substrate and the cover and the sample chamber is defined by the void volume of the porous patch.
  • FIG. 5 is a cross-sectional view through a longitudinal central portion of an analytical assembly according an embodiment of the present invention wherein sample chambers comprise absorbent material patches or comprise the volume between complementary opposing patches of sample retaining materials.
  • The assembly of FIG. 5 comprises a substrate 134 and a cover 136 attached to one another. In the embodiment depicted, the substrate and cover comprise substantially rigid plates such as microscope slides. The substrate includes a bottom plate 138 having an inner surface 140, and a patterned layer 142 of a first material disposed on the inner surface. The first material may be a hydrophobic material, and provides the substrate 134 with a facing surface 144 which faces the cover 136. On the patterned layer 142 are formed a plurality of sample retaining patches 146 which define sample chambers by absorbency or surface energy or other retentive property.
  • The cover 136 comprises a top plate 148 and a patterned layer 150 of a second material defining a facing surface 152. The second material may be the same as the first material, and in some embodiments is preferably a hydrophilic material if aqueous samples are to be retained and isolated. The patterned layer 150 may be smooth and of uniform thickness or, as shown in FIG. 5, the patterned layer 150 may have a plurality of sample retaining patches 154 complementary to and mirroring patches 146.
  • The substrate 134 and cover 136 are attached together, with the facing surface 152 of the cover being spaced from the facing surface 144 of the substrate. The space between the facing surfaces 152 and 144 defines one or more flow-through channels 156 through which sample fluid and displacing fluid may travel. An entrance opening 158 comprising a hole formed through the cover and in communication with the flow-through channel 156. An exit vent 160 comprising a hole through the substrate 134 is provided for sample to exit the channel 156 as the sample is displaced from the channel by the displacing fluid.
  • The facing surfaces 152 and 144 are maintained spaced apart by spacer strips 162, which may comprise transfer adhesive strips applied to edge regions of the substrate. In embodiments wherein a spacer strip is used and comprises an adhesive material, the spacer may also provide means to hold the substrate and cover together. Other means of holding the substrate and cover together may be used and include clips and clamps.
  • According to some embodiments, the patches comprise an absorbent sample retaining material. According to some embodiments, the patches retain sample by surface energy, and have an affinity for a sample, for example, a hydrophilic material patch which retains an aqueous sample on a surface 164 thereof. In some embodiments, the affinity may be induced by optical or electromagnetic means. The sample chamber may comprise the volume 166 between the facing surfaces of each complementary pair of patches, wherein the sample chambers have no sidewalls but are defined as the volume between the two complementary patch surfaces. The affinity of the two opposing patch surfaces to a retained sample is sufficient to support a column of sample between the two patches while a displacing flows through the channel adjacent the column. In some embodiments, patches of porous material extending from the substrate to the cover may interrupt the flow-through channel and the sample chamber may be defined as the void volume of a porous patch.
  • Sample flows through and fills the flow-through channel and the sample chambers, which are in fluid communication with the flow-through channel. A displacing fluid can subsequently be caused to enter the flow-through channel through the entrance opening, displacing sample from within the channel but not displacing sample from the sample chambers. The result is a plurality of discrete, isolated portions of the sample, held or retained or absorbed by the sample chambers.
  • FIG. 6A is a perspective view of another embodiment of the present invention, and FIG. 6B shows an enlargement of portion VIB from FIG. 6A. As can be seen in FIGS. 6A and 6B, a bottom support plate 174 supports a sample retaining means 167 comprising a plurality of pores or cavities 168 having open ends in communication with an exposed surface 170 on which a sample of fluid is applied. The pores have a first affinity to a sample of fluid medium such that when the sample is disposed upon the exposed porous surface 170 the sample is drawn into and retained by the plurality of pores 168. For example, through capillary or other force, the sample may wet and fill the pores 168. The pores 168 have substantially the same volume as one another and each has a closed lower end 169. Preferably the pores 168 each have a volume of about 1 μl or less, more preferably, about 10 nl or less, and for some applications about 1 nl or less. The closed lower ends 169 of the pores are defined or bound by a layer of coating material 172 deposited on a bottom plate 174. The coating material may be a hydrophilic material if aqueous samples are to be retained in the pores.
  • A cover 171, is provided on one of the sample retaining means shown in FIG. 6A. The cover 171 can be used to displace sample fluid from the porous surface 170 of the retaining means and for sealing sample within the pores 168. The cover 171 displaces sample fluid from the porous surface without displacing sample from within the pores. Preferably, the cover 171 comprises a hydrophobic coating 173 on the surface of the cover which contacts the exposed surface 170 of the sample retaining means. The coating 173 contacts sample and can be used to squeeze excess sample off of the surface 170. A means for sealing the sample of fluid within the pores is also provided, and in the embodiment shown in FIG. 6B the means for displacing excess sample and the means for sealing sample in the pores are the same means, that is, the cover 171. Preferably, the coating 173 is adhesive as well as hydrophobic, although an adhesive and/or hydrophobic coating may instead or additionally be provided in the exposed surface 170 of the sample retaining means. Sealing the sample in the pores prevents evaporation and contamination of the sealed sample.
  • The displacing means and the sealing means, for example the cover 170 shown in FIGS. 6A and 6B, may be pressed against the exposed surface 170 by any of a variety of means. Clamps, clips or springs may be used to attach the sealing means to the exposed surface 170, and/or to force the displacing means against the exposed surface.
  • According to some embodiments of the invention, other means may be used as displacing means for a device similar to, or the same as, that shown in FIGS. 6A and 6B. For example, according to some embodiments, a drop or bead of curable fluid, for example, a curable adhesive, can be forced across an exposed surface of a sample retaining means having one or more sample retaining cavity, recess, hole or pore formed in the surface. Gravity, pressurized gas, or mechanical means, for example, can be used to force the curable fluid across the exposed surface, displacing excess sample from the surface without displacing sample from within the sample retaining cavity. According to some embodiments of the invention, as the curable fluid traverses the exposed surface a thin layer of the fluid is deposited on the surface and coats the top of a sample portion retained in the cavity. Upon curing, the curable fluid forms a seal for the sample retained within the cavity such that the sample retained is isolated from other cavities and from excess sample. The sealed sample is protected from contamination and evaporation. Preferably, the curable fluid seal is sufficient to prevent contamination and evaporation of the entrapped sample during thermal cycling conditions generally used in PCR amplification methods.
  • According to some embodiments of the invention, separate displacing means and sealing means are provided for isolating a sample portion within a sample retaining cavity. For example, according to embodiments of the invention, a displacing means is provided for removing excess sample from an exposed surface of a device having a sample retaining cavity associated therewith. The sample retaining cavity may be formed on, formed in, in contact with or adjacent to a substrate. The cavity may be defined by at least one sidewall, and the sidewall may comprise a hydrophilic material. The displacing means may comprise a wiping device such as a squeegy, a wiper, a blade or other scraping or rubbing device which can physically move excess sample away from the open upper end of a sample retaining cavity and preferably off of the exposed surface of the sample retaining means. Preferred displacing means may comprise a wiping device made of an elastomeric material, for example, a stiff silicone rubber blade. Preferably, the wiping device comprises a hydrophobic material, to which aqueous sample fluids will not cling.
  • According to some embodiments, the displacing means comprises an opening or channel through which a sample retaining means snugly fits, and a wiping device is provided adjacent to the opening or channel such that the wiping device wipes excess sample from an exposed surface of the sample retaining means as the retaining means is forced through the opening or channel.
  • According to some embodiments of the invention, sealing means are applied to the sample retaining cavity immediately after the displacing means displaces excess sample from adjacent the sample retaining cavity. When retained sample portions having volumes of about 1 μl or less are formed, they tend to evaporate rapidly and thus require prompt sealing to protect sample integrity. According to some embodiments of the invention, a wiping device is used to displace excess sample fluid from an exposed surface of a sample retaining means, and the wiping device is provided with a trailing edge that pulls a bead or drop of a curable sealing fluid across the exposed surface as a leading edge of the wiping device displaces excess sample.
  • EXAMPLE 1 AND CONTROL 1
  • Conventional PCR was performed in 0.2 ml polypropylene ependorf tubes to set standards. Microcapillary PCR was then performed according to the present invention on the same sample material in quartz glass microcapillaries. The PCR sample containing the nucleic acid sequence to be amplified was prepared and included materials from a “TaqMan” kit available from Perkin-Elmer, Applied Biosystems Division, Foster City, Calif. The kit contained human DNA at 10 ng/μl, the forward primer 5′-TCACCCACACTGTGCCCATCTACGA-3′ (SEQUENCE ID NO:1) and the reverse primer 5′-CAGCGGAACCGCTCATTGCCAATGG-3′ (SEQUENCE ID NO:2) that amplify a 295 bp segment of the human β actin gene, and a dual fluor-labeled probe comprising 5′-[6FAM]-ATGCCC-[TAMRA]-CCCCCATGCCATCCTGCGT-3′ (SEQUENCE ID NO:3) that is complementary to bases 31, to 56 of the PCR product. The designation FAM represents 6-carboxyfluorescein, and TAMRA represents 6-carboxytetramethyl-rhodamine. With reference to the Control 1 and Example 1, the term “FAM” is referred to herein as “fluorescein” and the term “TAMRA” is referred to herein as “rhodamine”.
  • The PCR sample comprised Taq polymerase available from Boehringer Mannheim, Indianapolis, Ind., and anti-Taq antibody from Clonetech, Palo Alto, Calif. The sample also comprised concentrations of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, about 0.01% by weight gelatin, 500 μg/ml to 5 mg/ml bovine serum albumin (BSA), 3.5 mM MgCl2, 0.2 mM each of dATP, dCTP, dGTP and dUTP, 0.3 μM forward and reverse primers, 0.2 mM dual-fluor-labeled probe, 0.5 manufacturer's units (u) Taq polymerase per 1.0 μl PCR mixture, 0.1 μl anti-Taq antibody per 10 μl PCR mixture, and varying amounts of template DNA. The specific activity of Tag polymerase was about 250,000 units per mg which, at a molecular weight of 100,000 Daltons, translates to about 109 molecules per μl. Since β actin is a single copy gene, it was estimated that there is one copy of β actin template per 3 pg of human genomic DNA. In some PCRs the dual-fluor-labeled probe was replaced with the fluorescent, DNA-staining dye SYBR™ Green I (product # S-7567) available from Molecular Probes, Eugene, Oreg., used a 10−4 dilution from the stock supplied by the manufacturer.
  • The conventional PCRs (CONTROL 1) performed in the 0.2 ml polypropylene tubes were thermocycled in a model 9600 thermocycler from Perkin Elmer using 92° C. for 15 seconds, 54° C. for 15 seconds, and 72° C. for 15 seconds, for 40 cycles.
  • Microcapillary PCR was performed according to the present invention in quartz glass microcapillaries from Polymicro Technologies (Phoenix, Ariz.). These capillaries had inner diameters ranging from 20 μm to 75 μm and outer diameters of 250 μm to 375 μl. The capillaries come with either a polyimide or Teflon external coating to make them flexible. Because the polyimide coating is opaque and fluorescent, it had to be removed before use. The coating was removed by flaming a segment of polyimide capillary with a Bunson burner for several seconds and then gently wiping off the burned coating. Flaming and wiping was repeated as necessary until the capillary was clear. The resulting bare capillaries were very fragile. The Teflon coated microcapillaries were easier to work with since the optically clear and non-fluorescent Teflon coating did not need to be removed. Both types of capillaries gave equivalent results in PCR.
  • Hundreds of microcapillary tubes (EXAMPLE 1) were filled by touching an open end to a drop of the PCR sample which wicked in by capillary action. The microcapillaries were then sealed and supported by gluing the two ends thereof to two respective coverslips, leaving an unsupported segment in the middle, thus minimizing thermal mass. A UV-curable fluid glue was used to seal the end of the tube and to glue the tube ends to coverslips. Assemblies comprising a plurality of microcapillaries were formed by sealing the ends of each tube in the assembly to the same pair of coverslips.
  • The glue was available as optical adhesive #81 from Norland Products, New Brunswick, N.J. The glue was cured by exposure to 366 nm UV light. A source of 366 nm wavelength light is UV lamp model UVL-21, available from UVP Inc., San Gabriel, Calif. The lamp was held about 1 cm from the sample for 30 seconds. The PCR mixture was shielded from UV light by laying a small piece of opaque paper over the center section of the capillary during UV exposure.
  • FIG. 7 is a top plan view of an exemplary microcapillary device used in accordance with Example 1 of the present invention. As shown in FIG. 7, an assembly 176 is provided having four microcapillary tubes 178 having inner diameters of about 100 microns each, and two support tubes 180 having outer diameters of about 1.5 mm. The ends of the tubes 178 and 180 were adhered to two respective plates or bases 182 with UV-curable adhesive 184. One end of each tube microcapillary and support tube shared a respective plate 182. In the embodiment shown in FIG. 7, the plates comprised standard 1″×1″ microscope cover slips and the tubes were each about 4 cm long. All the tubes were arranged substantially parallel to one another with the microcapillary tubes 178 each being positioned between the two larger diameter support tubes.
  • The sample holding assembly 176 was attached with SCOTCH tape to the sample holder of a Rapidcycler air oven available from Idaho Technologies, Idaho Falls, Id., and cycled through a protocol comprising cycles of 92° C. for 5 seconds, 54° C. for 5 seconds, and 72° C. for 15 seconds, for 40 cycles. The cycling protocol took about 30 minutes in the Rapidcycler.
  • After PCR cycling, fluorescence of the samples was measured with a Zeiss Axiovert 410 laser scanning microscope using a 20×0.5NA objective, 15 mW external argon laser approximately 5% of the power of which was focused to a spot size of 1 μm2, and band pass filters of 515-565 nm for fluorescein and SYBR™ Green, and >590 nm for rhodamine (power loss and spot size estimates provided from the manufacturer). Average pixel intensity was measured in regions of about 20 μm×50 μm overlying the capillary image. Fluorescence intensity was examined visually along the 2.5 cm lengths of capillaries by manually translating the stage; quantitative measurements were made every 2-5 mm or more often if variability in the fluorescence signal was observed.
  • Results
  • When PCRs were performed in 20 μl volumes in ependorf tubes in a model 9600 Thermocycler (Perkin Elmer, Norwalk, Conn.), the β actin primers amplified an approximately 300 bp segment from human DNA as expected. PCRs performed in the presence of the TaqMan probe were transferred to capillary tubes and analyzed by fluorescence microscopy. Typical values for average pixel intensity were about 130 (relative fluorescence units) for fluorescein and about 60 for rhodamine, with values of background emission from empty capillaries of about 20 at both wavelengths. In different experiments the fluorescein:rhodamine (F/R) intensity ratio varied from about 1.0:1.0 to about 2.0:1.0 in samples containing PCR product. For negative control PCRs containing no template DNA, no Taq polymerase, or no reverse primer, the rhodamine emission was about the same (about 60), while the fluorescein emission was reduced to about 30, giving a F/R intensity ratio of about 0.5. The absolute values of fluorescein and rhodamine emission varied between experiments and with small changes in machine settings (laser power, attenuation, brightness, contrast) whereas the F/R intensity ratio was fairly constant. Therefore, the F/R intensity ratio was used as a measure of whether the β actin product had been amplified.
  • The yield of PCR product in conventional reactions in polypropylene tubes was estimated by ethidium bromide staining of product in agarose gels, and by adding a known amount of 32P-dCTP to a PCR and counting radioactivity in the purified PCR product. Both methods gave an estimate of about 1011 product molecules/μl of PCR. This corresponds to a product concentration of about 0.16 μM which implies that about half of the PCR primers were converted to product.
  • To assess the extent of degradation of TaqMan probe following PCR, the effect of mung bean nuclease on the F/R intensity ratio was examined. Treatment of probe with mung bean nuclease for 10 minutes at 37° C. raised the F/R intensity ratio from 0.5 to 5. This presumably represents complete degradation since further incubation did not increase the ratio. An F/R intensity ratio of 1.5, characteristic of positive PCRs, therefore suggests that about 30% of probe was degraded. This corresponds to a concentration of degraded probe of 0.06 μM and implies that about one third of the probe that could have hybridized to PCR product was degraded.
  • When PCRs were performed in small diameter glass capillaries, the volume of the reaction was too small to detect PCR product by standard gel electrophoresis. While products might have been detectable by capillary electrophoresis, it was of interest to see whether the TaqMan assay could be used as a detection method. The F/R intensity ratio was therefore used as a surrogate measure of amplification. This ratio was about 0.5 in negative control reactions (no template, no enzyme, or no reverse primer) and was usually greater than 1 in samples where product was expected. In capillaries containing terminal dilutions of genomic DNA template, the ratio sometimes varied with position along the capillary, which was attributed to localized accumulation of degraded probe, discussed in more detail below. In cases where the intensity ratio varied, the maximum value of the F/R intensity ratio in the capillary was used as the measure of whether the target sequence had been amplified.
  • A histogram of the maximum values of the F/R intensity ratio in over 100 capillary reactions of terminally diluted genomic DNA is shown in FIG. 8, along with the corresponding values for negative control reactions. The negative controls had a mean ratio of 0.5 with a range of 0.4 to 0.9. The experimental samples had a bimodal distribution with one arm of the distribution paralleling that of the negative control samples. This suggests that the experimental samples consisted of positive and negative samples. Since the nadir of the experimental sample distribution occurred at about an F/R intensity ratio of 1, we chose this value as a “cut-off” to distinguish positive from negative samples. This “cut-off” is consistent with the F/R values of 1 to 2 in PCRs carried out in conventional volumes in ependorf tubes.
  • Using a “cut-off” of F/R≧1, the sensitivity of the detection system was estimated by mixing exonuclease-digested probe with undegraded probe. An F/R ratio of ≧1 was obtained when ≧0.02 μM degraded probe was mixed with 0.2 μM undegraded probe. This corresponds to about 10 molecules of degraded probe in a 10 nl volume. Using the confocal feature of the microscope, it was determined that the signal decreased rapidly when the depth of field dropped below 20 μm. Thus, an estimate of the lower limit of detection for this system is about 105 molecules of degraded probe in a volume of 20 μm×20 μm×20 μm, that is, about 10 picoliters (pl).
  • As has been noted by others performing PCR in glass tubes, for example in the publication of Wittwer et al., Rapid Cycle DNA Amplification: Time and Temperature optimization, BioTechniques, Vol. 10, pp. 76-83 (1991), it was important to include bovine serum albumin (BSA) in the PCRs. Presumably, BSA blocks non-specific sticking of DNA to glass. When BSA was not included, the F/R intensity ratio was about 0.5. Generally, a 500 μg/ml, final concentration of BSA was used in the PCRs although for some batches of BSA the concentration was increased to 5 mg/ml.
  • Human DNA was diluted so that PCRs contained 0-14 haploid genome equivalents (0-42 pg)/capillary. Reactions were scored as positive if the maximum F/R intensity ratio along the tube was 1.0 or greater. The results for a series of PCRs in capillaries with internal diameters of 20 to 75μ are shown in Table 1 below and shown graphically in FIG. 8.
  • TABLE 1
    Replicate PCRs in microcapillaries with
    terminal dilutions of genomic DNA
    Haploid
    genome Probability
    Capillary equivalents of ≧1 template Fraction
    diameter per capillary, per capillary positive Number of
    (microns) m 1-e−m PCRs PCRs
    20 0 0.00 0.00 2
    0.2 0.18 0.10 10
    0.5 0.39 0.33 15
    25 0 0.00 0.00 4
    0.4 0.33 0.28 18
    0.8 0.55 0.50 8
    1.5 0.78 1.00 3
    3 0.95 1.00 3
    30 0 0.00 0.00 8
    0.5 0.39 0.52 23
    1 0.63 0.92 13
    1.5 0.78 1.00 10
    4 0.98 1.00 3
    50 0 0.00 0.00 13
    0.4 0.33 0.00 3
    0.8 0.55 0.67 27
    1.5 0.78 0.82 28
    3 0.95 1.00 2
    6 1.00 0.89 9
    13 1.00 1.00 7
    75 0 0.00 0.00 7
    0.8 0.55 0.50 6
    1.7 0.82 0.67 12
    3.4 0.97 1.00 9
    7 1.00 1.00 5
    14 1.00 1.00 6
  • Capillaries containing more than one haploid genome equivalent generally had F/R intensity ratios greater than 1. In capillaries containing less than one haploid genome equivalent, the fraction of capillaries with F/R intensity ratio≧1 was roughly proportional to the fraction of capillaries expected to contain 1 or more template molecules. This fraction was calculated from the Poisson distribution as 1−e−m where m=the amount of DNA/capillary/3 pg. The results provide strong support for the hypothesis that reactions were positive when capillaries contained 1 or more template molecules.
  • EXAMPLE 2
  • Similar results were obtained with another preparation of human genomic DNA obtained from Promega: at 8 haploid genome equivalents (24 pg) per capillary, 4 of 4 capillaries gave maximum F/R intensity ratios≧1; at 0.7 haploid genome equivalents (2 pg) per capillary, 3 of 4 capillaries were positive; at 0.1 haploid genome equivalents (0.4 pg) per capillary, 0 of 4 capillaries were positive.
  • EXAMPLE 3
  • The inhomogeneity of F/R intensity ratio along the length of capillaries containing about 1 template molecule suggested that residual localization of degraded probe may be observed as a result of localized accumulation of PCR product. To investigate this possibility, amplifications in 2.5 cm long sections of capillaries containing about 0.5 haploid genome equivalent per capillary were performed. A plot of F/R intensity ratio along a few representative capillaries is shown in FIGS. 9-14. Some capillaries had a single peak while others had two. Two peaks indicate two areas where PCR product and degraded probe had accumulated. The half-widths of the peaks (measured at half-height) were about 3-6 mm. When capillaries were left overnight, the distributions broadened and flattened. Inhomogeneities in F/R intensity ratio were not seen when capillaries were examined before PCR, or after PCR in capillaries containing no template DNA or about 75 initial template molecules. Representative experiments are shown in Table 2 below. The results indicate that high variability in the F/R intensity ratio is specific for capillaries with about 1 target molecule and decreases with time.
  • TABLE 2
    NUMBER OF
    HAPLOID CAPILLARIES STANDARD
    GENE WITH AVERAGE DEVIATION
    EQUIVALENTS TIME WHEN MAXIMUM F/R F/R OF F/R
    PER FLUORESCENCE NUMBER OF INTENSITY INTENSITY INTENSITY
    GROUP CAPILLARY ANALYZED CAPILLARIES RATIO >1 RATIO RATIO
    A
    0 1 HOUR AFTER PCR 9 0 0.50 0.05
    B 75 1 HOUR AFTER PCR 10 10 1.75 0.10
    C 1 BEFORE PCR 5 0 0.51 0.04
    D 1 1 HOUR AFTER PCR 5 4 0.83 0.46
    E 1 24 HOURS AFTER PCR 5 3 0.89 0.23
    F 1 48 HOURS AFTER PCR 5 1 0.82 0.23
    G 1 BEFORE PCR 5 0 0.46 0.03
    H 1 1 HOUR AFTER PCR 5 5 1.22 0.43
    I 1 24 HOURS AFTER PCR 5 5 1.14 0.25
    J 1 48 HOURS AFTER PCR 5 5 1.11 0.21
  • These results support a theory that the inhomogeneities were not due to smudges blocking light transmission, thermal variations during PCR, or photobleaching. It was also determined that the 30 seconds of UV irradiation used to cure the sealing glue at the ends of the capillaries did not alter the F/R ratio. Photobleaching of fluorescein (but not the rhodamine) was detectable with repeating laser scanning at the highest power, with 10 scans reducing the fluorescein signal about 10%; however, only 1 or 2 scans at this power were performed at any one location when collecting data, and thus photobleaching does not explain the inhomogeneities. To see if convection after PCR might be broadening peaks, 0.2% by weight to about 0.8% by weight low-melt agarose was added to some PCRs but no effect of the agarose was noted. A few of the capillaries fortuitously contained air bubbles that divided the sample into two or more segments. In several of these cases, the F/R intensity ratio was ≧1 on one side of a bubble and 0.5 on the other side, consistent with blocked diffusion of degraded probe.
  • To confirm the results of the TaqMan assay, the fluorescent dye SYBR™ Green I was substituted for the TaqMan probe. Because the fluorescence of SYBR™ Green I increases many fold in the presence of double stranded DNA, it can be used to detect double stranded PCR product, although it does not distinguish spurious product such as “primer dimer” from desired product. The SYBR™ Green I fluorescence assay has to be performed at elevated temperature to reduce background fluorescence from non-specific annealing of primers. To do this, segments of capillaries were placed, after PCR, in about 1 ml of mineral oil in a special 35 mm petri dish, the bottom of which was made of optically clear, conducting glass coated with a thin layer of indium tin oxide available from Bioptechs, of Butler, Pa. By applying 3-4 volts across the bottom of the dish, the temperature in the oil, was raised to about 70° C. Because only a portion of the bottom of the petri dish was flat and accessible in the microscope, the capillaries had to be cut after PCR into approximately 1 cm segments in order to be imaged.
  • Using this device, PCR product derived from single template molecules could be detected. For example, the fluorescence intensity was 155-194 in 7 capillary segments derived from a PCR containing 30 haploid genome equivalents per cm of capillary length, compared to a fluorescence intensity of 40-57 in 7 capillary segments containing no template DNA. The variability in fluorescence at 2-3 mm intervals along these capillaries was about 20%. In contrast, in 7 capillary segments derived from PCRs containing 0.3 haploid genome equivalents per cm of capillary, the fluorescence intensity varied from 49 to 136, with 4 capillary segments having fluorescence intensity <73 at all tested positions along their lengths, 2 capillary segments having fluorescence intensity >100 at all positions, and one capillary having a fluorescence intensity of 68 at one end increasing to 122 at the other end thereof. These results provide additional evidence that PCR products derived from single molecules can be detected and remain localized in microcapilaries for several hours after PCR.
  • EXAMPLE 4
  • A device substantially similar to that depicted in FIG. 3, having a substrate and a cover comprising microscope slide coverslips, and provided with first and second patterned layers comprising cured Norland 68 UV-curable adhesive coated respectively thereon by screen printing, was filled by capillary action with a Beta-actin polymerase chain reaction solution. The substrate and coverslip were spaced apart and held together with adhesive strips and the first and second patterned layers had complementary sample chamber portions formed therein having radii of about 1 mm. A displacing fluid comprising uncured Norland 81 UV-curable adhesive was then loaded into the flow-through channel by capillary action and displaced the polymerase chain reaction solution from the flow-through channel but not from the sample chambers. The device was then exposed to UV light to cure the displacing fluid, and the sample portions were shielded from the light with a transparency laid on top of the device and having inked spots aligned with the sample chambers. The device was then thermocycled and analyzed by fluorescence microscopy as described in connection with Example 1. Six of six sample chambers estimated to contain an average of 3 copies of genomic DNA template had F/R intensity ratios greater than 1 and four of six sample chambers estimated to contain an average of 0.3 template copies had F/R intensity ratios of greater than 1.
  • Discussion
  • The results presented above provide strong evidence that the TaqMan assay can easily detect as little as 1 template molecule when the volume of the reaction is on the order of 10 nl. For 50 μm inner diameter capillaries, the reaction volume is about 20 nl per 1 cm length of capillary. Using terminal dilutions of two preparations of genomic DNA, good correlation has been found according to the invention between the number of capillaries giving positive reactions and the number of capillaries calculated to contain 1 or more template molecules. The inference of single molecule sensitivity is further supported by the observation of peaks of elevated F/R emission along the length or capillaries estimated to contain 1 or 2 template molecules. Presumably these peaks results from localized accumulation of PCR product and corresponding degraded probe.
  • The localized accumulations of PCR product and degraded probe remained detectable for several hours after PCR. It is believed that the narrowness of the capillaries effectively eliminates convection so that molecular movement is dominated by diffusion. Molecules the size of completely degraded probe (e.g. rhodamine-dGTP) have diffusion constants of about 3-5×10−6 cm2/sec in water at room temperature as reported in the publication of Chang, PHYSICAL CHEMISTRY with application to Biological Systems, MacMillan Publishing Co., New York, page 87. The diffusion constant increases with temperature as D is proportional to kT/η, where T is measured in degrees Kelvin and η, the viscosity, decreases with temperature. The viscosity of water decreases about 3-fold as temperature increases from 25° C. (298° K.) to 92° C. (365° K.); thus, D would increase about 3.25-fold over this temperature range. The root mean square distance traveled by a molecule with diffusion constant D in time t is (2Dt)1/2 or about 2-5 mm in 2 hours for molecules the size of completely degraded probe at temperatures between 25° C. and 92° C. The PCR product, based on its molecular weight, should have a diffusion constant of about 0.45×10−6 cm2/sec and should diffuse about 3 times less far than degraded probe in the same time. These calculations indicate that, the widths of the observed fluorescent peaks are consistent with diffusion-mediated spreading of PCR product and degraded probe.
  • The width of peaks might be slightly larger than predicted by diffusion, due to the tendency of PCR to saturate in regions where the concentration of PCR product is high. So long as all of the amplified molecules are replicated each cycle, the progeny from a single starting template will have the same average displacement (i.e., root mean square displacement) as a collection of independent molecules, that is, they will appear to diffuse with a root mean square displacement that is proportional to the square root of the time. However, as PCR begins to saturate, molecules near the center of the distribution where concentration is high have a lower probability of being replicated than molecules near the “edge” of the distribution where concentration is low. This unequal probability of replication tends to make the distribution broader.
  • The diffusion model suggests that detection of single target molecules by TaqMan assay would be difficult using conventional size capillaries. A 5 mm segment (characteristic diffusion distance for degraded probe) in a 0.8 mm inner diameter capillary contains about 2.5 μl. After spreading in 1/50th of this volume (about 50 nl), the fluorescent signal obtained from single starting molecules in 50 μm inner diameter capillaries was sometimes not above the background (see Table 2, average F/R intensity at 24 and 48 hours and number of capillaries in which maximum F/R>1). Thus, PCR would have to be significantly more efficient than achieved to detect single molecules in volumes greater than 1 μl.
  • While limited diffusion of product and degraded probe was important for our ability to detect single starting molecules in capillaries, diffusion of reactants present in the original reaction mixture is usually not limiting for PCR; for example, at the conventional concentration of Tag polymerase used here, the average distance between polymerase molecules is about 1 μm, and polymerase molecules (MW about 100,000 Daltons) diffuse this distance in about 0.01 second. Thus, all portions of the reaction should be sampled by a polymerase molecule many times each second.
  • The data also shows that single DNA molecules or segments can be detected with the “TaqMan” system when PCRs are confined to volumes of 100 nanoliters or less, preferably 60 nanoliters or less, by using capillaries with small diameters and relying on the fortuitously slow rate of diffusion. Many PCR reactions with single molecule sensitivity can be performed simultaneously in small spaces by confining PCR's to small regions in 3 dimensions as described in other embodiments of the present invention. The devices of the invention can be used to measure the number of template molecules in a sample simply by counting the number of positive reactions in replicate PCRs containing terminal dilutions of sample. Due to the closed system environment which prevents carryover contamination, and the ability to automate fluorescence detection, devices according to the present invention and methods for using the devices have significant potential for clinical uses of PCR. An assay based on presence versus absence of PCR product in replicate reactions may be more robust with respect to small changes in amplification efficiency than quantitative competitive assays or time-to-reach-threshold level assays that require assumptions about relative or absolute amplification rates.
  • Although the present invention has been described in connection with preferred embodiments, it will be appreciated by those skilled in the art that additions, modifications, substitutions and deletions not specifically described may be made without departing from the spirit and scope of the invention defined in the appended claims.

Claims (252)

1. A method for detecting whether at least one molecule of a target nucleic acid is present in a sample portion, said method comprising:
loading a first sample portion into a first porous sample structure, said first sample portion comprising at least part of a sample, whereby if said first sample portion contains at least a single molecule of said target nucleic acid, said first sample portion would attain a detectable concentration of said target nucleic acid within a portion of said first porous sample structure after a single round of amplification;
subjecting said first sample portion in said first porous sample structure to at least a first amplification step; and then
determining whether said first sample portion contains at least one molecule of said target nucleic acid.
2. A method as recited in claim 1, wherein if said first sample portion contains at least a single molecule of said target nucleic acid, said first sample portion would attain a detectable concentration of said target nucleic acid within a portion of said first porous sample structure after a single amplification step.
3. A method as recited in claim 1, wherein said first amplification step is a homogeneous amplification step.
4. A method as recited in claim 1, wherein said first amplification step is a thermocycle step
5. A method as recited in claim 1, wherein at least one of said first porous sample structure and said first sample portion comprises constituents for enabling amplification of a target nucleic acid.
6. A method as recited in claim 1, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being open.
7. A method as recited in claim 1, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a first end and a second end, said first and second ends of each of said pores being open.
8. A method as recited in claim 1, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being hydrophobic.
9. A method as recited in claim 1, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a hydrophilic interior.
10. A method as recited in claim 1, wherein said first porous sample structure comprises a plurality of pores, an interior of each of said pores being hydrophilic, and an exposed surface of said first porous sample structure being hydrophobic.
11. A method as recited in claim 1, wherein said first porous sample structure comprises a plurality of pores, an interior of each of said pores being hydrophobic, and an exposed surface of said first porous sample structure being hydrophilic.
12. A method as recited in claim 1, wherein said first porous sample structure comprises a plurality of pores, an interior of each of said pores being hydrophilic, and an exposed surface of each of said pores being hydrophobic.
13. A method as recited in claim 1, wherein said first porous sample structure comprises at least one structure selected from the group consisting of microchannel arrays, structures having pores formed therein, metal screens, plastic screens, glass screens, ceramic screens, cellulosic screens, polymeric screens, metal sieves, plastic sieves, glass sieves, ceramic sieves, cellulosic sieves and polymeric sieves.
14. A method as recited in claim 1, wherein said first porous sample structure comprises at least one affinity material which provides an affinity to said first sample portion.
15. A method as recited in claim 14, wherein said affinity material is coated on exposed surfaces of said first porous sample structure.
16. A method as recited in claim 1, wherein said first porous sample structure has been subjected to at least one affinity treatment which provides an affinity to said first sample portion.
17. A method as recited in claim 1, wherein said first sample portion has a volume of about 1 picoliter or less.
18. A method as recited in claim 1, wherein said first sample portion has a volume of about 10 picoliters.
19. A method as recited in claim 1, wherein said first sample portion has a volume of about 10 nanoliters or less.
20. A method as recited in claim 1, wherein said first sample portion has a volume of about 100 nanoliters or less.
21. A method as recited in claim 1, wherein said first sample portion has a volume in the range of from about 100 nanoliters to about 1 microliter.
22. A method as recited in claim 1, wherein said first porous sample structure has an internal volume of about 1 picoliter or less.
23. A method as recited in claim 1, wherein said first porous sample structure has an internal volume in the range of from about 1 picoliter to about 1 microliter.
24. A method as recited in claim 1, wherein said first porous sample structure has an internal volume of about 1 nanoliter or less.
25. A method as recited in claim 1, wherein said first porous sample structure has an internal volume of about 10 nanoliters or less.
26. A method as recited in claim 1, wherein said first porous sample structure has an internal volume of about 100 nanoliters or less.
27. A method as recited in claim 1, wherein said first porous sample structure has an internal volume of about 1 microliter or less.
28. A method as recited in claim 1, wherein said first porous sample structure has an internal volume of about 1 micron.
29. A method as recited in claim 1, wherein said first porous sample structure is positioned in a microfluidic device which comprises a plurality of porous sample structures.
30. A method as recited in claim 29, wherein each of said porous sample structures comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being open.
31. A method as recited in claim 29, wherein each of said porous sample structures comprises a plurality of pores, each of said pores having a first end and a second end, said first and second ends of each of said pores being open.
32. A method as recited in claim 29, wherein each of said porous sample structures comprises a plurality of pores, each of said pores being formed by at least one method selected from the group consisting of ablating, molding, etching and drilling.
33. A method as recited in claim 29, wherein each of said porous sample structures comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being hydrophobic.
34. A method as recited in claim 29, wherein each of said porous sample structures contains at least one amplification targeting reagent.
35. A method as recited in claim 29, wherein at least said first porous sample structure contains at least a first amplification targeting reagent, and at least a second porous sample structure contains at least a second amplification targeting reagent, said first amplification targeting reagent differing from said second amplification targeting reagent.
36. A method as recited in claim 29, wherein each of said porous sample structures comprises at least one structure selected from the group consisting of microchannel arrays, structures having pores formed therein, metal screens, plastic screens, glass screens, ceramic screens, cellulosic screens, polymeric screens, metal sieves, plastic sieves, glass sieves, ceramic sieves, cellulosic sieves and polymeric sieves.
37. A method as recited in claim 29, wherein each of said porous sample structures comprises at least one affinity material which provides an affinity to said first sample portion.
38. A method as recited in claim 37, wherein said affinity material is coated on exposed surfaces of said porous sample structures.
39. A method as recited in claim 29, wherein said porous sample structures have been subjected to at least one affinity treatment which provides an affinity to said first sample portion.
40. A method as recited in claim 29, wherein each of said porous sample structures comprises a plurality of pores, an interior of each of said pores being hydrophilic, and exposed surfaces of said porous sample structures being hydrophobic.
41. A method as recited in claim 29, wherein said method further comprises detecting, for each of said individual porous sample structures, whether there is amplified product in said individual porous sample structure.
42. A method as recited in claim 41, wherein said method further comprises determining the number of said porous sample structures in which there is amplified product.
43. A method as recited in claim 29, wherein each of said first sample portions has a volume of about 1 picoliter or less.
44. A method as recited in claim 29, wherein each of said first sample portions has a volume of about 10 picoliters.
45. A method as recited in claim 29, wherein each of said first sample portions has a volume of about 10 nanoliters or less.
46. A method as recited in claim 29, wherein each of said first sample portions has a volume of about 100 nanoliters or less.
47. A method as recited in claim 29, wherein each of said first sample portions has a volume in the range of from about 100 nanoliters to about 1 microliter.
48. A method as recited in claim 29, wherein each of said porous sample structures has an internal volume of about 1 picoliter or less.
49. A method as recited in claim 29, wherein each of said porous sample structures has an internal volume in the range of from about 1 picoliter to about 1 microliter.
50. A method as recited in claim 29, wherein each of said porous sample structures has an internal volume of about 1 nanoliter or less.
51. A method as recited in claim 29, wherein each of said porous sample structures has an internal volume of about 10 nanoliters or less.
52. A method as recited in claim 29, wherein each of said porous sample structures has an internal volume of about 100 nanoliters or less.
53. A method as recited in claim 29, wherein each of said porous sample structures has an internal volume of about 1 microliter or less.
54. A method as recited in claim 29, wherein each of said porous sample structures has an internal volume of about 1 micron.
55. A method as recited in claim 1, wherein said first porous sample structure comprises a plurality of pores, each of said pores being formed by at least one method selected from the group consisting of ablating, molding, etching and drilling.
56. A method as recited in claim 1, wherein said first porous sample structure contains at least one amplification targeting reagent.
57. A method as recited in claim 1, wherein said method further comprises loading at least a first amplification targeting reagent into said first porous sample structure.
58. A method as recited in claim 57, wherein said first loading a first sample portion is carried out before said loading at least a first amplification targeting reagent.
59. A method as recited in claim 57, wherein said first loading a first sample portion is carried out after said loading at least a first amplification targeting reagent.
60. A method as recited in claim 57, wherein said first loading a first sample portion is carried out simultaneously with said loading at least a first amplification targeting reagent.
61. A method as recited in claim 1, wherein said first porous sample structure is positioned in a microfluidic device, and said microfluidic device comprises at least one means for minimizing diffusion of said first sample portion.
62. A method as recited in claim 61, wherein said means for minimizing diffusion of said first sample portion comprises at least one physical restraint on diffusion.
63. A method as recited in claim 61, wherein said means for minimizing diffusion of said first sample portion comprises at least one chemical restraint on diffusion.
64. A method as recited in claim 1, wherein said method further comprises positioning a sealing device on at least a first surface of said first porous sample structure.
65. A method as recited in claim 64, wherein said sealing device is selected from the group consisting of microscope slide coverslips, tapes, films, silicon films, silicon devices, and devices comprising an array of reactants.
66. A method as recited in claim 64, wherein said sealing device displaces first sample portion fluid from said first surface of said first porous sample structure, without displacing first sample portion fluid from within pores of said first porous sample structure.
67. A method as recited in claim 1, wherein said loading a first sample portion into a first porous sample structure comprises applying centrifugal force.
68. A method as recited in claim 1, wherein said loading a first sample portion into a first porous sample structure comprises loading said first sample portion into said first porous sample structure through at least one ink jet.
69. A method as recited in claim 1, wherein said loading a first sample portion into a first porous sample structure is carried out using at least pressure.
70. A method as recited in claim 1, wherein said loading a first sample portion into a first porous sample structure is carried out using at least a vacuum.
71. A method as recited in claim 1, wherein said loading a first sample portion into a first porous sample structure is carried out using at least capillary action.
72. A method as recited in claim 1, wherein said first porous sample structure is positioned in a microfluidic device which comprises at least one flow-through surface defining at least one flow-through channel, at least a portion of said at least one flow-through surface being hydrophobic, at least a portion of said first porous sample structure being hydrophilic.
73. A method as recited in claim 72, wherein said microfluidic device comprises a plurality of porous sample structures.
74. A method as recited in claim 1, wherein:
said first porous sample structure is positioned in a microfluidic device which comprises at least one flow-through surface defining at least one flow-through channel,
said method further comprises supplying a displacing fluid into said flow-through channel after said loading said first sample portion into said first porous sample structure;
at least a portion of said at least one flow-through surface has a first affinity to said first sample portion and a second affinity to said displacing fluid,
said first porous sample structure has a third affinity to said first sample portion and a fourth affinity to said displacing fluid,
said second affinity is greater than said first affinity, and
said third affinity is greater than said fourth affinity.
75. A method as recited in claim 1, wherein said first porous sample structure is positioned in a microfluidic device which comprises at least one flow-through channel and said method further comprises supplying a displacing fluid into said flow-through channel, whereby said displacing fluid displaces first sample portion fluid from said flow-through channel.
76. A method as recited in claim 75, further comprising curing said displacing fluid to seal said first sample portion within said first porous sample structure.
77. A method as recited in claim 1, wherein:
said first porous sample structure is positioned in a microfluidic device which comprises at least one flow-through channel which communicates with said first porous sample structure, and
said method further comprises supplying at least one sealing fluid to said flow-through channel after loading a first sample portion into said first porous sample structure, whereby said sealing fluid seals said first sample portion within said first porous sample structure.
78. A method as recited in claim 77, wherein said method further comprises curing said sealing fluid after said supplying said sealing fluid to said flow-through channel.
79. A method as recited in claim 77, wherein said sealing fluid comprises at least one adhesive.
80. A method as recited in claim 77, wherein said sealing fluid is immiscible with said first sample portion.
81. A method as recited in claim 77, wherein said sealing fluid displaces part of said first sample portion from said flow-through channel as said sealing fluid enters said flow-through channel.
82. A method as recited in claim 1, wherein:
said loading comprises applying centrifugal force,
said first porous sample structure is positioned in a microfluidic device which comprises at least one flow-through surface defining at least one flow-through channel,
at least a portion of said at least one flow-through surface is hydrophobic,
at least a portion of said first porous sample structure is hydrophilic,
said first porous sample structure is in communication with said flow-through channel,
at least a portion of said at least one flow-through surface has a first affinity to said fluid sample and a second affinity to a displacing fluid, said second affinity being greater than said first affinity,
said first porous sample structure has a third affinity to said sample and a fourth affinity to said displacing fluid, said third affinity being greater than said fourth affinity, and
said method further comprises supplying a displacing fluid into said flow-through channel, whereby said displacing fluid displaces first sample portion fluid from said flow-through channel.
83. A method as recited in claim 1, wherein said first porous sample structure is positioned in a microfluidic device which comprises:
a plurality of porous sample structures, each of said porous sample structures being confined in at least one dimension by opposing barriers separated by about 500 microns or less;
means for sealing said plurality of porous sample structures to prevent evaporation and contamination of sample constituents confined within said plurality of porous sample structures; and
means for restraining amplification product.
84. A method as recited in claim 1, wherein said first porous sample structure is positioned in a microfluidic device which comprises:
a plurality of porous sample structures, each of said porous sample structures being confined in at least one dimension by opposing barriers separated by about 500 microns or less;
means for sealing said plurality of porous sample structures to prevent evaporation and contamination of sample constituents confined within said plurality of porous sample structures; and
means for restraining amplification product, said means for restraining amplification product comprising a patterned layer disposed on at least one of said opposing barriers and at least partially defining each of said plurality of porous sample structures.
85. A method as recited in claim 84, wherein said opposing barriers are separated by 100 microns or less.
86. A method as recited in claim 1, wherein said first porous sample structure is positioned in a microfluidic device which comprises:
a plurality of porous sample structures;
a substrate and a cover, said substrate comprising a first surface, said cover comprising a second surface, said first surface facing and being spaced from said second surface, at least one of said first surface and said second surface comprising a first material;
a flow-through channel, said flow-through channel being positioned between said substrate and said cover,
said first porous sample structure being bounded on at least one side thereof by said first material and being in communication with said flow-through channel, said first porous sample structure having a first affinity to said first sample portion and a second affinity to a displacing fluid, said flow-through channel having a third affinity to said first sample portion and a fourth affinity to said displacing fluid, wherein said first, second, third and fourth affinities are such that said first porous sample structure will retain first sample portion fluid while a displacing fluid displaces first sample portion fluid from said flow-through channel.
87. A method as recited in claim 1, wherein said first porous sample structure is positioned in a microfluidic device which comprises:
a plurality of porous sample structures;
means for facilitating loading sample portions into said porous sample structures;
means for displacing sample away from at least one end of each of said porous sample structures to isolate said first sample portion within said porous sample structures; and
means for sealing said at least one end of each of said porous sample structures immediately after displacing first sample portion fluid away from said ends.
88. A method as recited in claim 1, wherein said first porous sample structure is positioned in a microfluidic device which comprises:
a plurality of porous sample structures;
a substrate and a cover, said substrate comprising a first surface, said cover comprising a second surface, said first surface facing and being spaced from said second surface, at least one of said substrate and said cover being substantially rigid;
a flow-through channel, said flow-through channel being positioned between said substrate and said cover,
said first porous sample structure being in communication with said flow-through channel.
89. A method as recited in claim 88, wherein said microfluidic device further comprises at least one holding element which holds said substrate and said cover together.
90. A method as recited in claim 89, wherein said holding element is selected from the group consisting of glues, adhesives, clamps, clips and springs.
91. A method as recited in claim 1, wherein said first porous sample structure is positioned in a microfluidic device which comprises:
a plurality of porous sample structures;
a substrate and a cover, said substrate comprising a first surface, said cover comprising a second surface, said first surface facing and being spaced from said second surface, at least one of said substrate and said cover being flexible;
a flow-through channel, said flow-through channel being positioned between said substrate and said cover,
said first porous sample structure being in communication with said flow-through channel.
92. A method as recited in claim 91, wherein said microfluidic device further comprises at least one holding element which holds said substrate and said cover together.
93. A method as recited in claim 92, wherein said holding element is selected from the group consisting of glues, adhesives, clamps, clips and springs.
94. A method as recited in claim 1, wherein said target nucleic acid comprises at least one nucleic acid sequence of at least one pathogenic organism.
95. A method as recited in claim 1, wherein said first sample portion comprises at least one forensic sample.
96. A method as recited in claim 1, wherein said target nucleic acid is indicative of the likelihood or presence of at least one genetic disorder.
97. A method as recited in claim 1, wherein said method for detecting whether at least one molecule of said target nucleic acid is present in said first sample portion is part of a procedure selected from among the group consisting of analyzing mutations in activated oncogenes, molecular cloning, analyzing DNA, and detecting at least one sequence difference.
98. A method as recited in claim 97, wherein said procedure comprises at least one task selected from among the group consisting of generating specific sequences of DNA for cloning or use as probes, detecting segments of DNA for genetic mapping, detecting expressed sequences by amplification of particular segments of cDNA, analyzing expressed sequences by amplification of particular segments of cDNA, generating libraries of cDNA from small amounts of mRNA, generating large amounts of DNA for sequencing, analyzing mutations, and chromosome crawling.
99. A method as recited in claim 97, wherein said sequence difference is selected from among insertions, deletions and changes.
100. A method as recited in claim 1, wherein said method for detecting whether at least one molecule of said target nucleic acid is present in said first sample portion is part of a procedure selected from among the group consisting of fertility procedures, immunology procedures, cytology procedures, gas analysis procedures and pharmaceutical screening procedures.
101. A microfluidic device comprising:
a first porous sample structure; and
a first sample portion, said first sample portion being positioned in said first porous sample structure, whereby if said first sample portion contains at least a single molecule of a target nucleic acid, said first sample portion would attain a detectable concentration of said target nucleic acid within a portion of said first porous sample structure after a single round of amplification.
102. A microfluidic device as recited in claim 101, wherein if said first sample portion contains at least a single molecule of said target nucleic acid, said first sample portion would attain a detectable concentration of said target nucleic acid within a portion of said first porous sample structure after a single amplification step.
103. A microfluidic device as recited in claim 101, wherein at least one of said first porous sample structure and said first sample portion comprises constituents for enabling amplification of a target nucleic acid.
104. A microfluidic device as recited in claim 101, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being open.
105. A microfluidic device as recited in claim 101, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a first end and a second end, said first and second ends of each of said pores being open.
106. A microfluidic device as recited in claim 101, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being hydrophobic.
107. A microfluidic device as recited in claim 101, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a hydrophilic interior.
108. A microfluidic device as recited in claim 101, wherein said first porous sample structure comprises a plurality of pores, an interior of each of said pores being hydrophilic, and an exposed surface of said first porous sample structure being hydrophobic.
109. A microfluidic device as recited in claim 101, wherein said first porous sample structure comprises a plurality of pores, an interior of each of said pores being hydrophobic, and an exposed surface of said first porous sample structure being hydrophilic.
110. A microfluidic device as recited in claim 101, wherein said first porous sample structure comprises a plurality of pores, an interior of each of said pores being hydrophilic, and an exposed surface of each of said pores being hydrophobic.
111. A microfluidic device as recited in claim 101, wherein said first porous sample structure comprises at least one structure selected from the group consisting of microchannel arrays, structures having pores formed therein, metal screens, plastic screens, glass screens, ceramic screens, cellulosic screens, polymeric screens, metal sieves, plastic sieves, glass sieves, ceramic sieves, cellulosic sieves and polymeric sieves.
112. A microfluidic device as recited in claim 101, wherein said first porous sample structure comprises at least one affinity material which provides an affinity to said first sample portion.
113. A microfluidic device as recited in claim 112, wherein said affinity material is coated on exposed surfaces of said first porous sample structure.
114. A microfluidic device as recited in claim 101, wherein said first porous sample structure has been subjected to at least one affinity treatment which provides an affinity to said first sample portion.
115. A microfluidic device as recited in claim 101, wherein said first sample portion has a volume of about 1 picoliter or less.
116. A microfluidic device as recited in claim 101, wherein said first sample portion has a volume of about 10 picoliters.
117. A microfluidic device as recited in claim 101, wherein said first sample portion has a volume of about 10 nanoliters or less.
118. A microfluidic device as recited in claim 101, wherein said first sample portion has a volume of about 100 nanoliters or less.
119. A microfluidic device as recited in claim 101, wherein said first sample portion has a volume in the range of from about 100 nanoliters to about 1 microliter.
120. A microfluidic device as recited in claim 101, wherein said first porous sample structure has an internal volume of about 1 picoliter or less.
121. A microfluidic device as recited in claim 101, wherein said first porous sample structure has an internal volume in the range of from about 1 picoliter to about 1 microliter.
122. A microfluidic device as recited in claim 101, wherein said first porous sample structure has an internal volume of about 1 nanoliter or less.
123. A microfluidic device as recited in claim 101, wherein said first porous sample structure has an internal volume of about 10 nanoliters or less.
124. A microfluidic device as recited in claim 101, wherein said first porous sample structure has an internal volume of about 100 nanoliters or less.
125. A microfluidic device as recited in claim 101, wherein said first porous sample structure has an internal volume of about 1 microliter or less.
126. A microfluidic device as recited in claim 101, wherein said first porous sample structure has an internal volume of about 1 micron.
127. A microfluidic device as recited in claim 101, wherein said microfluidic device comprises a plurality of porous sample structures.
128. A microfluidic device as recited in claim 127, wherein each of said porous sample structures comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being open.
129. A microfluidic device as recited in claim 127, wherein each of said porous sample structures comprises a plurality of pores, each of said pores having a first end and a second end, said first and second ends of each of said pores being open.
130. A microfluidic device as recited in claim 127, wherein each of said porous sample structures comprises a plurality of pores, each of said pores being formed by at least one method selected from the group consisting of ablating, molding, etching and drilling.
131. A microfluidic device as recited in claim 127, wherein each of said porous sample structures comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being hydrophobic.
132. A microfluidic device as recited in claim 127, wherein each of said porous sample structures contains at least one amplification targeting reagent.
133. A microfluidic device as recited in claim 127, wherein at least said first porous sample structure contains at least a first amplification targeting reagent, and at least a second porous sample structure contains at least a second amplification targeting reagent, said first amplification targeting reagent differing from said second amplification targeting reagent.
134. A microfluidic device as recited in claim 127, wherein each of said porous sample structures comprises at least one structure selected from the group consisting of microchannel arrays, structures having pores formed therein, metal screens, plastic screens, glass screens, ceramic screens, cellulosic screens, polymeric screens, metal sieves, plastic sieves, glass sieves, ceramic sieves, cellulosic sieves and polymeric sieves.
135. A microfluidic device as recited in claim 127, wherein each of said porous sample structures comprises at least one affinity material which provides an affinity to said first sample portion.
136. A microfluidic device as recited in claim 135, wherein said affinity material is coated on exposed surfaces of said porous sample structures.
137. A microfluidic device as recited in claim 127, wherein said porous sample structures have been subjected to at least one affinity treatment which provides an affinity to said first sample portion.
138. A microfluidic device as recited in claim 127, wherein each of said porous sample structures comprises a plurality of pores, an interior of each of said pores being hydrophilic, and exposed surfaces of said porous sample structures being hydrophobic.
139. A microfluidic device as recited in claim 127, wherein each of said porous sample structures has an internal volume of about 1 picoliter or less.
140. A microfluidic device as recited in claim 127, wherein each of said porous sample structures has an internal volume in the range of from about 1 picoliter to about 1 microliter.
141. A microfluidic device as recited in claim 127, wherein each of said porous sample structures has an internal volume of about 1 nanoliter or less.
142. A microfluidic device as recited in claim 127, wherein each of said porous sample structures has an internal volume of about 10 nanoliters or less.
143. A microfluidic device as recited in claim 127, wherein each of said porous sample structures has an internal volume of about 100 nanoliters or less.
144. A microfluidic device as recited in claim 127, wherein each of said porous sample structures has an internal volume of about 1 microliter or less.
145. A microfluidic device as recited in claim 127, wherein each of said porous sample structures has an internal volume of about 1 micron.
146. A microfluidic device as recited in claim 101, wherein said first porous sample structure comprises a plurality of pores, each of said pores being formed by at least one method selected from the group consisting of ablating, molding, etching and drilling.
147. A microfluidic device as recited in claim 101, wherein said first porous sample structure contains at least one amplification targeting reagent.
148. A microfluidic device as recited in claim 101, wherein said microfluidic device comprises a plurality of porous sample structures, and said microfluidic device comprises at least one means for minimizing diffusion of said first sample portion.
149. A microfluidic device as recited in claim 148, wherein said means for minimizing diffusion of said first sample portion comprises at least one physical restraint on diffusion.
150. A microfluidic device as recited in claim 148, wherein said means for minimizing diffusion of said first sample portion comprises at least one chemical restraint on diffusion.
151. A microfluidic device as recited in claim 148, wherein said microfluidic device further comprises a sealing device positioned on at least a first surface of each of said porous sample structures.
152. A microfluidic device as recited in claim 151, wherein said sealing device is selected from the group consisting of microscope slide coverslips, tapes, films, silicon films, silicon devices, and devices comprising an array of reactants.
153. A microfluidic device as recited in claim 101, wherein said microfluidic device comprises at least one means for minimizing diffusion of said first sample portion.
154. A microfluidic device as recited in claim 153, wherein said means for minimizing diffusion of said first sample portion comprises at least one physical restraint on diffusion.
155. A microfluidic device as recited in claim 153, wherein said means for minimizing diffusion of said first sample portion comprises at least one chemical restraint on diffusion.
156. A microfluidic device as recited in claim 101, wherein said microfluidic device further comprises a sealing device positioned on at least a first surface of said first porous sample structure.
157. A microfluidic device as recited in claim 156, wherein said sealing device is selected from the group consisting of microscope slide coverslips, tapes, films, silicon films, silicon devices, and devices comprising an array of reactants.
158. A microfluidic device as recited in claim 101, wherein said microfluidic device comprises at least one flow-through surface defining at least one flow-through channel, at least a portion of said at least one flow-through surface being hydrophobic, at least a portion of said first porous sample structure being hydrophilic.
159. A microfluidic device as recited in claim 158, wherein said microfluidic device comprises a plurality of porous sample structures.
160. A microfluidic device as recited in claim 101, wherein:
said microfluidic device comprises at least one flow-through surface defining at least one flow-through channel,
at least a portion of said at least one flow-through surface has a first affinity to said first sample portion and a second affinity to a displacing fluid,
said first porous sample structure has a third affinity to said first sample portion and a fourth affinity to said displacing fluid,
said second affinity is greater than said first affinity, and
said third affinity is greater than said fourth affinity.
161. A microfluidic device as recited in claim 101, wherein:
said microfluidic device comprises at least one flow-through surface defining at least one flow-through channel,
at least a portion of said at least one flow-through surface is hydrophobic,
at least a portion of said first porous sample structure is hydrophilic,
said first porous sample structure is in communication with said flow-through channel,
at least a portion of said at least one flow-through surface has a first affinity to said fluid sample and a second affinity to a displacing fluid, said second affinity being greater than said first affinity,
said first porous sample structure has a third affinity to said sample and a fourth affinity to said displacing fluid, said third affinity being greater than said fourth affinity.
162. A microfluidic device as recited in claim 101, wherein said microfluidic device comprises:
a plurality of porous sample structures, each of said porous sample structures being confined in at least one dimension by opposing barriers separated by about 500 microns or less;
means for sealing said plurality of porous sample structures to prevent evaporation and contamination of sample constituents confined within said plurality of porous sample structures; and
means for restraining amplification product.
163. A microfluidic device as recited in claim 101, wherein said microfluidic device comprises:
a plurality of porous sample structures, each of said porous sample structures being confined in at least one dimension by opposing barriers separated by about 500 microns or less;
means for sealing said plurality of porous sample structures to prevent evaporation and contamination of sample constituents confined within said plurality of porous sample structures; and
means for restraining amplification product, said means for restraining amplification product comprising a patterned layer disposed on at least one of said opposing barriers and at least partially defining each of said plurality of porous sample structures.
164. A microfluidic device as recited in claim 163, wherein said opposing barriers are separated by 100 microns or less.
165. A microfluidic device as recited in claim 101, wherein said microfluidic device comprises:
a plurality of porous sample structures;
a substrate and a cover, said substrate comprising a first surface, said cover comprising a second surface, said first surface facing and being spaced from said second surface, at least one of said first surface and said second surface comprising a first material;
a flow-through channel, said flow-through channel being positioned between said substrate and said cover,
said first porous sample structure being bounded on at least one side thereof by said first material and being in communication with said flow-through channel, said first porous sample structure having a first affinity to said first sample portion and a second affinity to a displacing fluid, said flow-through channel having a third affinity to said first sample portion and a fourth affinity to said displacing fluid, wherein said first, second, third and fourth affinities are such that said first porous sample structure will retain first sample portion fluid while a displacing fluid displaces first sample portion fluid from said flow-through channel.
166. A microfluidic device as recited in claim 101, wherein said microfluidic device comprises:
a plurality of porous sample structures;
means for facilitating loading sample portions into said porous sample structures;
means for displacing sample away from ends of said porous sample structures to isolate said first sample portion within said porous sample structures; and
means for sealing said ends of said porous sample structures immediately after displacing first sample portion fluid away from said ends.
167. A microfluidic device as recited in claim 101, wherein said microfluidic device comprises:
a plurality of porous sample structures;
a substrate and a cover, said substrate comprising a first surface, said cover comprising a second surface, said first surface facing and being spaced from said second surface, at least one of said substrate and said cover being substantially rigid;
a flow-through channel, said flow-through channel being positioned between said substrate and said cover,
said first porous sample structure being in communication with said flow-through channel.
168. A microfluidic device as recited in claim 167, wherein said microfluidic device further comprises at least one holding element which holds said substrate and said cover together.
169. A microfluidic device as recited in claim 168, wherein said holding element is selected from the group consisting of glues, adhesives, clamps, clips and springs.
170. A microfluidic device as recited in claim 101, wherein said microfluidic device comprises:
a plurality of porous sample structures;
a substrate and a cover, said substrate comprising a first surface, said cover comprising a second surface, said first surface facing and being spaced from said second surface, at least one of said substrate and said cover being flexible;
a flow-through channel, said flow-through channel being positioned between said substrate and said cover,
said first porous sample structure being in communication with said flow-through channel.
171. A microfluidic device as recited in claim 170, wherein said microfluidic device further comprises at least one holding element which holds said substrate and said cover together.
172. A microfluidic device as recited in claim 171, wherein said holding element is selected from the group consisting of glues, adhesives, clamps, clips and springs.
173. A microfluidic device as recited in claim 101, wherein said microfluidic device further comprises at least one cured displacing fluid which seals said first sample portion within said first porous sample structure.
174. A microfluidic device as recited in claim 101, wherein said microfluidic device further comprises at least one cured adhesive which seals said first sample portion within said first porous sample structure.
175. A microfluidic device comprising:
a first porous sample structure; and
at least one amplification targeting reagent positioned in said first porous sample structure,
whereby if a sample portion which comprises at least a single molecule of a target nucleic acid is positioned in said first porous sample structure, said sample portion would attain a detectable concentration of said target nucleic acid within a portion of said first porous sample structure after a single round of amplification.
176. A microfluidic device as recited in claim 175, wherein if said first sample portion contains at least a single molecule of said target nucleic acid, said first sample portion would attain a detectable concentration of said target nucleic acid within a portion of said first porous sample structure after a single amplification step.
177. A microfluidic device as recited in claim 175, wherein said first porous sample structure further comprises constituents for enabling amplification of said target nucleic acid.
178. A microfluidic device as recited in claim 175, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being open.
179. A microfluidic device as recited in claim 175, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a first end and a second end, said first and second ends of each of said pores being open.
180. A microfluidic device as recited in claim 175, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being hydrophobic.
181. A microfluidic device as recited in claim 175, wherein said first porous sample structure comprises a plurality of pores, each of said pores having a hydrophilic interior.
182. A microfluidic device as recited in claim 175, wherein said first porous sample structure comprises a plurality of pores, an interior of each of said pores being hydrophilic, and an exposed surface of said first porous sample structure being hydrophobic.
183. A microfluidic device as recited in claim 175, wherein said first porous sample structure comprises a plurality of pores, an interior of each of said pores being hydrophobic, and an exposed surface of said first porous sample structure being hydrophilic.
184. A microfluidic device as recited in claim 175, wherein said first porous sample structure comprises a plurality of pores, an interior of each of said pores being hydrophilic, and an exposed surface of each of said pores being hydrophobic.
185. A microfluidic device as recited in claim 175, wherein said first porous sample structure comprises at least one structure selected from the group consisting of microchannel arrays, structures having pores formed therein, metal screens, plastic screens, glass screens, ceramic screens, cellulosic screens, polymeric screens, metal sieves, plastic sieves, glass sieves, ceramic sieves, cellulosic sieves and polymeric sieves.
186. A microfluidic device as recited in claim 175, wherein said first porous sample structure comprises at least one affinity material which provides an affinity to said first sample portion.
187. A microfluidic device as recited in claim 186, wherein said affinity material is coated on exposed surfaces of said first porous sample structure.
188. A microfluidic device as recited in claim 175, wherein said first porous sample structure has been subjected to at least one affinity treatment which provides an affinity to said first sample portion.
189. A microfluidic device as recited in claim 175, wherein said first sample portion has a volume of about 1 picoliter or less.
190. A microfluidic device as recited in claim 175, wherein said first sample portion has a volume of about 10 picoliters.
191. A microfluidic device as recited in claim 175, wherein said first sample portion has a volume of about 10 nanoliters or less.
192. A microfluidic device as recited in claim 175, wherein said first sample portion has a volume of about 100 nanoliters or less.
193. A microfluidic device as recited in claim 175, wherein said first sample portion has a volume in the range of from about 100 nanoliters to about 1 microliter.
194. A microfluidic device as recited in claim 175, wherein said first porous sample structure has an internal volume of about 1 picoliter or less.
195. A microfluidic device as recited in claim 175, wherein said first porous sample structure has an internal volume in the range of from about 1 picoliter to about 1 microliter.
196. A microfluidic device as recited in claim 175, wherein said first porous sample structure has an internal volume of about 1 nanoliter or less.
197. A microfluidic device as recited in claim 175, wherein said first porous sample structure has an internal volume of about 10 nanoliters or less.
198. A microfluidic device as recited in claim 175, wherein said first porous sample structure has an internal volume of about 100 nanoliters or less.
199. A microfluidic device as recited in claim 175, wherein said first porous sample structure has an internal volume of about 1 microliter or less.
200. A microfluidic device as recited in claim 175, wherein said first porous sample structure has an internal volume of about 1 micron.
201. A microfluidic device as recited in claim 175, wherein said microfluidic device comprises a plurality of porous sample structures.
202. A microfluidic device as recited in claim 201, wherein each of said porous sample structures comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being open.
203. A microfluidic device as recited in claim 201, wherein each of said porous sample structures comprises a plurality of pores, each of said pores having a first end and a second end, said first and second ends of each of said pores being open.
204. A microfluidic device as recited in claim 201, wherein each of said porous sample structures comprises a plurality of pores, each of said pores being formed by at least one method selected from the group consisting of ablating, molding, etching and drilling.
205. A microfluidic device as recited in claim 201, wherein each of said porous sample structures comprises a plurality of pores, each of said pores having a first end and a second end, said first end of each of said pores being hydrophobic.
206. A microfluidic device as recited in claim 201, wherein each of said porous sample structures contains at least one amplification targeting reagent.
207. A microfluidic device as recited in claim 201, wherein at least said first porous sample structure contains at least a first amplification targeting reagent, and at least a second porous sample structure contains at least a second amplification targeting reagent, said first amplification targeting reagent differing from said second amplification targeting reagent.
208. A microfluidic device as recited in claim 201, wherein each of said porous sample structures comprises at least one structure selected from the group consisting of microchannel arrays, structures having pores formed therein, metal screens, plastic screens, glass screens, ceramic screens, cellulosic screens, polymeric screens, metal sieves, plastic sieves, glass sieves, ceramic sieves, cellulosic sieves and polymeric sieves.
209. A microfluidic device as recited in claim 201, wherein each of said porous sample structures comprises at least one affinity material which provides an affinity to said first sample portion.
210. A microfluidic device as recited in claim 209, wherein said affinity material is coated on exposed surfaces of said porous sample structures.
211. A microfluidic device as recited in claim 201, wherein said porous sample structures have been subjected to at least one affinity treatment which provides an affinity to said first sample portion.
212. A microfluidic device as recited in claim 201, wherein each of said porous sample structures comprises a plurality of pores, an interior of each of said pores being hydrophilic, and exposed surfaces of said porous sample structures being hydrophobic.
213. A microfluidic device as recited in claim 201, wherein each of said first sample portions has a volume of about 1 picoliter or less.
214. A microfluidic device as recited in claim 201, wherein each of said first sample portions has a volume of about 10 picoliters.
215. A microfluidic device as recited in claim 201, wherein each of said first sample portions has a volume of about 10 nanoliters or less.
216. A microfluidic device as recited in claim 201, wherein each of said first sample portions has a volume of about 100 nanoliters or less.
217. A microfluidic device as recited in claim 201, wherein each of said first sample portions has a volume in the range of from about 100 nanoliters to about 1 microliter.
218. A microfluidic device as recited in claim 201, wherein each of said porous sample structures has an internal volume of about 1 picoliter or less.
219. A microfluidic device as recited in claim 201, wherein each of said porous sample structures has an internal volume in the range of from about 1 picoliter to about 1 microliter.
220. A microfluidic device as recited in claim 201, wherein each of said porous sample structures has an internal volume of about 1 nanoliter or less.
221. A microfluidic device as recited in claim 201, wherein each of said porous sample structures has an internal volume of about 10 nanoliters or less.
222. A microfluidic device as recited in claim 201, wherein each of said porous sample structures has an internal volume of about 100 nanoliters or less.
223. A microfluidic device as recited in claim 201, wherein each of said porous sample structures has an internal volume of about 1 microliter or less.
224. A microfluidic device as recited in claim 201, wherein each of said porous sample structures has an internal volume of about 1 micron.
225. A microfluidic device as recited in claim 175, wherein said first porous sample structure comprises a plurality of pores, each of said pores being formed by at least one method selected from the group consisting of ablating, molding, etching and drilling.
226. A microfluidic device as recited in claim 175, wherein said microfluidic device comprises a plurality of porous sample structures, and said microfluidic device comprises at least one means for minimizing diffusion of said first sample portion.
227. A microfluidic device as recited in claim 226, wherein said means for minimizing diffusion of said first sample portion comprises at least one physical restraint on diffusion.
228. A microfluidic device as recited in claim 226, wherein said means for minimizing diffusion of said first sample portion comprises at least one chemical restraint on diffusion.
229. A microfluidic device as recited in claim 226, wherein said microfluidic device further comprises a sealing device positioned on at least a first surface of each of said porous sample structures.
230. A microfluidic device as recited in claim 229, wherein said sealing device is selected from the group consisting of microscope slide coverslips, tapes, films, silicon films, silicon devices, and devices comprising an array of reactants.
231. A microfluidic device as recited in claim 175, wherein said microfluidic device comprises at least one means for minimizing diffusion of said first sample portion.
232. A microfluidic device as recited in claim 231, wherein said means for minimizing diffusion of said first sample portion comprises at least one physical restraint on diffusion.
233. A microfluidic device as recited in claim 231, wherein said means for minimizing diffusion of said first sample portion comprises at least one chemical restraint on diffusion.
234. A microfluidic device as recited in claim 175, wherein said microfluidic device further comprises a sealing device positioned on at least a first surface of said first porous sample structure.
235. A microfluidic device as recited in claim 234, wherein said sealing device is selected from the group consisting of microscope slide coverslips, tapes, films, silicon films, silicon devices, and devices comprising an array of reactants.
236. A microfluidic device as recited in claim 175, wherein said microfluidic device comprises at least one flow-through surface defining at least one flow-through channel, at least a portion of said at least one flow-through surface being hydrophobic, at least a portion of said first porous sample structure being hydrophilic.
237. A microfluidic device as recited in claim 236, wherein said microfluidic device comprises a plurality of porous sample structures.
238. A microfluidic device as recited in claim 175, wherein:
said microfluidic device comprises at least one flow-through surface defining at least one flow-through channel,
at least a portion of said at least one flow-through surface has a first affinity to said first sample portion and a second affinity to a displacing fluid,
said first porous sample structure has a third affinity to said first sample portion and a fourth affinity to said displacing fluid,
said second affinity is greater than said first affinity, and
said third affinity is greater than said fourth affinity.
239. A microfluidic device as recited in claim 175, wherein:
said microfluidic device comprises at least one flow-through surface defining at least one flow-through channel,
at least a portion of said at least one flow-through surface is hydrophobic, at least a portion of said first porous sample structure is hydrophilic,
said first porous sample structure is in communication with said flow-through channel,
at least a portion of said at least one flow-through surface has a first affinity to said fluid sample and a second affinity to a displacing fluid, said second affinity being greater than said first affinity,
said first porous sample structure has a third affinity to said sample and a fourth affinity to said displacing fluid, said third affinity being greater than said fourth affinity.
240. A microfluidic device as recited in claim 175, wherein said microfluidic device comprises:
a plurality of porous sample structures, each of said porous sample structures being confined in at least one dimension by opposing barriers separated by about 500 microns or less;
means for sealing said plurality of porous sample structures to prevent evaporation and contamination of sample constituents confined within said plurality of porous sample structures; and
means for restraining amplification product.
241. A microfluidic device as recited in claim 175, wherein said microfluidic device comprises:
a plurality of porous sample structures, each of said porous sample structures being confined in at least one dimension by opposing barriers separated by about 500 microns or less;
means for sealing said plurality of porous sample structures to prevent evaporation and contamination of sample constituents confined within said plurality of porous sample structures; and
means for restraining amplification product, said means for restraining amplification product comprising a patterned layer disposed on at least one of said opposing barriers and at least partially defining each of said plurality of porous sample structures.
242. A microfluidic device as recited in claim 241, wherein said opposing barriers are separated by 100 microns or less.
243. A microfluidic device as recited in claim 175, wherein said microfluidic device comprises:
a plurality of porous sample structures;
a substrate and a cover, said substrate comprising a first surface, said cover comprising a second surface, said first surface facing and being spaced from said second surface, at least one of said first surface and said second surface comprising a first material;
a flow-through channel, said flow-through channel being positioned between said substrate and said cover,
said first porous sample structure being bounded on at least one side thereof by said first material and being in communication with said flow-through channel, said first porous sample structure having a first affinity to said first sample portion and a second affinity to a displacing fluid, said flow-through channel having a third affinity to said first sample portion and a fourth affinity to said displacing fluid, wherein said first, second, third and fourth affinities are such that said first porous sample structure will retain first sample portion fluid while a displacing fluid displaces first sample portion fluid from said flow-through channel.
244. A microfluidic device as recited in claim 175, wherein said microfluidic device comprises:
a plurality of porous sample structures;
means for facilitating loading sample portions into said porous sample structures;
means for displacing sample away from ends of said porous sample structures to isolate said first sample portion within said porous sample structures; and
means for sealing said ends of said porous sample structures immediately after displacing first sample portion fluid away from said ends.
245. A microfluidic device as recited in claim 175, wherein said microfluidic device comprises:
a plurality of porous sample structures;
a substrate and a cover, said substrate comprising a first surface, said cover comprising a second surface, said first surface facing and being spaced from said second surface, at least one of said substrate and said cover being substantially rigid;
a flow-through channel, said flow-through channel being positioned between said substrate and said cover,
said first porous sample structure being in communication with said flow-through channel.
246. A microfluidic device as recited in claim 245, wherein said microfluidic device further comprises at least one holding element which holds said substrate and said cover together.
247. A microfluidic device as recited in claim 246 herein said holding element is selected from the group consisting of glues, adhesives, clamps, clips and springs.
248. A microfluidic device as recited in claim 175, wherein said microfluidic device comprises:
a plurality of porous sample structures;
a substrate and a cover, said substrate comprising a first surface, said cover comprising a second surface, said first surface facing and being spaced from said second surface, at least one of said substrate and said cover being flexible;
a flow-through channel, said flow-through channel being positioned between said substrate and said cover,
said first porous sample structure being in communication with said flow-through channel.
249. A microfluidic device as recited in claim 248, wherein said microfluidic device further comprises at least one holding element which holds said substrate and said cover together.
250. A microfluidic device as recited in claim 249, wherein said holding element is selected from the group consisting of glues, adhesives, clamps, clips and springs.
251. A microfluidic device as recited in claim 175, wherein said microfluidic device further comprises at least one cured displacing fluid which seals said first sample portion within said first porous sample structure.
252. A microfluidic device as recited in claim 175, wherein said microfluidic device further comprises at least one cured adhesive which seals said first sample portion within said first porous sample structure.
US11/837,559 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in a sample Abandoned US20080160525A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/837,559 US20080160525A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in a sample

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/838,262 US6143496A (en) 1997-04-17 1997-04-17 Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US09/563,714 US6391559B1 (en) 1997-04-17 2000-05-02 Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US10/131,854 US7459315B2 (en) 1997-04-17 2002-04-25 Miniaturized assembly and method of filling assembly
US10/798,857 US7972778B2 (en) 1997-04-17 2004-03-11 Method for detecting the presence of a single target nucleic acid in a sample
US11/837,559 US20080160525A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in a sample

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/798,857 Continuation US7972778B2 (en) 1997-04-17 2004-03-11 Method for detecting the presence of a single target nucleic acid in a sample

Publications (1)

Publication Number Publication Date
US20080160525A1 true US20080160525A1 (en) 2008-07-03

Family

ID=25276672

Family Applications (23)

Application Number Title Priority Date Filing Date
US08/838,262 Expired - Lifetime US6143496A (en) 1997-04-17 1997-04-17 Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US09/563,714 Expired - Lifetime US6391559B1 (en) 1997-04-17 2000-05-02 Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US10/131,854 Expired - Fee Related US7459315B2 (en) 1997-04-17 2002-04-25 Miniaturized assembly and method of filling assembly
US10/798,857 Expired - Fee Related US7972778B2 (en) 1997-04-17 2004-03-11 Method for detecting the presence of a single target nucleic acid in a sample
US11/837,620 Abandoned US20080171325A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in a sample
US11/837,564 Abandoned US20080171382A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in a sample
US11/837,600 Expired - Fee Related US8067159B2 (en) 1997-04-17 2007-08-13 Methods of detecting amplified product
US11/837,656 Expired - Fee Related US8278071B2 (en) 1997-04-17 2007-08-13 Method for detecting the presence of a single target nucleic acid in a sample
US11/837,569 Abandoned US20080171324A1 (en) 1997-04-17 2007-08-13 Method for quantifying number of molecules of target nucleic acid contained in a sample
US11/837,565 Expired - Fee Related US8859204B2 (en) 1997-04-17 2007-08-13 Method for detecting the presence of a target nucleic acid sequence in a sample
US11/837,608 Expired - Fee Related US8551698B2 (en) 1997-04-17 2007-08-13 Method of loading sample into a microfluidic device
US11/837,581 Abandoned US20080213766A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in samples
US11/837,651 Abandoned US20080171326A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in a sample
US11/837,559 Abandoned US20080160525A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in a sample
US11/837,613 Abandoned US20080153091A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of target nucleic acids in a sample, and microfluidic device for use in such methods
US11/837,561 Abandoned US20080171380A1 (en) 1997-04-17 2007-08-13 Microfluidic assembly with reagent
US13/108,959 Expired - Fee Related US8257925B2 (en) 1997-04-17 2011-05-16 Method for detecting the presence of a single target nucleic acid in a sample
US13/269,226 Abandoned US20120063972A1 (en) 1997-04-17 2011-10-07 Device having regions of differing affinities to fluid, methods of making such devices, and methods of using such devices
US13/572,649 Expired - Fee Related US8563275B2 (en) 1997-04-17 2012-08-11 Method and device for detecting the presence of a single target nucleic acid in a sample
US13/764,970 Expired - Fee Related US8822183B2 (en) 1997-04-17 2013-02-12 Device for amplifying target nucleic acid
US14/142,488 Abandoned US20140329305A1 (en) 1997-04-17 2013-12-27 Devices, methods, and systems for nucleic acid amplification
US14/456,592 Expired - Fee Related US9506105B2 (en) 1997-04-17 2014-08-11 Device and method for amplifying target nucleic acid
US14/486,467 Abandoned US20150017709A1 (en) 1997-04-17 2014-09-15 Method for detecting the presence of a target nucleic acid sequence in a sample

Family Applications Before (13)

Application Number Title Priority Date Filing Date
US08/838,262 Expired - Lifetime US6143496A (en) 1997-04-17 1997-04-17 Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US09/563,714 Expired - Lifetime US6391559B1 (en) 1997-04-17 2000-05-02 Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US10/131,854 Expired - Fee Related US7459315B2 (en) 1997-04-17 2002-04-25 Miniaturized assembly and method of filling assembly
US10/798,857 Expired - Fee Related US7972778B2 (en) 1997-04-17 2004-03-11 Method for detecting the presence of a single target nucleic acid in a sample
US11/837,620 Abandoned US20080171325A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in a sample
US11/837,564 Abandoned US20080171382A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in a sample
US11/837,600 Expired - Fee Related US8067159B2 (en) 1997-04-17 2007-08-13 Methods of detecting amplified product
US11/837,656 Expired - Fee Related US8278071B2 (en) 1997-04-17 2007-08-13 Method for detecting the presence of a single target nucleic acid in a sample
US11/837,569 Abandoned US20080171324A1 (en) 1997-04-17 2007-08-13 Method for quantifying number of molecules of target nucleic acid contained in a sample
US11/837,565 Expired - Fee Related US8859204B2 (en) 1997-04-17 2007-08-13 Method for detecting the presence of a target nucleic acid sequence in a sample
US11/837,608 Expired - Fee Related US8551698B2 (en) 1997-04-17 2007-08-13 Method of loading sample into a microfluidic device
US11/837,581 Abandoned US20080213766A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in samples
US11/837,651 Abandoned US20080171326A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of a single target nucleic acid in a sample

Family Applications After (9)

Application Number Title Priority Date Filing Date
US11/837,613 Abandoned US20080153091A1 (en) 1997-04-17 2007-08-13 Method and device for detecting the presence of target nucleic acids in a sample, and microfluidic device for use in such methods
US11/837,561 Abandoned US20080171380A1 (en) 1997-04-17 2007-08-13 Microfluidic assembly with reagent
US13/108,959 Expired - Fee Related US8257925B2 (en) 1997-04-17 2011-05-16 Method for detecting the presence of a single target nucleic acid in a sample
US13/269,226 Abandoned US20120063972A1 (en) 1997-04-17 2011-10-07 Device having regions of differing affinities to fluid, methods of making such devices, and methods of using such devices
US13/572,649 Expired - Fee Related US8563275B2 (en) 1997-04-17 2012-08-11 Method and device for detecting the presence of a single target nucleic acid in a sample
US13/764,970 Expired - Fee Related US8822183B2 (en) 1997-04-17 2013-02-12 Device for amplifying target nucleic acid
US14/142,488 Abandoned US20140329305A1 (en) 1997-04-17 2013-12-27 Devices, methods, and systems for nucleic acid amplification
US14/456,592 Expired - Fee Related US9506105B2 (en) 1997-04-17 2014-08-11 Device and method for amplifying target nucleic acid
US14/486,467 Abandoned US20150017709A1 (en) 1997-04-17 2014-09-15 Method for detecting the presence of a target nucleic acid sequence in a sample

Country Status (3)

Country Link
US (23) US6143496A (en)
AU (1) AU7128998A (en)
WO (1) WO1998047003A1 (en)

Cited By (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040171055A1 (en) * 1997-04-17 2004-09-02 Cytonix Corporation Method for detecting the presence of a single target nucleic acid in a sample
US20060054503A1 (en) * 2002-09-24 2006-03-16 Duke University Methods for manipulating droplets by electrowetting-based techniques
US20070037294A1 (en) * 2002-09-24 2007-02-15 Duke University Methods for performing microfluidic sampling
US20070241068A1 (en) * 2006-04-13 2007-10-18 Pamula Vamsee K Droplet-based washing
US20080044893A1 (en) * 2006-04-18 2008-02-21 Pollack Michael G Multiwell Droplet Actuator, System and Method
US20080050834A1 (en) * 2006-04-18 2008-02-28 Pamula Vamsee K Protein Crystallization Droplet Actuator, System and Method
US20080274513A1 (en) * 2005-05-11 2008-11-06 Shenderov Alexander D Method and Device for Conducting Biochemical or Chemical Reactions at Multiple Temperatures
US7727723B2 (en) 2006-04-18 2010-06-01 Advanced Liquid Logic, Inc. Droplet-based pyrosequencing
US20100143963A1 (en) * 2006-05-09 2010-06-10 Advanced Liquid Logic, Inc. Modular Droplet Actuator Drive
USRE41780E1 (en) 2003-03-14 2010-09-28 Lawrence Livermore National Security, Llc Chemical amplification based on fluid partitioning in an immiscible liquid
US20100258441A1 (en) * 2006-04-18 2010-10-14 Advanced Liquid Logic, Inc. Manipulation of Beads in Droplets and Methods for Splitting Droplets
US7816121B2 (en) 2006-04-18 2010-10-19 Advanced Liquid Logic, Inc. Droplet actuation system and method
US7815871B2 (en) 2006-04-18 2010-10-19 Advanced Liquid Logic, Inc. Droplet microactuator system
US7822510B2 (en) 2006-05-09 2010-10-26 Advanced Liquid Logic, Inc. Systems, methods, and products for graphically illustrating and controlling a droplet actuator
US7901947B2 (en) 2006-04-18 2011-03-08 Advanced Liquid Logic, Inc. Droplet-based particle sorting
US7939021B2 (en) 2007-05-09 2011-05-10 Advanced Liquid Logic, Inc. Droplet actuator analyzer with cartridge
US8048628B2 (en) 2002-09-24 2011-11-01 Duke University Methods for nucleic acid amplification on a printed circuit board
US8268246B2 (en) 2007-08-09 2012-09-18 Advanced Liquid Logic Inc PCB droplet actuator fabrication
US8492168B2 (en) 2006-04-18 2013-07-23 Advanced Liquid Logic Inc. Droplet-based affinity assays
US8633015B2 (en) 2008-09-23 2014-01-21 Bio-Rad Laboratories, Inc. Flow-based thermocycling system with thermoelectric cooler
US8637317B2 (en) 2006-04-18 2014-01-28 Advanced Liquid Logic, Inc. Method of washing beads
US8637324B2 (en) 2006-04-18 2014-01-28 Advanced Liquid Logic, Inc. Bead incubation and washing on a droplet actuator
US8663920B2 (en) 2011-07-29 2014-03-04 Bio-Rad Laboratories, Inc. Library characterization by digital assay
US8709762B2 (en) 2010-03-02 2014-04-29 Bio-Rad Laboratories, Inc. System for hot-start amplification via a multiple emulsion
US8716015B2 (en) 2006-04-18 2014-05-06 Advanced Liquid Logic, Inc. Manipulation of cells on a droplet actuator
US8730479B2 (en) 2010-03-25 2014-05-20 Bio-Rad Laboratories, Inc. Detection system for droplet-based assays
US8809068B2 (en) 2006-04-18 2014-08-19 Advanced Liquid Logic, Inc. Manipulation of beads in droplets and methods for manipulating droplets
US8951939B2 (en) 2011-07-12 2015-02-10 Bio-Rad Laboratories, Inc. Digital assays with multiplexed detection of two or more targets in the same optical channel
US8961764B2 (en) 2010-10-15 2015-02-24 Lockheed Martin Corporation Micro fluidic optic design
US8980198B2 (en) 2006-04-18 2015-03-17 Advanced Liquid Logic, Inc. Filler fluids for droplet operations
US9050606B2 (en) 2006-04-13 2015-06-09 Advanced Liquid Logic, Inc. Bead manipulation techniques
US9067207B2 (en) 2009-06-04 2015-06-30 University Of Virginia Patent Foundation Optical approach for microfluidic DNA electrophoresis detection
US9089844B2 (en) 2010-11-01 2015-07-28 Bio-Rad Laboratories, Inc. System for forming emulsions
CN104884168A (en) * 2012-11-08 2015-09-02 瓦弗根公司 Extraction of restrained liquid from wells
US9126160B2 (en) 2008-09-23 2015-09-08 Bio-Rad Laboratories, Inc. System for forming an array of emulsions
US9132394B2 (en) 2008-09-23 2015-09-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US9194861B2 (en) 2009-09-02 2015-11-24 Bio-Rad Laboratories, Inc. Method of mixing fluids by coalescence of multiple emulsions
US9222128B2 (en) 2011-03-18 2015-12-29 Bio-Rad Laboratories, Inc. Multiplexed digital assays with combinatorial use of signals
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
US9347059B2 (en) 2011-04-25 2016-05-24 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis
US9393560B2 (en) 2010-03-25 2016-07-19 Bio-Rad Laboratories, Inc. Droplet transport system for detection
US9399215B2 (en) 2012-04-13 2016-07-26 Bio-Rad Laboratories, Inc. Sample holder with a well having a wicking promoter
US9417190B2 (en) 2008-09-23 2016-08-16 Bio-Rad Laboratories, Inc. Calibrations and controls for droplet-based assays
US9476856B2 (en) 2006-04-13 2016-10-25 Advanced Liquid Logic, Inc. Droplet-based affinity assays
US9492797B2 (en) 2008-09-23 2016-11-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US9500664B2 (en) 2010-03-25 2016-11-22 Bio-Rad Laboratories, Inc. Droplet generation for droplet-based assays
US9513253B2 (en) 2011-07-11 2016-12-06 Advanced Liquid Logic, Inc. Droplet actuators and techniques for droplet-based enzymatic assays
US9598725B2 (en) 2010-03-02 2017-03-21 Bio-Rad Laboratories, Inc. Emulsion chemistry for encapsulated droplets
US9764322B2 (en) 2008-09-23 2017-09-19 Bio-Rad Laboratories, Inc. System for generating droplets with pressure monitoring
US10078078B2 (en) 2006-04-18 2018-09-18 Advanced Liquid Logic, Inc. Bead incubation and washing on a droplet actuator
US10512910B2 (en) 2008-09-23 2019-12-24 Bio-Rad Laboratories, Inc. Droplet-based analysis method
US11130128B2 (en) 2008-09-23 2021-09-28 Bio-Rad Laboratories, Inc. Detection method for a target nucleic acid
WO2021219675A1 (en) 2020-04-30 2021-11-04 F. Hoffmann-La Roche Ag A method for detecting reaction volume deviations in a digital polymerase chain reaction
US11255809B2 (en) 2006-04-18 2022-02-22 Advanced Liquid Logic, Inc. Droplet-based surface modification and washing
US11369968B2 (en) 2017-04-21 2022-06-28 Essenlix Corporation Molecular manipulation and assay with controlled temperature (II)

Families Citing this family (473)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070269799A9 (en) * 1994-06-22 2007-11-22 Zhang David Y Nucleic acid amplification methods
DK0912766T4 (en) * 1996-06-04 2012-04-02 Univ Utah Res Found Hybridization monitoring during PCR
GB9620934D0 (en) * 1996-10-08 1996-11-27 Molecular Drives Limited Multi-well containers
JP3935509B2 (en) 1997-02-12 2007-06-27 ワイ. チャン,ユージーン Methods and products for polymer analysis
US6090251A (en) * 1997-06-06 2000-07-18 Caliper Technologies, Inc. Microfabricated structures for facilitating fluid introduction into microfluidic devices
US6664044B1 (en) * 1997-06-19 2003-12-16 Toyota Jidosha Kabushiki Kaisha Method for conducting PCR protected from evaporation
US6548020B2 (en) * 1997-08-01 2003-04-15 Canon Kabushiki Kaisha Reaction site array with a black matrix to decrease cross-contamination between reaction regions
ATE205300T1 (en) * 1997-12-17 2001-09-15 Ecole Polytech POSITIONING AND ELECTROPHYSIOLOGICAL CHARACTERIZATION OF INDIVIDUAL CELLS AND RECONSTITUTED MEMBRANE SYSTEMS ON MICROSTRUCTURED SUPPORTS
US20020144905A1 (en) * 1997-12-17 2002-10-10 Christian Schmidt Sample positioning and analysis system
US7244349B2 (en) 1997-12-17 2007-07-17 Molecular Devices Corporation Multiaperture sample positioning and analysis system
US6893877B2 (en) 1998-01-12 2005-05-17 Massachusetts Institute Of Technology Methods for screening substances in a microwell array
ES2350702T3 (en) * 1998-01-12 2011-01-26 Massachusetts Institute Of Technology SYSTEM TO ANALYZE A PLURALITY OF SAMPLES.
US6818451B2 (en) * 1998-02-10 2004-11-16 Lee H. Angros Analytic plate with containment border
US6713304B2 (en) * 1998-02-10 2004-03-30 Lee H. Angros Method of forming a containment border on an analytic plate
US8192994B2 (en) 1998-02-10 2012-06-05 Angros Lee H Method of applying a biological specimen to an analytic plate
US6756019B1 (en) 1998-02-24 2004-06-29 Caliper Technologies Corp. Microfluidic devices and systems incorporating cover layers
GB9812783D0 (en) 1998-06-12 1998-08-12 Cenes Ltd High throuoghput screen
WO2000036405A2 (en) * 1998-12-18 2000-06-22 Symyx Technologies, Inc. Apparatus and method for characterizing libraries of different materials using x-ray scattering
CN1195585C (en) * 1998-12-23 2005-04-06 病理学美国登记处 Apparatus and methods for efficient processing of biological samples on slides
US6296702B1 (en) * 1999-03-15 2001-10-02 Pe Corporation (Ny) Apparatus and method for spotting a substrate
US6306578B1 (en) * 1999-03-19 2001-10-23 Genencor International, Inc. Multi-through hole testing plate for high throughput screening
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
CA2386791A1 (en) 1999-10-08 2001-04-19 Protogene Laboratories, Inc. Method and apparatus for performing large numbers of reactions using array assembly
AU1047401A (en) * 1999-11-08 2001-06-06 Cytion Sa Apparatus and methods for positioning and analyzing biological membranous objects
US6642046B1 (en) * 1999-12-09 2003-11-04 Motorola, Inc. Method and apparatus for performing biological reactions on a substrate surface
US6642000B1 (en) * 1999-11-12 2003-11-04 University Of Chicago PCR amplification on microarrays of gel immobilized oligonucleotides
NL1014217C2 (en) * 2000-01-28 2001-07-31 Cellvision Technologies B V I Counting chamber with reference and method for manufacturing a counting chamber with reference.
CA2399908A1 (en) * 2000-02-10 2001-08-16 Todd Dickinson Array of individual arrays as substrate for bead-based simultaneous processing of samples and manufacturing method therefor
US6770441B2 (en) * 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
US7332271B2 (en) 2000-02-18 2008-02-19 Board Of Trustees Of The Leland Stanford Junior University Apparatus and methods for parallel processing of micro-volume liquid reactions
US20020151040A1 (en) * 2000-02-18 2002-10-17 Matthew O' Keefe Apparatus and methods for parallel processing of microvolume liquid reactions
DE10011022A1 (en) * 2000-03-07 2001-09-27 Meinhard Knoll Apparatus for performing synthesis, analysis or transport processes with a process fluid has a reaction zone with controlled delivery of a process fluid and control fluids with inner analysis and reaction interfaces at the side walls
DE10045521A1 (en) * 2000-03-31 2001-10-04 Roche Diagnostics Gmbh Determining amplification efficiency of a target nucleic acid comprises measuring real-time amplification of diluted series, setting signal threshold value, and determining cycle number at which threshold is exceeded
US6691041B2 (en) * 2000-03-31 2004-02-10 Roche Molecular Systems, Inc. Method for the efficiency-corrected real-time quantification of nucleic acids
US7867763B2 (en) 2004-01-25 2011-01-11 Fluidigm Corporation Integrated chip carriers with thermocycler interfaces and methods of using the same
WO2001077641A1 (en) * 2000-04-06 2001-10-18 Caliper Technologies Corp. Microfluidic devices and systems incorporating cover layers
ES2273835T3 (en) * 2000-04-27 2007-05-16 Consejo Superior De Investigaciones Cientificas METHOD FOR DETECTION OF MINORITY GENOME IN VIRAL QUASISPECIES USING DNA MICROCHIPS.
RU2181487C2 (en) 2000-05-11 2002-04-20 Никитин Петр Иванович Process of optical detection of attachment of real component to sensor material based on biological, chemical or physical coupling and device for its implementation ( variants )
SG90149A1 (en) * 2000-07-18 2002-07-23 Government Of The Republic Of Diagnostic assay
US7270730B2 (en) 2000-08-04 2007-09-18 Essen Instruments, Inc. High-throughput electrophysiological measurement system
US7067046B2 (en) 2000-08-04 2006-06-27 Essen Instruments, Inc. System for rapid chemical activation in high-throughput electrophysiological measurements
US6783735B2 (en) * 2000-09-15 2004-08-31 Agfa-Gevaert Web material having wells for combinatorial applications
CA2426686A1 (en) * 2000-10-30 2002-07-18 Sequenom, Inc. Method and apparatus for delivery of submicroliter volumes onto a substrate
US7678541B2 (en) * 2000-11-21 2010-03-16 Hologic, Inc. Methods and compositions for the detection of a nucleic acid using a non-invasive cleavage reaction
DE10058394C1 (en) * 2000-11-24 2002-07-11 Siemens Ag Methods for biochemical analysis and associated arrangement
WO2002044425A2 (en) 2000-12-01 2002-06-06 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
JP3778041B2 (en) * 2000-12-08 2006-05-24 コニカミノルタホールディングス株式会社 Particle separation mechanism and particle separation apparatus
EP1372848A4 (en) * 2001-03-09 2006-08-09 Biomicro Systems Inc Method and system for microfluidic interfacing to arrays
AU785425B2 (en) 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
WO2002088388A1 (en) * 2001-04-26 2002-11-07 Ruebben Albert A method and a device for quantification of mutation loads
CA2457527A1 (en) * 2001-08-31 2003-03-13 Gen-Probe Incorporated Affinity-shifted probes for quantifying analyte polynucleotides
US6898531B2 (en) 2001-09-05 2005-05-24 Perlegen Sciences, Inc. Algorithms for selection of primer pairs
US6740510B2 (en) * 2001-09-05 2004-05-25 Perlegen Sciences, Inc. Methods for amplification of nucleic acids
US20030108919A1 (en) * 2001-09-05 2003-06-12 Perlegen Sciences, Inc. Methods for amplification of nucleic acids
DE10152690A1 (en) * 2001-10-19 2003-05-08 Genescan Europ Ag Flow reaction chamber for sensor chips
US20030138819A1 (en) * 2001-10-26 2003-07-24 Haiqing Gong Method for detecting disease
US7338760B2 (en) 2001-10-26 2008-03-04 Ntu Ventures Private Limited Sample preparation integrated chip
US7691333B2 (en) 2001-11-30 2010-04-06 Fluidigm Corporation Microfluidic device and methods of using same
JP4355210B2 (en) 2001-11-30 2009-10-28 フルイディグム コーポレイション Microfluidic device and method of using microfluidic device
AU2003217261B2 (en) 2002-01-28 2007-03-22 Nanosphere, Inc. Hybridization device and method
WO2003073911A2 (en) * 2002-02-28 2003-09-12 Georgetown University Method and composition for detection and treatment of breast cancer
US7081339B2 (en) * 2002-04-12 2006-07-25 Primera Biosystems, Inc. Methods for variation detection
DE10224150B4 (en) * 2002-05-27 2004-04-01 Siemens Ag Reactor for the treatment of a sample medium
JP2004031651A (en) 2002-06-26 2004-01-29 Sony Corp Element mounting substrate and its manufacturing method
JP4013671B2 (en) * 2002-07-05 2007-11-28 松下電器産業株式会社 Polymerase chain reaction vessel and method for producing the same
US20040011650A1 (en) * 2002-07-22 2004-01-22 Frederic Zenhausern Method and apparatus for manipulating polarizable analytes via dielectrophoresis
EP1532275A4 (en) * 2002-07-26 2005-09-14 Applera Corp Mg-mediated hot start biochemical reactions
US7452712B2 (en) 2002-07-30 2008-11-18 Applied Biosystems Inc. Sample block apparatus and method of maintaining a microcard on a sample block
US6962822B2 (en) * 2002-08-07 2005-11-08 International Business Machines Corporation Discrete nano-textured structures in biomolecular arrays, and method of use
US8277753B2 (en) * 2002-08-23 2012-10-02 Life Technologies Corporation Microfluidic transfer pin
EP2213615A3 (en) 2002-09-25 2012-02-29 California Institute of Technology Microfluidic Large Scale Integration
DE10393406T5 (en) * 2002-09-30 2005-12-22 Nimblegen Systems, Inc., Madison Parallel loading of arrays
JP5695287B2 (en) 2002-10-02 2015-04-01 カリフォルニア インスティテュート オブ テクノロジー Nucleic acid analysis of microfluids
US7682565B2 (en) * 2002-12-20 2010-03-23 Biotrove, Inc. Assay apparatus and method using microfluidic arrays
US7323305B2 (en) 2003-01-29 2008-01-29 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
US20050145496A1 (en) 2003-04-03 2005-07-07 Federico Goodsaid Thermal reaction device and method for using the same
WO2006102264A1 (en) 2005-03-18 2006-09-28 Fluidigm Corporation Thermal reaction device and method for using the same
US8828663B2 (en) 2005-03-18 2014-09-09 Fluidigm Corporation Thermal reaction device and method for using the same
US7476363B2 (en) 2003-04-03 2009-01-13 Fluidigm Corporation Microfluidic devices and methods of using same
JP5419248B2 (en) 2003-04-03 2014-02-19 フルイディグム コーポレイション Microfluidic device and method of use thereof
US7604965B2 (en) 2003-04-03 2009-10-20 Fluidigm Corporation Thermal reaction device and method for using the same
US7858387B2 (en) * 2003-04-30 2010-12-28 Perkinelmer Health Sciences, Inc. Method of scanning a sample plate surface mask in an area adjacent to a conductive area using matrix-assisted laser desorption and ionization mass spectrometry
US6891156B2 (en) * 2003-04-30 2005-05-10 Perkin Elmer Instruments Llc Sample plate for matrix-assisted laser desorption and ionization mass spectrometry
US7578916B2 (en) * 2004-05-25 2009-08-25 Applied Biosystems, Llc Emulsions of ionic liquids
US7572409B2 (en) * 2003-05-23 2009-08-11 Applied Biosystems, Llc Ionic liquid apparatus and method for biological samples
US7517498B2 (en) * 2003-08-19 2009-04-14 Agilent Technologies, Inc. Apparatus for substrate handling
WO2005023427A1 (en) 2003-09-05 2005-03-17 Stokes Bio Limited A microfluidic analysis system
US20050059139A1 (en) * 2003-09-11 2005-03-17 Norihisa Mino Device substrate, method of manufacturing the same, and microchip
US7460223B2 (en) * 2003-09-19 2008-12-02 Applied Biosystems Inc. Inverted orientation for a microplate
US20050237528A1 (en) * 2003-09-19 2005-10-27 Oldham Mark F Transparent heater for thermocycling
WO2005028629A2 (en) * 2003-09-19 2005-03-31 Applera Corporation Whole genome expression analysis system
WO2005028110A2 (en) * 2003-09-19 2005-03-31 Applera Corporation Microplates useful for conducting thermocycled nucleotide amplification
US20070207055A1 (en) * 2003-10-31 2007-09-06 Commissariat A L'energie Atomique Operating Device Comprising A Localized Zone For The Capture Of A Drop A Liquid Of Interest
FR2861609B1 (en) * 2003-10-31 2006-02-03 Commissariat Energie Atomique METHOD FOR DISTRIBUTING DROPS OF A LIQUID OF INTEREST ON A SURFACE
US20050130213A1 (en) * 2003-12-10 2005-06-16 Tom Morrison Selective ligation and amplification assay
US20050208539A1 (en) * 2003-12-31 2005-09-22 Vann Charles S Quantitative amplification and detection of small numbers of target polynucleotides
US8592219B2 (en) * 2005-01-17 2013-11-26 Gyros Patent Ab Protecting agent
ATE471212T1 (en) * 2004-01-23 2010-07-15 Qiagen Gmbh CONTAMINATION BARRIER
CA2554240A1 (en) 2004-01-25 2005-08-11 Fluidigm Corporation Crystal forming devices and systems and methods for making and using the same
US8105554B2 (en) 2004-03-12 2012-01-31 Life Technologies Corporation Nanoliter array loading
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
EP1600213B1 (en) * 2004-05-21 2012-05-02 Schott AG Apparatus with microtiter plate format for multiplexed arraying
US7834530B2 (en) * 2004-05-27 2010-11-16 California Institute Of Technology Carbon nanotube high-current-density field emitters
EP1621417B1 (en) * 2004-07-29 2007-10-31 Delphi Korea Corporation Guide anchor for seat belt of vehicle and method for manufacturing the same
US20060105453A1 (en) 2004-09-09 2006-05-18 Brenan Colin J Coating process for microfluidic sample arrays
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
FR2880880B1 (en) * 2005-01-18 2008-06-20 Bertin Technologies Soc Par Ac FILLING A MICROCANAL OF A COMPONENT OF A FLUIDIC MICROSYSTEM
US8496799B2 (en) * 2005-02-08 2013-07-30 The Trustees Of Columbia University In The City Of New York Systems and methods for in situ annealing of electro- and electroless platings during deposition
US8529738B2 (en) * 2005-02-08 2013-09-10 The Trustees Of Columbia University In The City Of New York In situ plating and etching of materials covered with a surface film
EP1693337A1 (en) * 2005-02-18 2006-08-23 Infineon Technologies AG Macroporous support for amplification reactions
US20060246576A1 (en) 2005-04-06 2006-11-02 Affymetrix, Inc. Fluidic system and method for processing biological microarrays in personal instrumentation
KR20080005947A (en) 2005-04-08 2008-01-15 더 트러스티스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 Systems and methods for monitoring plating and etching baths
EP1712284B1 (en) * 2005-04-15 2012-10-10 Samsung Electronics Co., Ltd. Cell separation method using hydrophobic solid supports
BRPI0609303A2 (en) 2005-04-15 2010-11-23 Lee H Angros point of use analytical substrate coating system, applicator cartridge, and, methods for attaching a biological specimen to an analytical substrate and applying a coating to an analytical substrate at an analytical substrate use point
CA2607661C (en) 2005-05-09 2017-08-08 Idaho Technology, Inc. A device and method for two-stage nucleic acid amplification
WO2007044091A2 (en) 2005-06-02 2007-04-19 Fluidigm Corporation Analysis using microfluidic partitioning devices
CN101223425B (en) * 2005-07-18 2011-03-30 皇家飞利浦电子股份有限公司 Luminescence sensor using multi-layer substrate structure
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US8532930B2 (en) 2005-11-26 2013-09-10 Natera, Inc. Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
EP1928571B1 (en) * 2005-08-22 2013-03-13 Life Technologies Corporation Device and method for microfluidic control of a first fluid in contact with a second fluid, wherein the first and second fluids are immiscible
CA2614771A1 (en) * 2005-08-31 2007-03-08 Egomedical Technologies Ag Analyte test system using non-enzymatic analyte recognition elements
WO2007027907A2 (en) * 2005-09-02 2007-03-08 The Trustees Of Columbia University In The City Of New York A system and method for obtaining anisotropic etching of patterned substrates
US7754148B2 (en) 2006-12-27 2010-07-13 Progentech Limited Instrument for cassette for sample preparation
US7727473B2 (en) 2005-10-19 2010-06-01 Progentech Limited Cassette for sample preparation
US20100073766A1 (en) * 2005-10-26 2010-03-25 Angros Lee H Microscope slide testing and identification assembly
US20100072272A1 (en) * 2005-10-26 2010-03-25 Angros Lee H Microscope slide coverslip and uses thereof
US8007267B2 (en) * 2005-11-02 2011-08-30 Affymetrix, Inc. System and method for making lab card by embossing
US8075852B2 (en) 2005-11-02 2011-12-13 Affymetrix, Inc. System and method for bubble removal
US20080311585A1 (en) * 2005-11-02 2008-12-18 Affymetrix, Inc. System and method for multiplex liquid handling
US20100137163A1 (en) 2006-01-11 2010-06-03 Link Darren R Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors
HUE045358T2 (en) * 2006-02-02 2019-12-30 Univ Leland Stanford Junior Non-invasive fetal genetic screening by digital analysis
WO2007091228A1 (en) 2006-02-07 2007-08-16 Stokes Bio Limited A liquid bridge and system
US8460878B2 (en) 2006-02-21 2013-06-11 The Trustees Of Tufts College Methods and arrays for detecting cells and cellular components in small defined volumes
US11237171B2 (en) 2006-02-21 2022-02-01 Trustees Of Tufts College Methods and arrays for target analyte detection and determination of target analyte concentration in solution
EP2004328B1 (en) 2006-03-09 2014-06-04 Agency for Science, Technology and Research Method for performing a reaction in a droplet
US7455844B2 (en) 2006-03-29 2008-11-25 Merial Limited Vaccine against streptococci
WO2007133710A2 (en) 2006-05-11 2007-11-22 Raindance Technologies, Inc. Microfluidic devices and methods of use thereof
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
KR100785016B1 (en) * 2006-05-22 2007-12-12 삼성전자주식회사 Method and apparatus for the concentration and amplification of nucleic acids in a single micro chamber
US8137912B2 (en) * 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc Use of highly parallel snp genotyping for fetal diagnosis
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
JP4292279B2 (en) * 2006-07-18 2009-07-08 ファルマ・アクセス株式会社 Crystal production tool
WO2008021123A1 (en) 2006-08-07 2008-02-21 President And Fellows Of Harvard College Fluorocarbon emulsion stabilizing surfactants
US20080056952A1 (en) 2006-08-25 2008-03-06 Angros Lee H Analytic plates with markable portions and methods of use
WO2008039130A1 (en) * 2006-09-29 2008-04-03 Ge Healthcare Bio-Sciences Ab Method and device for small scale reactions
US8518479B2 (en) * 2006-10-12 2013-08-27 Affymetrix, Inc. Fabrication of fluidic features within a plastic substrate
US9102911B2 (en) 2009-05-15 2015-08-11 Biofire Diagnostics, Llc High density self-contained biological analysis
CA2669943C (en) * 2006-11-15 2016-05-31 Idaho Technology, Inc. High density self-contained biological analysis
WO2008063135A1 (en) 2006-11-24 2008-05-29 Agency For Science, Technology And Research Apparatus for processing a sample in a liquid droplet and method of using the same
US9874501B2 (en) 2006-11-24 2018-01-23 Curiox Biosystems Pte Ltd. Use of chemically patterned substrate for liquid handling, chemical and biological reactions
WO2008070786A1 (en) * 2006-12-06 2008-06-12 The Trustees Of Columbia University In The City Of New York Microfluidic systems and methods for screening plating and etching bath compositions
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US9029085B2 (en) 2007-03-07 2015-05-12 President And Fellows Of Harvard College Assays and other reactions involving droplets
EP2140031A4 (en) 2007-03-26 2011-04-20 Sequenom Inc Restriction endonuclease enhanced polymorphic sequence detection
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
KR101972994B1 (en) 2007-07-23 2019-04-29 더 차이니즈 유니버시티 오브 홍콩 Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
US20100112590A1 (en) 2007-07-23 2010-05-06 The Chinese University Of Hong Kong Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment
WO2009025161A1 (en) * 2007-08-17 2009-02-26 Toppan Printing Co., Ltd. Reaction field independent jig, and reaction chip treating device using the jig
ES2556627T3 (en) 2007-08-30 2016-01-19 Trustees Of Tufts College Methods to determine the concentration of an analyte in solution
BRPI0816393A2 (en) * 2007-09-07 2015-03-03 Fluidigm Corp METHOD FOR DETERMINING THE NUMBER OF COPIES REGARDING A TARGET POLINUCLEOTIDE SEQUENCE IN A GENOME OF AN INDIVIDUAL
CN101910415B (en) * 2007-11-07 2015-02-25 不列颠哥伦比亚大学 Microfluidic device and method of using same
US10725020B2 (en) 2007-11-14 2020-07-28 Curiox Biosystems Pte Ltd. High throughput miniaturized assay system and methods
WO2013114217A1 (en) 2012-02-05 2013-08-08 Curiox Biosystems Pte Ltd. Array plates and methods for making and using same
US8911938B2 (en) * 2007-12-10 2014-12-16 The Trustees Of The University Of Pennsylvania Reaction chamber having pre-stored reagents
CN101896275A (en) * 2007-12-17 2010-11-24 龚海庆 Microfluidic device
WO2009085215A1 (en) 2007-12-21 2009-07-09 President And Fellows Of Harvard College Systems and methods for nucleic acid sequencing
WO2009126352A2 (en) * 2008-01-24 2009-10-15 Sandia National Laboratories Novel micropores and methods of making and using thereof
DE102008009184B4 (en) * 2008-02-15 2015-10-22 Boehringer Ingelheim Vetmedica Gmbh Device and method with a sensor array and with a stamp and their use
JP5283924B2 (en) * 2008-02-21 2013-09-04 株式会社日立製作所 Nucleic acid amplification device
WO2009114543A2 (en) 2008-03-11 2009-09-17 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
AU2009228312B2 (en) 2008-03-26 2015-05-21 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
US9664619B2 (en) * 2008-04-28 2017-05-30 President And Fellows Of Harvard College Microfluidic device for storage and well-defined arrangement of droplets
JP2011525252A (en) * 2008-06-19 2011-09-15 フェイズ ホログラフィック イメージング ペーホーイー アーベー Transparent living body analysis
EP4047367A1 (en) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Method for detecting target analytes with droplet libraries
ES2620431T3 (en) 2008-08-04 2017-06-28 Natera, Inc. Methods for the determination of alleles and ploidy
WO2010021936A1 (en) * 2008-08-16 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Digital pcr calibration for high throughput sequencing
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
CA3209502A1 (en) 2008-09-16 2010-03-25 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
WO2010033200A2 (en) 2008-09-19 2010-03-25 President And Fellows Of Harvard College Creation of libraries of droplets and related species
EP3378951B1 (en) 2008-09-20 2020-05-13 The Board of Trustees of the Leland Stanford Junior University Noninvasive diagnosis of aneuploidy by sequencing
US8222047B2 (en) 2008-09-23 2012-07-17 Quanterix Corporation Ultra-sensitive detection of molecules on single molecule arrays
FR2937050A1 (en) * 2008-10-10 2010-04-16 Inst Curie CELL CULTURE DEVICE
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
EP3699296A1 (en) 2008-11-07 2020-08-26 Adaptive Biotechnologies Corporation Methods of monitoring conditions by sequence analysis
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
EP3150724A1 (en) 2008-12-19 2017-04-05 President and Fellows of Harvard College Particle-assisted nucleic acid sequencing
DK3059337T3 (en) 2009-01-15 2019-07-22 Adaptive Biotechnologies Corp Adaptive immunity profiling and methods for producing monoclonal antibodies
JP5909095B2 (en) 2009-03-13 2016-04-26 プレジデント アンド フェローズ オブ ハーバード カレッジ Scale up microfluidic devices
EP3415235A1 (en) 2009-03-23 2018-12-19 Raindance Technologies Inc. Manipulation of microfluidic droplets
KR101796906B1 (en) 2009-03-24 2017-11-10 유니버시티 오브 시카고 Method for carrying out a reaction
US9447461B2 (en) * 2009-03-24 2016-09-20 California Institute Of Technology Analysis devices, kits, and related methods for digital quantification of nucleic acids and other analytes
US10196700B2 (en) 2009-03-24 2019-02-05 University Of Chicago Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes
WO2010115100A1 (en) 2009-04-03 2010-10-07 L&C Diagment, Inc. Multiplex nucleic acid detection methods and systems
US8784752B2 (en) 2009-04-17 2014-07-22 Curiox Biosystems Pte Ltd Use of chemically patterned substrate for liquid handling, chemical and biological reactions
US9085798B2 (en) 2009-04-30 2015-07-21 Prognosys Biosciences, Inc. Nucleic acid constructs and methods of use
AU2010263172B2 (en) 2009-06-25 2016-03-31 Fred Hutchinson Cancer Research Center Method of measuring adaptive immunity
EP2456887B1 (en) * 2009-07-21 2015-11-25 Gen-Probe Incorporated Methods and compositions for quantitative detection of nucleic acid sequences over an extended dynamic range
US9364831B2 (en) 2009-08-08 2016-06-14 The Regents Of The University Of California Pulsed laser triggered high speed microfluidic switch and applications in fluorescent activated cell sorting
WO2011028764A2 (en) 2009-09-02 2011-03-10 President And Fellows Of Harvard College Multiple emulsions created using jetting and other techniques
US20110059864A1 (en) * 2009-09-07 2011-03-10 Caerus Molecular Diagnostics Incorporated Sequence Determination By Use Of Opposing Forces
EP2854056A3 (en) 2009-09-30 2015-06-03 Natera, Inc. Methods for non-invasive pre-natal ploidy calling
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP3461558B1 (en) 2009-10-27 2021-03-17 President and Fellows of Harvard College Droplet creation techniques
US8985050B2 (en) * 2009-11-05 2015-03-24 The Trustees Of Columbia University In The City Of New York Substrate laser oxide removal process followed by electro or immersion plating
JP2013511991A (en) * 2009-11-25 2013-04-11 クアンタライフ, インコーポレイテッド Methods and compositions for detecting genetic material
DK2516680T3 (en) 2009-12-22 2016-05-02 Sequenom Inc Method and kits to identify aneuploidy
WO2011079176A2 (en) 2009-12-23 2011-06-30 Raindance Technologies, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
WO2011094865A1 (en) * 2010-02-02 2011-08-11 Arash Zarrine-Afsar Fluid sampling device and method of use thereof
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US8535889B2 (en) * 2010-02-12 2013-09-17 Raindance Technologies, Inc. Digital analyte analysis
JP6154137B2 (en) 2010-02-23 2017-06-28 ルミネックス コーポレーション Apparatus and method for integrated sample preparation, reaction, and detection
US9248422B2 (en) 2010-02-23 2016-02-02 Luminex Corporation Apparatus and methods for integrated sample preparation, reaction and detection
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
US8415171B2 (en) 2010-03-01 2013-04-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
US9678068B2 (en) 2010-03-01 2017-06-13 Quanterix Corporation Ultra-sensitive detection of molecules using dual detection methods
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
EP2542890B1 (en) 2010-03-01 2015-05-06 Quanterix Corporation Methods for extending dynamic range in assays for the detection of molecules or particles
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
WO2011127099A1 (en) 2010-04-05 2011-10-13 Prognosys Biosciences, Inc. Spatially encoded biological assays
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
BR112012025593A2 (en) 2010-04-06 2019-06-25 Caris Life Sciences Luxembourg Holdings circulating biomarkers for disease
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
CA3037126C (en) 2010-05-18 2023-09-12 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
WO2012011877A2 (en) 2010-07-23 2012-01-26 Curiox Biosystems Pte Ltd Apparatus and method for multiple reactions in small volumes
EP2596127A2 (en) 2010-07-23 2013-05-29 Esoterix Genetic Laboratories, LLC Identification of differentially represented fetal or maternal genomic regions and uses thereof
WO2012032510A1 (en) 2010-09-07 2012-03-15 Yeda Research And Development Co. Ltd. Primers for amplifying dna and methods of selecting same
AU2011305445B2 (en) 2010-09-24 2017-03-16 The Board Of Trustees Of The Leland Stanford Junior University Direct capture, amplification and sequencing of target DNA using immobilized primers
US9562897B2 (en) 2010-09-30 2017-02-07 Raindance Technologies, Inc. Sandwich assays in droplets
US9184099B2 (en) 2010-10-04 2015-11-10 The Board Of Trustees Of The Leland Stanford Junior University Biosensor devices, systems and methods therefor
US9399217B2 (en) 2010-10-04 2016-07-26 Genapsys, Inc. Chamber free nanoreactor system
NZ610129A (en) 2010-10-04 2014-08-29 Genapsys Inc Systems and methods for automated reusable parallel biological reactions
EP2656263B1 (en) 2010-12-22 2019-11-06 Natera, Inc. Methods for non-invasive prenatal paternity testing
US9952237B2 (en) 2011-01-28 2018-04-24 Quanterix Corporation Systems, devices, and methods for ultra-sensitive detection of molecules or particles
EP2670893B1 (en) 2011-02-02 2018-06-27 Exact Sciences Development Company, LLC Digital sequence analysis of dna methylation
CN103608818B (en) 2011-02-09 2017-12-08 纳特拉公司 The antenatal ploidy identification device of Noninvasive
CA2826748C (en) 2011-02-09 2020-08-04 Bio-Rad Laboratories, Inc. Method of detecting variations in copy number of a target nucleic acid
EP3412778A1 (en) 2011-02-11 2018-12-12 Raindance Technologies, Inc. Methods for forming mixed droplets
US9176504B2 (en) 2011-02-11 2015-11-03 The Regents Of The University Of California High-speed on demand droplet generation and single cell encapsulation driven by induced cavitation
EP3736281A1 (en) 2011-02-18 2020-11-11 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US9322055B2 (en) 2011-04-01 2016-04-26 Life Technologies Corporation System and method for determining copies-per-unit-volume using PCR and flow control of droplets
WO2012142301A2 (en) 2011-04-12 2012-10-18 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
US8455221B2 (en) 2011-04-29 2013-06-04 Sequenom, Inc. Quantification of a minority nucleic acid species
US9238206B2 (en) 2011-05-23 2016-01-19 President And Fellows Of Harvard College Control of emulsions, including multiple emulsions
US8585973B2 (en) 2011-05-27 2013-11-19 The Board Of Trustees Of The Leland Stanford Junior University Nano-sensor array
US9926596B2 (en) 2011-05-27 2018-03-27 Genapsys, Inc. Systems and methods for genetic and biological analysis
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
WO2012167142A2 (en) 2011-06-02 2012-12-06 Raindance Technolgies, Inc. Enzyme quantification
WO2012174142A1 (en) 2011-06-17 2012-12-20 Life Technologies Corporation Flat-field imaging system and methods of use
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
SG11201401917QA (en) * 2011-09-30 2014-09-26 Life Technologies Corp Methods and systems for visualizing and evaluating data
AU2012325791B2 (en) 2011-10-21 2018-04-05 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
DE102011085473A1 (en) 2011-10-28 2013-05-02 Albert-Ludwigs-Universität Freiburg Method for the identification of aptamers
CN104105797B (en) 2011-12-01 2016-08-31 吉纳普赛斯股份有限公司 System and method for efficent electronic order-checking with detection
WO2013086450A1 (en) 2011-12-09 2013-06-13 Adaptive Biotechnologies Corporation Diagnosis of lymphoid malignancies and minimal residual disease detection
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
CA2863121A1 (en) 2011-12-30 2013-07-04 Abbott Molecular Inc. Microorganism nucleic acid purification from host samples
US20130210638A1 (en) * 2012-02-10 2013-08-15 Jeffrey Charles Olson Methods for sequencing nucleic acid
PT2814959T (en) 2012-02-17 2018-04-12 Hutchinson Fred Cancer Res Compositions and methods for accurately identifying mutations
EP4155401A1 (en) 2012-03-02 2023-03-29 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP2823060B1 (en) 2012-03-05 2018-02-14 Adaptive Biotechnologies Corporation Determining paired immune receptor chains from frequency matched subunits
DK2825309T3 (en) * 2012-03-16 2018-07-30 Stat Diagnostica & Innovation Sl Sample cartridge with integrated transfer module
KR20140140080A (en) * 2012-03-16 2014-12-08 라이프 테크놀로지스 코포레이션 Systems and methods for containing biological samples
US9067189B2 (en) 2012-03-30 2015-06-30 General Electric Company Microfluidic device and a related method thereof
JP6168140B2 (en) * 2012-04-19 2017-07-26 和光純薬工業株式会社 Method for sampling reaction products in real time
EP3524693A1 (en) 2012-04-30 2019-08-14 Raindance Technologies, Inc. Digital analyte analysis
HUE029357T2 (en) 2012-05-08 2017-02-28 Adaptive Biotechnologies Corp Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
SG11201407901PA (en) 2012-05-21 2015-01-29 Fluidigm Corp Single-particle analysis of particle populations
EP2856177B1 (en) 2012-05-25 2020-11-18 The University of North Carolina At Chapel Hill Microfluidic devices, solid supports for reagents and related methods
US20150184235A1 (en) * 2012-07-10 2015-07-02 Lexogen Gmbh Flexible sensor carrier and method
AU2013290102B2 (en) 2012-07-13 2018-11-15 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
AU2013202793B2 (en) 2012-07-31 2014-09-18 Gen-Probe Incorporated System, method and apparatus for automated incubation
EP4001426A1 (en) 2012-08-13 2022-05-25 The Regents of The University of California Methods and systems for detecting biological components
US10584381B2 (en) 2012-08-14 2020-03-10 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10323279B2 (en) 2012-08-14 2019-06-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9701998B2 (en) 2012-12-14 2017-07-11 10X Genomics, Inc. Methods and systems for processing polynucleotides
CA3216609A1 (en) 2012-08-14 2014-02-20 10X Genomics, Inc. Microcapsule compositions and methods
US10221442B2 (en) 2012-08-14 2019-03-05 10X Genomics, Inc. Compositions and methods for sample processing
US10752949B2 (en) 2012-08-14 2020-08-25 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10273541B2 (en) 2012-08-14 2019-04-30 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9951386B2 (en) 2014-06-26 2018-04-24 10X Genomics, Inc. Methods and systems for processing polynucleotides
US20150376609A1 (en) 2014-06-26 2015-12-31 10X Genomics, Inc. Methods of Analyzing Nucleic Acids from Individual Cells or Cell Populations
US11591637B2 (en) 2012-08-14 2023-02-28 10X Genomics, Inc. Compositions and methods for sample processing
JP6449160B2 (en) 2012-10-01 2019-01-09 アダプティブ バイオテクノロジーズ コーポレイション Cross-reference of applications related to immune competence assessment by adaptive immune receptor diversity and clonal characterization
WO2015160439A2 (en) 2014-04-17 2015-10-22 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
US10533221B2 (en) 2012-12-14 2020-01-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
EP3567116A1 (en) 2012-12-14 2019-11-13 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9932626B2 (en) 2013-01-15 2018-04-03 Quanterix Corporation Detection of DNA or RNA using single molecule arrays and other techniques
EP3998342A1 (en) 2013-02-08 2022-05-18 10X Genomics, Inc. Partitioning and processing of analytes and other species
EP3597774A1 (en) 2013-03-13 2020-01-22 Sequenom, Inc. Primers for dna methylation analysis
AU2013202805B2 (en) 2013-03-14 2015-07-16 Gen-Probe Incorporated System and method for extending the capabilities of a diagnostic analyzer
US9809852B2 (en) 2013-03-15 2017-11-07 Genapsys, Inc. Systems and methods for biological analysis
US10071359B2 (en) 2013-03-15 2018-09-11 The Regents Of The University Of California High-speed on demand microfluidic droplet generation and manipulation
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
CN111500680A (en) 2013-06-25 2020-08-07 普罗格诺西斯生物科学公司 Method and system for detecting spatial distribution of biological targets in a sample
US20150003580A1 (en) * 2013-06-27 2015-01-01 Olympus Scientific Solutions of America, Inc. Assembly of xrd/xrf sample cells
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
US9557318B2 (en) 2013-07-09 2017-01-31 Curiox Biosystems Pte Ltd. Array plates for washing samples
CN105555972B (en) 2013-07-25 2020-07-31 伯乐生命医学产品有限公司 Genetic assay
US10395758B2 (en) 2013-08-30 2019-08-27 10X Genomics, Inc. Sequencing methods
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US9499870B2 (en) 2013-09-27 2016-11-22 Natera, Inc. Cell free DNA diagnostic testing standards
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9463461B2 (en) * 2013-10-25 2016-10-11 The Johns Hopkins University Self-contained cartridge and methods for integrated biochemical assay at the point-of-care
WO2015069634A1 (en) 2013-11-08 2015-05-14 President And Fellows Of Harvard College Microparticles, methods for their preparation and use
EP3792921A1 (en) 2013-12-11 2021-03-17 Genapsys, Inc. Systems and methods for biological analysis and computation
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US9824068B2 (en) 2013-12-16 2017-11-21 10X Genomics, Inc. Methods and apparatus for sorting data
US9988681B2 (en) 2013-12-18 2018-06-05 James M. Sikela Diagnosis and prognosis of severity of autism spectrum disorders
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
WO2015116627A1 (en) 2014-01-29 2015-08-06 Arizona Board Of Regents On Behalf Of Arizona State University Microreactor array platform
US20150253239A1 (en) * 2014-03-05 2015-09-10 University Of Massachusetts Microplate for high performance spectroscopic applications
ES2741740T3 (en) 2014-03-05 2020-02-12 Adaptive Biotechnologies Corp Methods that use synthetic molecules that contain random nucleotide segments
EP3736344A1 (en) 2014-03-13 2020-11-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
EP3129143B1 (en) 2014-04-10 2022-11-23 10X Genomics, Inc. Method for partitioning microcapsules
EP3556864B1 (en) 2014-04-18 2020-12-09 Genapsys, Inc. Methods and systems for nucleic acid amplification
JP6659575B2 (en) 2014-04-21 2020-03-04 ナテラ, インコーポレイテッド Mutation detection and chromosomal segment ploidy
US20170080417A1 (en) 2014-05-14 2017-03-23 University Of Limerick Microfluidic devices that include channels that are slidable relative to each other and methods of use thereof
US10839939B2 (en) 2014-06-26 2020-11-17 10X Genomics, Inc. Processes and systems for nucleic acid sequence assembly
US10697007B2 (en) 2014-06-27 2020-06-30 The Regents Of The University Of California PCR-activated sorting (PAS)
CN107107058B (en) 2014-10-22 2021-08-10 加利福尼亚大学董事会 High-definition micro-droplet printer
EP3715455A1 (en) 2014-10-29 2020-09-30 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
CA2964472A1 (en) 2014-10-29 2016-05-06 10X Genomics, Inc. Methods and compositions for targeted nucleic acid sequencing
CN107109320B (en) * 2014-11-04 2021-08-06 凸版印刷株式会社 Nucleic acid introduction method, nucleic acid detection method, biological component analysis method, reagent kit, and array device for quantitative determination of biological component
US9975122B2 (en) 2014-11-05 2018-05-22 10X Genomics, Inc. Instrument systems for integrated sample processing
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
BR112017014902A2 (en) 2015-01-12 2018-03-13 10X Genomics Inc processes and systems for the preparation of nucleic acid sequencing libraries and libraries prepared using them
CA2968417A1 (en) 2015-01-13 2016-07-21 10X Genomics, Inc. Systems and methods for visualizing structural variation and phasing information
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
WO2016126871A2 (en) 2015-02-04 2016-08-11 The Regents Of The University Of California Sequencing of nucleic acids via barcoding in discrete entities
SG11201705996PA (en) 2015-02-09 2017-09-28 10X Genomics Inc Systems and methods for determining structural variation and phasing using variant call data
WO2016130962A1 (en) 2015-02-13 2016-08-18 Abbott Laboratories Automated storage modules for diagnostic analyzer liquids and related systems and methods
CN107532202A (en) 2015-02-24 2018-01-02 10X 基因组学有限公司 Method for targetting nucleotide sequence covering
WO2016137973A1 (en) 2015-02-24 2016-09-01 10X Genomics Inc Partition processing methods and systems
CN107532131B (en) * 2015-04-03 2021-11-02 国立研究开发法人产业技术总合研究所 Cell culture apparatus and cell culture method
ES2955488T3 (en) 2015-04-10 2023-12-01 Spatial Transcriptomics Ab Multiplex analysis of biological specimens of spatially distinguished nucleic acids
US11608516B2 (en) 2015-04-15 2023-03-21 Ecolab Usa Inc. Method for determination of diversity and viability thresholds used to assess microorganisms in process samples
WO2016175864A1 (en) 2015-04-30 2016-11-03 Hewlett-Packard Development Company, L.P. Target constituent location and discharge
EP3294906A1 (en) 2015-05-11 2018-03-21 Natera, Inc. Methods and compositions for determining ploidy
US10509028B2 (en) * 2015-05-19 2019-12-17 Bio-Rad Europe Gmbh Use of a low-density immiscible compound in a device for detecting an analyte in a sample
US10545139B2 (en) 2015-06-16 2020-01-28 Curiox Biosystems Pte Ltd. Methods and devices for performing biological assays using magnetic components
CN105039153B (en) * 2015-06-17 2016-09-14 中国科学院半导体研究所 A kind of silicon based array micro reaction pool digital pcr chip and preparation method thereof
WO2017004250A1 (en) 2015-06-29 2017-01-05 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Systems and methods for continuous flow digital droplet polymerase chain reaction bioanalysis
CN108025304B (en) 2015-07-22 2022-01-21 北卡罗来纳-查佩尔山大学 Fluidic devices containing bead well geometries with spatially separated bead retention and signal detection segments and related methods
KR20190057444A (en) 2015-08-10 2019-05-28 에센릭스 코프. Bio/chemical assay devices and methods for simplified steps, small samples, accelerated speed, and ease-of-use
USD804682S1 (en) 2015-08-10 2017-12-05 Opko Diagnostics, Llc Multi-layered sample cassette
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
EP3957996A1 (en) 2015-10-05 2022-02-23 The University of North Carolina at Chapel Hill Fluidic devices, kits, and solid supports for decoding methods for multiplexing assays
DK3245517T3 (en) 2015-10-07 2019-01-14 Selma Diagnostics Aps Flow system and method for digital counting
WO2017066231A1 (en) 2015-10-13 2017-04-20 President And Fellows Of Harvard College Systems and methods for making and using gel microspheres
EP3368220B1 (en) 2015-10-26 2020-07-22 IDEXX Laboratories, Inc. Hematology test slide
CN108431232B (en) 2015-12-04 2022-10-14 10X 基因组学有限公司 Methods and compositions for nucleic acid analysis
US10578857B2 (en) * 2016-02-05 2020-03-03 Aidmics Biotechnology Co., Ltd. Sample adhesive element, sample carrying module and portable microscope apparatus using the same
US11081208B2 (en) 2016-02-11 2021-08-03 10X Genomics, Inc. Systems, methods, and media for de novo assembly of whole genome sequence data
WO2017197338A1 (en) 2016-05-13 2017-11-16 10X Genomics, Inc. Microfluidic systems and methods of use
CN116397014A (en) 2016-07-20 2023-07-07 测序健康公司 Systems and methods for nucleic acid sequencing
JP6925051B2 (en) 2016-07-29 2021-08-25 セルマ・ダイアグノスティクス・アンパルトセルスカブSelma Diagnostics Aps Improved method for digital counting
CN110088290A (en) 2016-08-10 2019-08-02 加利福尼亚大学董事会 Multiple displacement amplification and PCR are combined in lotion droplet
EP3300801B1 (en) 2016-09-30 2019-09-04 Roche Diagniostics GmbH Microfluidic device and method for manufacturing the same
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
JP2020500517A (en) 2016-11-28 2020-01-16 アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ Systems and methods relating to continuous flow droplet reactions
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
EP3551745A4 (en) 2016-12-12 2020-07-15 Xcella Biosciences, Inc. Methods and systems for screening using microcapillary arrays
US11085039B2 (en) 2016-12-12 2021-08-10 xCella Biosciences, Inc. Methods and systems for screening using microcapillary arrays
WO2018114625A1 (en) 2016-12-19 2018-06-28 Elvesys Microfluidic sample chip, assay system using such a chip, and pcr method for detecting dna sequences
US20220033893A1 (en) 2016-12-21 2022-02-03 The Regents Of The University Of California Single Cell Genomic Sequencing Using Hydrogel Based Droplets
US10815525B2 (en) 2016-12-22 2020-10-27 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10011872B1 (en) 2016-12-22 2018-07-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10550429B2 (en) 2016-12-22 2020-02-04 10X Genomics, Inc. Methods and systems for processing polynucleotides
CN110382439A (en) 2016-12-30 2019-10-25 埃克切拉生物科学公司 Multistage sample retrieval system
CN110573253B (en) * 2017-01-13 2021-11-02 赛卢拉研究公司 Hydrophilic coating for fluid channels
EP4029939B1 (en) 2017-01-30 2023-06-28 10X Genomics, Inc. Methods and systems for droplet-based single cell barcoding
EP3357575B1 (en) 2017-02-06 2021-03-17 H. Hoffnabb-La Roche Ag Sealable microfluidic chip and method for thermocycling
CN111246945A (en) * 2017-02-07 2020-06-05 Essenlix公司 Compressed open flow assay and use
CA3052962A1 (en) * 2017-02-08 2018-08-16 Essenlix Corp. Digital assay
EP3583423A4 (en) * 2017-02-15 2021-03-31 Essenlix Corporation Assay with rapid temperature change
CA3049139A1 (en) 2017-02-21 2018-08-30 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
WO2018183723A1 (en) * 2017-03-29 2018-10-04 Cornell University Devices, processes, and systems for determination of nucleic acid sequence, expression, copy number, or methylation changes using combined nuclease, ligase, polymerase, and sequencing reactions
US11584958B2 (en) 2017-03-31 2023-02-21 Grail, Llc Library preparation and use thereof for sequencing based error correction and/or variant identification
KR102446247B1 (en) 2017-04-05 2022-09-21 큐리옥스 바이오시스템즈 피티이 엘티디. Methods, devices and apparatus for cleaning samples on array plates
JP6966860B2 (en) * 2017-04-07 2021-11-17 リンテック株式会社 Manufacturing method of inspection cover film, inspection member, and inspection cover film
WO2018213774A1 (en) 2017-05-19 2018-11-22 10X Genomics, Inc. Systems and methods for analyzing datasets
EP4230746A3 (en) 2017-05-26 2023-11-01 10X Genomics, Inc. Single cell analysis of transposase accessible chromatin
US20180340169A1 (en) 2017-05-26 2018-11-29 10X Genomics, Inc. Single cell analysis of transposase accessible chromatin
CN112689758A (en) 2017-08-01 2021-04-20 Essenlix公司 Device and method for examining the effect of a drug on microorganisms
WO2019028123A1 (en) 2017-08-01 2019-02-07 Essenlix Corporation Sample collection, holding, and assaying
CN111566224A (en) 2017-09-21 2020-08-21 吉纳普赛斯股份有限公司 Systems and methods for nucleic acid sequencing
US11393561B2 (en) 2017-10-13 2022-07-19 Essenlix Corporation Devices and methods for authenticating a medical test and use of the same
US10501739B2 (en) 2017-10-18 2019-12-10 Mission Bio, Inc. Method, systems and apparatus for single cell analysis
WO2019084492A1 (en) * 2017-10-26 2019-05-02 Essenlix Corporation Devices and methods for monitoring liquid-solid contact time
CN111051523A (en) 2017-11-15 2020-04-21 10X基因组学有限公司 Functionalized gel beads
US10829815B2 (en) 2017-11-17 2020-11-10 10X Genomics, Inc. Methods and systems for associating physical and genetic properties of biological particles
US11648551B2 (en) 2017-12-12 2023-05-16 Essenlix Corporation Sample manipulation and assay with rapid temperature change
US11510608B2 (en) 2017-12-14 2022-11-29 Essenlix Corporation Devices, systems, and methods for monitoring hair
GB201721430D0 (en) * 2017-12-20 2018-01-31 Q-Linea Ab Method and device for microscopy-based imaging of samples
US11156606B2 (en) 2018-01-11 2021-10-26 Essenlix Corporation Homogeneous assay (II)
CA3095292A1 (en) 2018-04-02 2019-10-10 Progenity, Inc. Methods, systems, and compositions for counting nucleic acid molecules
CN112236218B (en) 2018-04-02 2022-04-26 滴管公司 System and method for continuous flow emulsion processing
EP3775271A1 (en) 2018-04-06 2021-02-17 10X Genomics, Inc. Systems and methods for quality control in single cell processing
CN108855259A (en) * 2018-06-05 2018-11-23 中国科学院苏州生物医学工程技术研究所 A kind of surface modifying method of micro-array chip
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US11806717B2 (en) * 2018-08-16 2023-11-07 Essenlix Corporation Assay using sample thickness multiplexing
EP3610947B1 (en) * 2018-08-17 2021-04-21 F. Hoffmann-La Roche AG Microfluidic system for digital polymerase chain reaction of a biological sample, and respective method
US11519033B2 (en) 2018-08-28 2022-12-06 10X Genomics, Inc. Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
US11649485B2 (en) 2019-01-06 2023-05-16 10X Genomics, Inc. Generating capture probes for spatial analysis
CN109679836B (en) * 2019-01-14 2020-09-08 中国水产科学研究院黄海水产研究所 Slide trace detection system applied to prawn pathogen high-flux detection
EP3714977A1 (en) 2019-03-29 2020-09-30 Roche Diagnostics GmbH Microfluidic device
EP3947718A4 (en) 2019-04-02 2022-12-21 Enumera Molecular, Inc. Methods, systems, and compositions for counting nucleic acid molecules
CA3138806A1 (en) 2019-05-22 2020-11-26 Dalia Dhingra Method and apparatus for simultaneous targeted sequencing of dna, rna and protein
WO2021003255A1 (en) 2019-07-01 2021-01-07 Mission Bio Method and apparatus to normalize quantitative readouts in single-cell experiments
US11440057B2 (en) * 2019-07-11 2022-09-13 Verily Life Sciences Llc Pupae singulator and sex sorter
EP3996500A4 (en) * 2019-07-11 2023-07-05 Verily Life Sciences LLC Pupae singulator and sex sorter
US11712177B2 (en) 2019-08-12 2023-08-01 Essenlix Corporation Assay with textured surface
EP4055185A1 (en) 2019-11-08 2022-09-14 10X Genomics, Inc. Spatially-tagged analyte capture agents for analyte multiplexing
WO2021092433A2 (en) 2019-11-08 2021-05-14 10X Genomics, Inc. Enhancing specificity of analyte binding
SG11202106899SA (en) 2019-12-23 2021-09-29 10X Genomics Inc Methods for spatial analysis using rna-templated ligation
US11732299B2 (en) 2020-01-21 2023-08-22 10X Genomics, Inc. Spatial assays with perturbed cells
US11702693B2 (en) 2020-01-21 2023-07-18 10X Genomics, Inc. Methods for printing cells and generating arrays of barcoded cells
US11040343B1 (en) * 2020-01-28 2021-06-22 Plexium, Inc. Caps for assay devices
US11821035B1 (en) 2020-01-29 2023-11-21 10X Genomics, Inc. Compositions and methods of making gene expression libraries
US11898205B2 (en) 2020-02-03 2024-02-13 10X Genomics, Inc. Increasing capture efficiency of spatial assays
US11732300B2 (en) 2020-02-05 2023-08-22 10X Genomics, Inc. Increasing efficiency of spatial analysis in a biological sample
US11835462B2 (en) 2020-02-11 2023-12-05 10X Genomics, Inc. Methods and compositions for partitioning a biological sample
US11891654B2 (en) 2020-02-24 2024-02-06 10X Genomics, Inc. Methods of making gene expression libraries
CN111304072B (en) * 2020-02-28 2023-05-02 宁波胤瑞生物医学仪器有限责任公司 Oil seal device for digital PCR chip
US11768175B1 (en) 2020-03-04 2023-09-26 10X Genomics, Inc. Electrophoretic methods for spatial analysis
CN115916999A (en) 2020-04-22 2023-04-04 10X基因组学有限公司 Methods for spatial analysis using targeted RNA depletion
EP4153776A1 (en) 2020-05-22 2023-03-29 10X Genomics, Inc. Spatial analysis to detect sequence variants
EP4153775A1 (en) 2020-05-22 2023-03-29 10X Genomics, Inc. Simultaneous spatio-temporal measurement of gene expression and cellular activity
WO2021242834A1 (en) 2020-05-26 2021-12-02 10X Genomics, Inc. Method for resetting an array
WO2021247543A2 (en) 2020-06-02 2021-12-09 10X Genomics, Inc. Nucleic acid library methods
WO2021247568A1 (en) 2020-06-02 2021-12-09 10X Genomics, Inc. Spatial trancriptomics for antigen-receptors
EP4162074A1 (en) 2020-06-08 2023-04-12 10X Genomics, Inc. Methods of determining a surgical margin and methods of use thereof
WO2021252591A1 (en) 2020-06-10 2021-12-16 10X Genomics, Inc. Methods for determining a location of an analyte in a biological sample
EP4172362A1 (en) 2020-06-25 2023-05-03 10X Genomics, Inc. Spatial analysis of dna methylation
US11761038B1 (en) 2020-07-06 2023-09-19 10X Genomics, Inc. Methods for identifying a location of an RNA in a biological sample
EP3960292A1 (en) * 2020-09-01 2022-03-02 Roche Diagnostics GmbH System and method for separating an aqueous liquid into at least two cavities
AU2021345359A1 (en) 2020-09-21 2023-05-11 Progenity, Inc. Compositions and methods for isolation of cell-free dna
US11827935B1 (en) 2020-11-19 2023-11-28 10X Genomics, Inc. Methods for spatial analysis using rolling circle amplification and detection probes
AU2021409136A1 (en) 2020-12-21 2023-06-29 10X Genomics, Inc. Methods, compositions, and systems for capturing probes and/or barcodes
AU2022238446A1 (en) 2021-03-18 2023-09-07 10X Genomics, Inc. Multiplex capture of gene and protein expression from a biological sample
US20230068047A1 (en) 2021-08-19 2023-03-02 Luminex Corporation Digital amplification assay analysis method
EP4196605A1 (en) 2021-09-01 2023-06-21 10X Genomics, Inc. Methods, compositions, and kits for blocking a capture probe on a spatial array
CN113769801A (en) * 2021-09-14 2021-12-10 上海大学 Preparation method and system of microarray microporous plate and product collection silicon wafer
WO2023229982A2 (en) * 2022-05-24 2023-11-30 10X Genomics, Inc. Porous structure confinement for convection suppression

Citations (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US522332A (en) * 1894-07-03 Mohn van vleck
US2561339A (en) * 1944-01-10 1951-07-24 Chediak Alejandro Apparatus for laboratory investigations
US3389966A (en) * 1964-04-30 1968-06-25 Calvin A. Saravis Apparatus and process for semiqualitative, semiquantitative immunodiffusion reactions
US3390962A (en) * 1965-09-01 1968-07-02 Nat Instr Lab Inc Biochemical test plate
US3691017A (en) * 1970-05-06 1972-09-12 Worthington Bio Chem Corp Means and method for chemical analysis
US3865548A (en) * 1972-06-13 1975-02-11 Einstein Coll Med Analytical apparatus and process
US4065263A (en) * 1976-04-02 1977-12-27 Woodbridge Iii Richard G Analytical test strip apparatus
US4146365A (en) * 1977-11-07 1979-03-27 Litton Bionetics, Inc. Affinity detection apparatus
US4299920A (en) * 1979-01-19 1981-11-10 Peters J Hinrich Biological receptacle
US4468371A (en) * 1982-07-19 1984-08-28 Daryl Laboratories, Inc. Immunoassay test slide
US4483925A (en) * 1982-12-30 1984-11-20 Becton, Dickinson And Company Liquid removal device
US4591567A (en) * 1982-04-21 1986-05-27 California Institute Of Technology Recombinant DNA screening system including fixed array replicator and support
US4599315A (en) * 1983-09-13 1986-07-08 University Of California Regents Microdroplet test apparatus
US4834946A (en) * 1987-02-05 1989-05-30 Levin Andrew E Apparatus for blot screening numerous, small volume, antibody solutions
US4868130A (en) * 1985-08-21 1989-09-19 Biotope, Inc. Methods for conducting specific binding assays
US4911782A (en) * 1988-03-28 1990-03-27 Cyto-Fluidics, Inc. Method for forming a miniaturized biological assembly
US5017342A (en) * 1988-06-01 1991-05-21 Ortho Diagnostic Systems Inc. Device for immunoassay determinations
US5041266A (en) * 1989-12-21 1991-08-20 Hoffmann-La Roche Inc. Tray for immunometric determinations
US5073341A (en) * 1985-08-21 1991-12-17 Biotope, Inc. Devices for conducting specific binding assays
US5176203A (en) * 1989-08-05 1993-01-05 Societe De Conseils De Recherches Et D'applications Scientifiques Apparatus for repeated automatic execution of a thermal cycle for treatment of samples
US5182082A (en) * 1991-01-23 1993-01-26 Becton, Dickinson And Company Multiple aliquot device for distributing a liquid solution into a well
US5192659A (en) * 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5200152A (en) * 1988-03-28 1993-04-06 Cytonix Corporation Miniaturized biological assembly
US5229297A (en) * 1989-02-03 1993-07-20 Eastman Kodak Company Containment cuvette for PCR and method of use
US5276125A (en) * 1989-12-02 1994-01-04 Bayer Aktiengesellschaft Heat-curable coating compositions
US5299163A (en) * 1991-06-27 1994-03-29 Nec Corporation Semiconductor memory device with discriminator for diagnostic mode of operation
US5304487A (en) * 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US5346672A (en) * 1989-11-17 1994-09-13 Gene Tec Corporation Devices for containing biological specimens for thermal processing
US5376252A (en) * 1990-05-10 1994-12-27 Pharmacia Biosensor Ab Microfluidic structure and process for its manufacture
US5380489A (en) * 1992-02-18 1995-01-10 Eastman Kodak Company Element and method for nucleic acid amplification and detection using adhered probes
US5422270A (en) * 1987-05-19 1995-06-06 The United States Of America As Represented By The Department Of Health And Human Services One-step tray test for release of soluble mediators and apparatus therefore
US5498392A (en) * 1992-05-01 1996-03-12 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US5503803A (en) * 1988-03-28 1996-04-02 Conception Technologies, Inc. Miniaturized biological assembly
US5525464A (en) * 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5585069A (en) * 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5587128A (en) * 1992-05-01 1996-12-24 The Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification devices
US5601982A (en) * 1995-02-07 1997-02-11 Sargent; Jeannine P. Method and apparatus for determining the sequence of polynucleotides
US5610016A (en) * 1994-03-30 1997-03-11 Mochida Pharmaceutical Co., Ltd. Method for measuring adenyl group-containing substances using heteropoly-acid
US5614396A (en) * 1990-06-14 1997-03-25 Baylor College Of Medicine Methods for the genetic modification of endogenous genes in animal cells by homologous recombination
US5641658A (en) * 1994-08-03 1997-06-24 Mosaic Technologies, Inc. Method for performing amplification of nucleic acid with two primers bound to a single solid support
US5795748A (en) * 1996-09-26 1998-08-18 Becton Dickinson And Company DNA microwell device and method
US5830663A (en) * 1991-08-10 1998-11-03 Medical Research Council In situ recombinant PCR within single cells
US5948673A (en) * 1995-09-12 1999-09-07 Becton Dickinson And Company Device and method for DNA amplification and assay
US5976336A (en) * 1997-04-25 1999-11-02 Caliper Technologies Corp. Microfluidic devices incorporating improved channel geometries
US5994056A (en) * 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US6049380A (en) * 1997-11-12 2000-04-11 Regents Of The University Of California Single molecule identification using selected fluorescence characteristics
US6132580A (en) * 1995-09-28 2000-10-17 The Regents Of The University Of California Miniature reaction chamber and devices incorporating same
US6143496A (en) * 1997-04-17 2000-11-07 Cytonix Corporation Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US7687280B2 (en) * 1996-04-03 2010-03-30 Applied Biosystems, Llc Device and method for multiple analyte detection
US7833719B2 (en) * 2000-02-18 2010-11-16 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and methods for parallel processing of micro-volume liquid reactions
US20110065590A1 (en) * 1998-01-12 2011-03-17 Hunter Ian W Method and Apparatus for Performing Microassays

Family Cites Families (164)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US792778A (en) * 1904-04-25 1905-06-20 William A Koeneman Pebble-mill.
US3390966A (en) * 1962-11-13 1968-07-02 Du Pont Chemical products and their preparation
US4704256A (en) 1980-09-23 1987-11-03 California Institute Of Technology Apparatus for the sequential performance of chemical processes
CA1339981C (en) 1984-05-25 1998-08-04 Fred R. Kramer Replicatable hybridizable recombinant rna probes and methods of using same
US4683194A (en) 1984-05-29 1987-07-28 Cetus Corporation Method for detection of polymorphic restriction sites and nucleic acid sequences
AU606043B2 (en) 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
US5310652A (en) * 1986-08-22 1994-05-10 Hoffman-La Roche Inc. Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription
GB8728639D0 (en) 1987-12-08 1988-01-13 Scient Generics Ltd Device for analytical determinations
US4906840A (en) * 1988-01-27 1990-03-06 The Board Of Trustees Of Leland Stanford Jr., University Integrated scanning tunneling microscope
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5024934A (en) 1988-03-14 1991-06-18 The Board Of Regents, The University Of Texas System Detection of minimal numbers of neoplastic cells carrying DNA translocations by DNA sequence amplification
DE3808942A1 (en) 1988-03-17 1989-09-28 Bio Med Gmbh Ges Fuer Biotechn Incubator, in particular for the polymerase chain reaction
SE8801070D0 (en) 1988-03-23 1988-03-23 Pharmacia Ab METHOD FOR IMMOBILIZING A DNA SEQUENCE ON A SOLID SUPPORT
GB8807297D0 (en) 1988-03-26 1988-04-27 Dean P D G Intelligent heating block
US5225332A (en) * 1988-04-22 1993-07-06 Massachusetts Institute Of Technology Process for manipulation of non-aqueous surrounded microdroplets
WO1989010979A1 (en) 1988-05-10 1989-11-16 E.I. Du Pont De Nemours And Company Process for rapid nucleic acid detection
NO165894C (en) 1988-05-24 1991-04-24 Gunnar Paulsen METHOD OF ANALYSIS OF GENES.
US5188963A (en) * 1989-11-17 1993-02-23 Gene Tec Corporation Device for processing biological specimens for analysis of nucleic acids
US5077192A (en) 1988-10-25 1991-12-31 The General Hospital Corporation Method of detecting antigenic, nucleic acid-containing macromolecular entities
GB2228086A (en) 1988-11-25 1990-08-15 Ici Plc Characterisation of genomic DNA
JP3068848B2 (en) 1988-12-09 2000-07-24 アムラド・コーポレイション・リミテッド Amplified DNA assay
EP0462224B1 (en) 1989-03-10 1994-08-31 Millipore Corporation Sequencing nucleic acids using chemiluminescent detection
KR920700360A (en) 1989-03-22 1992-02-19 하리크 프리드리히 Sliding bearing
EP0392546A3 (en) 1989-04-14 1991-09-11 Ro Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Process for determination of a complete or a partial contents of very short sequences in the samples of nucleic acids connected to the discrete particles of microscopic size by hybridization with oligonucleotide probes
US5279938A (en) 1989-06-05 1994-01-18 The United States Of America As Represented By The Department Of Health And Human Services Sensitive diagnostic test for lyme disease
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
JPH04506599A (en) 1989-06-12 1992-11-19 セーイーエス ビオ アンテルナショナル Methods for detecting specific nucleic acid sequences and their applications
US5580722A (en) 1989-07-18 1996-12-03 Oncogene Science, Inc. Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
US5232829A (en) 1989-09-29 1993-08-03 Hoffmann-La Roche Inc. Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
US5184020A (en) 1989-10-26 1993-02-02 Hearst David P Device and method for photoactivation
ATE216401T1 (en) 1989-11-03 2002-05-15 Immulogic Pharma Corp T-CELL REACTIVE CAT PROTEIN ISOLATED FROM HOUSE DUST AND USES THEREOF
GB8926269D0 (en) 1989-11-21 1990-01-10 Dynal As Plasmid
US5229163A (en) 1989-12-21 1993-07-20 Hoffmann-La Roche Inc. Process for preparing a microtiter tray for immunometric determinations
GB8929293D0 (en) 1989-12-29 1990-02-28 3I Res Expl Ltd C.difficile dna probes
CA2032203C (en) 1989-12-29 2009-05-19 Christine L. Brakel Amplification capture assay
US5169039A (en) * 1990-02-28 1992-12-08 Photofinish Cosmetics, Inc. Two-stroke fluid dispenser with actuator-operated valve for controlling fluid flow between internal fluid chamber
DE69132332T2 (en) 1990-04-06 2000-11-30 Genelabs Tech Inc HEPATITIS C-VIRUS-EPITOPE
US5194370A (en) 1990-05-16 1993-03-16 Life Technologies, Inc. Promoter ligation activated transcription amplification of nucleic acid sequences
GB9011454D0 (en) 1990-05-22 1990-07-11 Medical Res Council Polynucleotide amplification
US5455175A (en) 1990-06-04 1995-10-03 University Of Utah Research Foundation Rapid thermal cycling device
US7081226B1 (en) 1996-06-04 2006-07-25 University Of Utah Research Foundation System and method for fluorescence monitoring
EP0786469B1 (en) 1990-06-11 2006-03-01 Gilead Sciences, Inc. Methods of use of nucleic acid ligands
US5114858A (en) 1990-06-26 1992-05-19 E. I. Du Pont De Nemours And Company Cellular component extraction process in a disposable filtration vessel
US5447679A (en) 1990-07-18 1995-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Process of producing plastic plates with wells by placing a film on a mold and applying hot gas
US5582665A (en) 1990-07-18 1996-12-10 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Process for sealing at least one well out of a number of wells provided in a plate for receiving chemical and/or biochemical and/or microbiological substances, and installation for carrying out the process
GB9016163D0 (en) 1990-07-24 1990-09-05 Cemu Bioteknik Chemical method
WO1992005443A1 (en) 1990-09-15 1992-04-02 Medical Research Council Reagent separation
US5168039A (en) 1990-09-28 1992-12-01 The Board Of Trustees Of The University Of Arkansas Repetitive DNA sequence specific for mycobacterium tuberculosis to be used for the diagnosis of tuberculosis
JP2985446B2 (en) 1990-10-31 1999-11-29 東ソー株式会社 Methods for detecting and measuring nucleic acids
KR100236506B1 (en) 1990-11-29 2000-01-15 퍼킨-엘머시터스인스트루먼츠 Apparatus for polymerase chain reaction
AU1258292A (en) 1991-01-18 1992-08-27 Oncogene Science, Inc. Methods of transcriptionally modulating expression of hematopoietic growth factor genes
GB9108066D0 (en) 1991-04-16 1991-06-05 Amersham Int Plc Method and apparatus for forming an array of biological particles
US5169766A (en) 1991-06-14 1992-12-08 Life Technologies, Inc. Amplification of nucleic acid molecules
US5260199A (en) * 1991-07-30 1993-11-09 Wisconsin Alumni Research Foundation Method of producing 1,25-dihydroxyvitamin D3 receptor protein
EP0549107B1 (en) 1991-10-11 1997-12-29 BEHRINGWERKE Aktiengesellschaft Method for producing a polynucleotide for use in single primer amplification and phosphorothioate-containing oligonucleotides as primers in nucleic acid amplification
AU3074992A (en) 1991-11-14 1993-06-15 Amgen, Inc. Expression of neurotrophic factors with heterologous prepro regions
DE4234086A1 (en) 1992-02-05 1993-08-12 Diagen Inst Molekularbio METHOD FOR DETERMINING NUCLEIC ACID SEQUENCES AMPLIFIED IN VITRO
WO1993018155A1 (en) 1992-03-02 1993-09-16 Kyowa Hakko Kogyo Co., Ltd. Novel plant gene
AU680195B2 (en) 1992-05-01 1997-07-24 Trustees Of The University Of Pennsylvania, The Analysis based on flow restriction
US5486335A (en) * 1992-05-01 1996-01-23 Trustees Of The University Of Pennsylvania Analysis based on flow restriction
GB9211979D0 (en) 1992-06-05 1992-07-15 Buchard Ole Uses of nucleic acid analogues
GB9218131D0 (en) 1992-08-26 1992-10-14 Slater James H A method of marking a liquid
US5639423A (en) 1992-08-31 1997-06-17 The Regents Of The University Of Calfornia Microfabricated reactor
EP0588171B1 (en) * 1992-09-08 1997-02-12 Hoechst Aktiengesellschaft Process for the transformation of water - sensitive ceramic powders into a flowable granulate
RU2048522C1 (en) 1992-10-14 1995-11-20 Институт белка РАН Method of nucleic acid copying, method of their expression and a medium for their realization
US5422271A (en) 1992-11-20 1995-06-06 Eastman Kodak Company Nucleic acid material amplification and detection without washing
US6001568A (en) 1992-10-26 1999-12-14 Institut Belka Solid medium for amplification and expression of nucleic acids as colonies
WO1994018218A1 (en) 1993-02-01 1994-08-18 Seq, Ltd. Methods and apparatus for dna sequencing
US5545528A (en) 1993-04-15 1996-08-13 Hitachi Chemical Research Center Rapid screening method of gene amplification products in polypropylene plates
US5579176A (en) * 1993-04-30 1996-11-26 Olympus Optical Co., Ltd. Optical system supporting device with flowable damping material
US5494795A (en) 1993-05-05 1996-02-27 The United States Of America As Represented By The Secretary Of The Navy Specific oligonucleotide primers for detection of pathogenic campylobacter bacteria by polymerase chain reaction
JP3594598B2 (en) 1993-07-09 2004-12-02 アクゾ・ノベル・エヌ・ベー Improved nucleic acid quantification method
JPH0756956A (en) * 1993-07-22 1995-03-03 Xerox Corp Method for access of data based on image created by human being
CA2126391C (en) 1993-09-13 2002-01-08 Nobuko Yamamoto Determination of nucleic acid by pcr, measurement of number of microbial cells, genes, or gene-copies by pcr, and measuring-kit employed for the same
WO1995008640A1 (en) * 1993-09-23 1995-03-30 E.I. Du Pont De Nemours And Company An electrophoretic method for the isolation and separation of microorganisms
US5374395A (en) 1993-10-14 1994-12-20 Amoco Corporation Diagnostics instrument
JP3457322B2 (en) 1993-10-21 2003-10-14 アボツト・ラボラトリーズ Apparatus and method for detecting target ligand
US5522974A (en) 1993-10-21 1996-06-04 Laurence A. Fishel Method of preparing gel containing capillaries
US5415839A (en) 1993-10-21 1995-05-16 Abbott Laboratories Apparatus and method for amplifying and detecting target nucleic acids
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
WO1995014109A1 (en) 1993-11-19 1995-05-26 U.S. Department Of The Army High through-put quantitative polymerase chain reaction for hiv clinical specimens
WO1995021382A2 (en) 1994-02-01 1995-08-10 Fields Robert E Molecular analyzer and method of use
WO1995021269A1 (en) 1994-02-04 1995-08-10 Perlin Mark K Method and apparatus for analyzing genetic material
US5576176A (en) 1994-03-03 1996-11-19 The Regents Of The University Of California Marker and an assay for detection and monitoring of human immunodeficiency virus latency and activation
US5725831A (en) 1994-03-14 1998-03-10 Becton Dickinson And Company Nucleic acid amplification apparatus
JPH07263028A (en) * 1994-03-25 1995-10-13 Fuji Photo Film Co Ltd Nonaqueous secondary battery
DE4412286A1 (en) 1994-04-09 1995-10-12 Boehringer Mannheim Gmbh System for contamination-free processing of reaction processes
WO1995030774A1 (en) 1994-05-05 1995-11-16 Beckman Instruments, Inc. Oligonucleotide repeat arrays
US5445175A (en) * 1994-06-06 1995-08-29 Cho; Kyungil Medical crutch
US5526705A (en) 1994-08-05 1996-06-18 Tyler Limited Partnership Automated work station for analyzing soil samples
US5580730A (en) 1994-08-19 1996-12-03 Olympus America, Inc. Enzyme digestion method for the detection of amplified DNA
US5861485A (en) 1994-08-23 1999-01-19 Millennium Pharmaceuticals, Inc. Polypeptides involved in body weight disorders, including obesity
US5456360A (en) 1994-09-30 1995-10-10 The Perkin-Elmer Corporation Holder assembly for reaction tubes
DE4435107C1 (en) 1994-09-30 1996-04-04 Biometra Biomedizinische Analy Miniaturized flow thermal cycler
US5571410A (en) * 1994-10-19 1996-11-05 Hewlett Packard Company Fully integrated miniaturized planar liquid sample handling and analysis device
US6410223B1 (en) 1994-11-04 2002-06-25 The United States Of America As Represented By The Secretary Of Agriculture Direct polymerase chain reaction assay, or bio-PCR
US5512441A (en) 1994-11-15 1996-04-30 American Health Foundation Quantative method for early detection of mutant alleles and diagnostic kits for carrying out the method
US5654141A (en) 1994-11-18 1997-08-05 Thomas Jefferson University Amplification based detection of bacterial infection
US5756295A (en) 1994-12-05 1998-05-26 Takeda Chemical Industries, Ltd. DNA primer and a method for screening DNAS
GB9425138D0 (en) 1994-12-12 1995-02-08 Dynal As Isolation of nucleic acid
US5952238A (en) 1995-02-02 1999-09-14 Chugai Seiyaku Kabushiki Kaisha Method of assaying specimen substance by controlling dose of chemiluminescence
US5763242A (en) 1995-02-08 1998-06-09 Thomas Jefferson University Method for increasing transduction efficiency of recombinant retroviral vectors
GB9503808D0 (en) 1995-02-24 1995-04-12 Univ Nottingham Detection assay
US5766851A (en) 1995-05-19 1998-06-16 The Johns Hopkins University School Of Medicine Susceptibility gene for obesity and type II diabetes mellitus
ATE215993T1 (en) 1995-05-19 2002-04-15 Abbott Lab DETECTION OF NUCLEIC ACIDS WITH WIDE DYNAMIC RANGE USING AGGREGATE PRIMER SERIES
DE19519015C1 (en) 1995-05-24 1996-09-05 Inst Physikalische Hochtech Ev Miniaturised multi-chamber thermo-cycler for polymerase chain reaction
WO1996039176A1 (en) 1995-06-05 1996-12-12 Brigham & Women's Hospital USE OF ORAL TOLERANCE TO SUPPRESS BOTH Th1 AND Th2 IMMUNE RESPONSES AND TO SUPPRESS ANTIBODY PRODUCTION
AU5885196A (en) 1995-06-06 1996-12-24 T Cell Diagnostics, Inc. Universal chemistry enzyme-linked immunosorbent assay for de tection of mrna expression
JP3996639B2 (en) 1995-06-07 2007-10-24 ジェン−プローブ・インコーポレーテッド Method and kit for determining the pre-amplification level of a nucleic acid target sequence from the post-amplification level of a product
US5882856A (en) 1995-06-07 1999-03-16 Genzyme Corporation Universal primer sequence for multiplex DNA amplification
US5589136A (en) 1995-06-20 1996-12-31 Regents Of The University Of California Silicon-based sleeve devices for chemical reactions
JPH0910000A (en) 1995-06-26 1997-01-14 Nippon Sekijiyuujishiya Detection of human parvovirus and reagent therefor
US5856174A (en) * 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5989813A (en) 1995-07-13 1999-11-23 Molecular Innovations, Inc. Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles
EP0843593A4 (en) 1995-08-11 1999-07-28 Robbins Scient Corp Compartmentalized multi-well container
US5866330A (en) 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5785926A (en) 1995-09-19 1998-07-28 University Of Washington Precision small volume fluid processing apparatus
US5716825A (en) 1995-11-01 1998-02-10 Hewlett Packard Company Integrated nucleic acid analysis system for MALDI-TOF MS
US5725931A (en) * 1995-11-03 1998-03-10 Minnesota Mining And Manufacturing Company Constrained layer damper with slit(s) and/or cutout(s)
US5800989A (en) 1995-11-15 1998-09-01 Becton, Dickinson And Company Method for detection of nucleic acid targets by amplification and fluorescence polarization
US20010055812A1 (en) 1995-12-05 2001-12-27 Alec Mian Devices and method for using centripetal acceleration to drive fluid movement in a microfluidics system with on-board informatics
AU1461397A (en) 1995-12-08 1997-06-27 Systemix, Inc. Rapid assay to estimate gene transfer into cells
US5856100A (en) 1995-12-08 1999-01-05 The Institute Of Physical And Chemical Research Method for purification and transfer to separation/detection systems of DNA sequencing samples and plates used therefor
JP2000508058A (en) 1995-12-18 2000-06-27 ニューカーマンズ、アーモンド、ピー Microfluidic valve and integrated microfluidic system
US5863502A (en) 1996-01-24 1999-01-26 Sarnoff Corporation Parallel reaction cassette and associated devices
GB9604267D0 (en) 1996-02-29 1996-05-01 Royal Infirmary Of Edinburgh N Mutation assay
US6825047B1 (en) 1996-04-03 2004-11-30 Applera Corporation Device and method for multiple analyte detection
US6126899A (en) 1996-04-03 2000-10-03 The Perkins-Elmer Corporation Device for multiple analyte detection
US7235406B1 (en) 1996-04-03 2007-06-26 Applera Corporation Nucleic acid analysis device
US5885470A (en) 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
EP2369007B1 (en) 1996-05-29 2015-07-29 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US5846727A (en) 1996-06-06 1998-12-08 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Microsystem for rapid DNA sequencing
US5985651A (en) 1996-06-17 1999-11-16 The Board Of Trustees Of The Leland Stanford Junior University Thermocycling apparatus and method
US6379929B1 (en) 1996-11-20 2002-04-30 The Regents Of The University Of Michigan Chip-based isothermal amplification devices and methods
US5804384A (en) * 1996-12-06 1998-09-08 Vysis, Inc. Devices and methods for detecting multiple analytes in samples
US6060240A (en) 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
JP3935509B2 (en) * 1997-02-12 2007-06-27 ワイ. チャン,ユージーン Methods and products for polymer analysis
DK2308995T3 (en) 1997-02-28 2015-08-03 Cepheid Chemical reaction unit with heat exchanger and optical detector
US5958345A (en) 1997-03-14 1999-09-28 Moxtek, Inc. Thin film sample support
JP2001521622A (en) 1997-04-04 2001-11-06 カリパー テクノロジーズ コーポレイション Closed-loop biochemical analyzer
JP3666604B2 (en) 1997-04-16 2005-06-29 アプレラ コーポレーション Nucleic acid archiving
US6893877B2 (en) 1998-01-12 2005-05-17 Massachusetts Institute Of Technology Methods for screening substances in a microwell array
EP0967370B1 (en) * 1998-06-26 2005-03-30 Yamaha Hatsudoki Kabushiki Kaisha Internal combustion engine
US6027873A (en) 1999-03-19 2000-02-22 Genencor International, Inc. Multi-through hole testing plate for high throughput screening
US6306578B1 (en) 1999-03-19 2001-10-23 Genencor International, Inc. Multi-through hole testing plate for high throughput screening
US6221600B1 (en) 1999-10-08 2001-04-24 Board Of Regents, The University Of Texas System Combinatorial oligonucleotide PCR: a method for rapid, global expression analysis
US20020151040A1 (en) 2000-02-18 2002-10-17 Matthew O' Keefe Apparatus and methods for parallel processing of microvolume liquid reactions
US6481453B1 (en) 2000-04-14 2002-11-19 Nanostream, Inc. Microfluidic branch metering systems and methods
WO2003046208A2 (en) * 2001-11-28 2003-06-05 Mj Bioworks Incorporated Parallel polymorphism scoring by amplification and error correction
WO2004031408A1 (en) * 2002-09-30 2004-04-15 F.Hoffmann-La Roche Ag Oligonucleotides for genotyping thymidylate synthase gene
CA2501863A1 (en) * 2002-10-11 2004-04-22 Erasmus Universiteit Rotterdam Nucleic acid amplification primers for pcr-based clonality studies
US8067205B2 (en) * 2003-03-28 2011-11-29 Japan As Represented By Director General Of National Rehabilitation Center For Persons With Disabilities Method of synthesizing cDNA
US7354706B2 (en) * 2003-09-09 2008-04-08 The Regents Of The University Of Colorado, A Body Corporate Use of photopolymerization for amplification and detection of a molecular recognition event
WO2005028629A2 (en) 2003-09-19 2005-03-31 Applera Corporation Whole genome expression analysis system
JP2007512811A (en) * 2003-11-10 2007-05-24 インベスチゲン, インコーポレイテッド Methods for preparing nucleic acids for detection
US20060223122A1 (en) * 2005-03-08 2006-10-05 Agnes Fogo Classifying and predicting glomerulosclerosis using a proteomics approach
GB2424946A (en) * 2005-04-05 2006-10-11 Stratec Biomedical Systems Ag A detection system for substance binding using up-converting fluorescent probes
US7797961B2 (en) * 2006-12-07 2010-09-21 Samsung Electronics Co., Ltd. Refrigerator having improved ice-making unit configuration
US9156010B2 (en) 2008-09-23 2015-10-13 Bio-Rad Laboratories, Inc. Droplet-based assay system
US9132394B2 (en) 2008-09-23 2015-09-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
CN102725424B (en) * 2010-01-25 2014-07-09 Rd生物科技公司 Self-folding amplification of target nucleic acid
US9506112B2 (en) * 2010-02-05 2016-11-29 Siemens Healthcare Diagnostics Inc. Increasing multiplex level by externalization of passive reference in polymerase chain reactions
PT2363502T (en) * 2010-03-04 2017-05-17 Miacom Diagnostics Gmbh Enhanced multiplex fish
WO2012162161A1 (en) * 2011-05-20 2012-11-29 Phthisis Diagnostics Microsporidia detection system and method

Patent Citations (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US522332A (en) * 1894-07-03 Mohn van vleck
US2561339A (en) * 1944-01-10 1951-07-24 Chediak Alejandro Apparatus for laboratory investigations
US3389966A (en) * 1964-04-30 1968-06-25 Calvin A. Saravis Apparatus and process for semiqualitative, semiquantitative immunodiffusion reactions
US3390962A (en) * 1965-09-01 1968-07-02 Nat Instr Lab Inc Biochemical test plate
US3691017A (en) * 1970-05-06 1972-09-12 Worthington Bio Chem Corp Means and method for chemical analysis
US3865548A (en) * 1972-06-13 1975-02-11 Einstein Coll Med Analytical apparatus and process
US4065263A (en) * 1976-04-02 1977-12-27 Woodbridge Iii Richard G Analytical test strip apparatus
US4146365A (en) * 1977-11-07 1979-03-27 Litton Bionetics, Inc. Affinity detection apparatus
US4299920A (en) * 1979-01-19 1981-11-10 Peters J Hinrich Biological receptacle
US4591567A (en) * 1982-04-21 1986-05-27 California Institute Of Technology Recombinant DNA screening system including fixed array replicator and support
US4468371A (en) * 1982-07-19 1984-08-28 Daryl Laboratories, Inc. Immunoassay test slide
US4483925A (en) * 1982-12-30 1984-11-20 Becton, Dickinson And Company Liquid removal device
US4599315A (en) * 1983-09-13 1986-07-08 University Of California Regents Microdroplet test apparatus
US5073341A (en) * 1985-08-21 1991-12-17 Biotope, Inc. Devices for conducting specific binding assays
US4868130A (en) * 1985-08-21 1989-09-19 Biotope, Inc. Methods for conducting specific binding assays
US4834946A (en) * 1987-02-05 1989-05-30 Levin Andrew E Apparatus for blot screening numerous, small volume, antibody solutions
US5525464A (en) * 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5422270A (en) * 1987-05-19 1995-06-06 The United States Of America As Represented By The Department Of Health And Human Services One-step tray test for release of soluble mediators and apparatus therefore
US4911782A (en) * 1988-03-28 1990-03-27 Cyto-Fluidics, Inc. Method for forming a miniaturized biological assembly
US5503803A (en) * 1988-03-28 1996-04-02 Conception Technologies, Inc. Miniaturized biological assembly
US5200152A (en) * 1988-03-28 1993-04-06 Cytonix Corporation Miniaturized biological assembly
US5017342A (en) * 1988-06-01 1991-05-21 Ortho Diagnostic Systems Inc. Device for immunoassay determinations
US5229297A (en) * 1989-02-03 1993-07-20 Eastman Kodak Company Containment cuvette for PCR and method of use
US5176203A (en) * 1989-08-05 1993-01-05 Societe De Conseils De Recherches Et D'applications Scientifiques Apparatus for repeated automatic execution of a thermal cycle for treatment of samples
US5192659A (en) * 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5346672A (en) * 1989-11-17 1994-09-13 Gene Tec Corporation Devices for containing biological specimens for thermal processing
US5276125A (en) * 1989-12-02 1994-01-04 Bayer Aktiengesellschaft Heat-curable coating compositions
US5041266A (en) * 1989-12-21 1991-08-20 Hoffmann-La Roche Inc. Tray for immunometric determinations
US5376252A (en) * 1990-05-10 1994-12-27 Pharmacia Biosensor Ab Microfluidic structure and process for its manufacture
US5614396A (en) * 1990-06-14 1997-03-25 Baylor College Of Medicine Methods for the genetic modification of endogenous genes in animal cells by homologous recombination
US5182082A (en) * 1991-01-23 1993-01-26 Becton, Dickinson And Company Multiple aliquot device for distributing a liquid solution into a well
US6814934B1 (en) * 1991-05-02 2004-11-09 Russell Gene Higuchi Instrument for monitoring nucleic acid amplification
US6171785B1 (en) * 1991-05-02 2001-01-09 Roche Molecular Systems, Inc. Methods and devices for hemogeneous nucleic acid amplification and detector
US5994056A (en) * 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5299163A (en) * 1991-06-27 1994-03-29 Nec Corporation Semiconductor memory device with discriminator for diagnostic mode of operation
US5830663A (en) * 1991-08-10 1998-11-03 Medical Research Council In situ recombinant PCR within single cells
US5380489A (en) * 1992-02-18 1995-01-10 Eastman Kodak Company Element and method for nucleic acid amplification and detection using adhered probes
US5304487A (en) * 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US5587128A (en) * 1992-05-01 1996-12-24 The Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification devices
US5498392A (en) * 1992-05-01 1996-03-12 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US5610016A (en) * 1994-03-30 1997-03-11 Mochida Pharmaceutical Co., Ltd. Method for measuring adenyl group-containing substances using heteropoly-acid
US5641658A (en) * 1994-08-03 1997-06-24 Mosaic Technologies, Inc. Method for performing amplification of nucleic acid with two primers bound to a single solid support
US5585069A (en) * 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5601982A (en) * 1995-02-07 1997-02-11 Sargent; Jeannine P. Method and apparatus for determining the sequence of polynucleotides
US5948673A (en) * 1995-09-12 1999-09-07 Becton Dickinson And Company Device and method for DNA amplification and assay
US6132580A (en) * 1995-09-28 2000-10-17 The Regents Of The University Of California Miniature reaction chamber and devices incorporating same
US7888108B2 (en) * 1996-04-03 2011-02-15 Applied Biosystems, Llc Device and method for multiple analyte detection
US20110003281A1 (en) * 1996-04-03 2011-01-06 Applera Corporation Device and method for multiple analyte detection
US7687280B2 (en) * 1996-04-03 2010-03-30 Applied Biosystems, Llc Device and method for multiple analyte detection
US7833711B2 (en) * 1996-04-03 2010-11-16 Applied Biosystems, Llc Device and method for multiple analyte detection
US5795748A (en) * 1996-09-26 1998-08-18 Becton Dickinson And Company DNA microwell device and method
US6143496A (en) * 1997-04-17 2000-11-07 Cytonix Corporation Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US6391559B1 (en) * 1997-04-17 2002-05-21 Cytonix Corporation Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US7972778B2 (en) * 1997-04-17 2011-07-05 Applied Biosystems, Llc Method for detecting the presence of a single target nucleic acid in a sample
US8067159B2 (en) * 1997-04-17 2011-11-29 Applied Biosystems, Llc Methods of detecting amplified product
US20110311979A1 (en) * 1997-04-17 2011-12-22 United States Department of Health and Human Services Method for detecting the presence of a single target nucleic acid in a sample
US5976336A (en) * 1997-04-25 1999-11-02 Caliper Technologies Corp. Microfluidic devices incorporating improved channel geometries
US6049380A (en) * 1997-11-12 2000-04-11 Regents Of The University Of California Single molecule identification using selected fluorescence characteristics
US20110065590A1 (en) * 1998-01-12 2011-03-17 Hunter Ian W Method and Apparatus for Performing Microassays
US7833719B2 (en) * 2000-02-18 2010-11-16 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and methods for parallel processing of micro-volume liquid reactions

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"How many species of bacteria are there" (wisegeek.com; accessed 23 September 2011). *
"Mammal," (Wikipedia.com; accessed 22 September 2011). *
"Viruses" (Wikipedia.com, accessed 24 November 2012). *

Cited By (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9506105B2 (en) 1997-04-17 2016-11-29 Applied Biosystems, Llc Device and method for amplifying target nucleic acid
US8551698B2 (en) 1997-04-17 2013-10-08 Applied Biosystems, Llc Method of loading sample into a microfluidic device
US8822183B2 (en) 1997-04-17 2014-09-02 Applied Biosystems, Llc Device for amplifying target nucleic acid
US8859204B2 (en) 1997-04-17 2014-10-14 Applied Biosystems, Llc Method for detecting the presence of a target nucleic acid sequence in a sample
US8278071B2 (en) 1997-04-17 2012-10-02 Applied Biosystems, Llc Method for detecting the presence of a single target nucleic acid in a sample
US8257925B2 (en) 1997-04-17 2012-09-04 Applied Biosystems, Llc Method for detecting the presence of a single target nucleic acid in a sample
US8067159B2 (en) 1997-04-17 2011-11-29 Applied Biosystems, Llc Methods of detecting amplified product
US20080138815A1 (en) * 1997-04-17 2008-06-12 Cytonix Method of loading sample into a microfluidic device
US20080171327A1 (en) * 1997-04-17 2008-07-17 Cytonix Method and device for detecting the presence of a single target nucleic acid in a sample
US20080171325A1 (en) * 1997-04-17 2008-07-17 Cytonix Method and device for detecting the presence of a single target nucleic acid in a sample
US20080213766A1 (en) * 1997-04-17 2008-09-04 Cytonix Method and device for detecting the presence of a single target nucleic acid in samples
US20040171055A1 (en) * 1997-04-17 2004-09-02 Cytonix Corporation Method for detecting the presence of a single target nucleic acid in a sample
US20090035759A1 (en) * 1997-04-17 2009-02-05 Cytonix Method and device for detecting the presence of a single target nucleic acid in a sample
US7972778B2 (en) 1997-04-17 2011-07-05 Applied Biosystems, Llc Method for detecting the presence of a single target nucleic acid in a sample
US8563275B2 (en) 1997-04-17 2013-10-22 Applied Biosystems, Llc Method and device for detecting the presence of a single target nucleic acid in a sample
US9180450B2 (en) 2002-09-24 2015-11-10 Advanced Liquid Logic, Inc. Droplet manipulation system and method
US8349276B2 (en) 2002-09-24 2013-01-08 Duke University Apparatuses and methods for manipulating droplets on a printed circuit board
US20060054503A1 (en) * 2002-09-24 2006-03-16 Duke University Methods for manipulating droplets by electrowetting-based techniques
US8524506B2 (en) 2002-09-24 2013-09-03 Duke University Methods for sampling a liquid flow
US20070037294A1 (en) * 2002-09-24 2007-02-15 Duke University Methods for performing microfluidic sampling
US8394249B2 (en) 2002-09-24 2013-03-12 Duke University Methods for manipulating droplets by electrowetting-based techniques
US8388909B2 (en) 2002-09-24 2013-03-05 Duke University Apparatuses and methods for manipulating droplets
US7759132B2 (en) 2002-09-24 2010-07-20 Duke University Methods for performing microfluidic sampling
US8871071B2 (en) 2002-09-24 2014-10-28 Duke University Droplet manipulation device
US8287711B2 (en) 2002-09-24 2012-10-16 Duke University Apparatus for manipulating droplets
US9110017B2 (en) 2002-09-24 2015-08-18 Duke University Apparatuses and methods for manipulating droplets
US7569129B2 (en) 2002-09-24 2009-08-04 Advanced Liquid Logic, Inc. Methods for manipulating droplets by electrowetting-based techniques
US8906627B2 (en) 2002-09-24 2014-12-09 Duke University Apparatuses and methods for manipulating droplets
US8221605B2 (en) 2002-09-24 2012-07-17 Duke University Apparatus for manipulating droplets
US8147668B2 (en) 2002-09-24 2012-04-03 Duke University Apparatus for manipulating droplets
US8048628B2 (en) 2002-09-24 2011-11-01 Duke University Methods for nucleic acid amplification on a printed circuit board
US9638662B2 (en) 2002-09-24 2017-05-02 Duke University Apparatuses and methods for manipulating droplets
USRE46322E1 (en) 2003-03-14 2017-02-28 Lawrence Livermore National Security, Llc Method for chemical amplification based on fluid partitioning in an immiscible liquid
USRE43365E1 (en) 2003-03-14 2012-05-08 Lawrence Livermore National Security, Llc Apparatus for chemical amplification based on fluid partitioning in an immiscible liquid
USRE41780E1 (en) 2003-03-14 2010-09-28 Lawrence Livermore National Security, Llc Chemical amplification based on fluid partitioning in an immiscible liquid
USRE47080E1 (en) 2003-03-14 2018-10-09 Lawrence Livermore National Security, Llc Chemical amplification based on fluid partitioning
USRE45539E1 (en) 2003-03-14 2015-06-02 Lawrence Livermore National Security, Llc Method for chemical amplification based on fluid partitioning in an immiscible liquid
USRE48788E1 (en) 2003-03-14 2021-10-26 Lawrence Livermore National Security, Llc Chemical amplification based on fluid partitioning
US9216415B2 (en) 2005-05-11 2015-12-22 Advanced Liquid Logic Methods of dispensing and withdrawing liquid in an electrowetting device
US20080274513A1 (en) * 2005-05-11 2008-11-06 Shenderov Alexander D Method and Device for Conducting Biochemical or Chemical Reactions at Multiple Temperatures
US9452433B2 (en) 2005-05-11 2016-09-27 Advanced Liquid Logic, Inc. Method and device for conducting biochemical or chemical reactions at multiple temperatures
US9517469B2 (en) 2005-05-11 2016-12-13 Advanced Liquid Logic, Inc. Method and device for conducting biochemical or chemical reactions at multiple temperatures
US9205433B2 (en) 2006-04-13 2015-12-08 Advanced Liquid Logic, Inc. Bead manipulation techniques
US9358551B2 (en) 2006-04-13 2016-06-07 Advanced Liquid Logic, Inc. Bead manipulation techniques
US20070241068A1 (en) * 2006-04-13 2007-10-18 Pamula Vamsee K Droplet-based washing
US9476856B2 (en) 2006-04-13 2016-10-25 Advanced Liquid Logic, Inc. Droplet-based affinity assays
US8613889B2 (en) 2006-04-13 2013-12-24 Advanced Liquid Logic, Inc. Droplet-based washing
US9050606B2 (en) 2006-04-13 2015-06-09 Advanced Liquid Logic, Inc. Bead manipulation techniques
US9097662B2 (en) 2006-04-18 2015-08-04 Advanced Liquid Logic, Inc. Droplet-based particle sorting
US10139403B2 (en) 2006-04-18 2018-11-27 Advanced Liquid Logic, Inc. Manipulation of beads in droplets and methods for manipulating droplets
US11789015B2 (en) 2006-04-18 2023-10-17 Advanced Liquid Logic, Inc. Manipulation of beads in droplets and methods for manipulating droplets
US8637317B2 (en) 2006-04-18 2014-01-28 Advanced Liquid Logic, Inc. Method of washing beads
US8637324B2 (en) 2006-04-18 2014-01-28 Advanced Liquid Logic, Inc. Bead incubation and washing on a droplet actuator
US11525827B2 (en) 2006-04-18 2022-12-13 Advanced Liquid Logic, Inc. Bead incubation and washing on a droplet actuator
US11255809B2 (en) 2006-04-18 2022-02-22 Advanced Liquid Logic, Inc. Droplet-based surface modification and washing
US8716015B2 (en) 2006-04-18 2014-05-06 Advanced Liquid Logic, Inc. Manipulation of cells on a droplet actuator
US20080044893A1 (en) * 2006-04-18 2008-02-21 Pollack Michael G Multiwell Droplet Actuator, System and Method
US8809068B2 (en) 2006-04-18 2014-08-19 Advanced Liquid Logic, Inc. Manipulation of beads in droplets and methods for manipulating droplets
US8470606B2 (en) 2006-04-18 2013-06-25 Duke University Manipulation of beads in droplets and methods for splitting droplets
US8845872B2 (en) 2006-04-18 2014-09-30 Advanced Liquid Logic, Inc. Sample processing droplet actuator, system and method
US8846410B2 (en) 2006-04-18 2014-09-30 Advanced Liquid Logic, Inc. Bead incubation and washing on a droplet actuator
US8389297B2 (en) 2006-04-18 2013-03-05 Duke University Droplet-based affinity assay device and system
US8313698B2 (en) 2006-04-18 2012-11-20 Advanced Liquid Logic Inc Droplet-based nucleic acid amplification apparatus and system
US8883513B2 (en) 2006-04-18 2014-11-11 Advanced Liquid Logic, Inc. Droplet-based particle sorting
US10809254B2 (en) 2006-04-18 2020-10-20 Advanced Liquid Logic, Inc. Manipulation of beads in droplets and methods for manipulating droplets
US10585090B2 (en) 2006-04-18 2020-03-10 Advanced Liquid Logic, Inc. Bead incubation and washing on a droplet actuator
US8492168B2 (en) 2006-04-18 2013-07-23 Advanced Liquid Logic Inc. Droplet-based affinity assays
US8980198B2 (en) 2006-04-18 2015-03-17 Advanced Liquid Logic, Inc. Filler fluids for droplet operations
US20080044914A1 (en) * 2006-04-18 2008-02-21 Pamula Vamsee K Protein Crystallization Screening and Optimization Droplet Actuators, Systems and Methods
US8007739B2 (en) 2006-04-18 2011-08-30 Advanced Liquid Logic, Inc. Protein crystallization screening and optimization droplet actuators, systems and methods
US10078078B2 (en) 2006-04-18 2018-09-18 Advanced Liquid Logic, Inc. Bead incubation and washing on a droplet actuator
US9081007B2 (en) 2006-04-18 2015-07-14 Advanced Liquid Logic, Inc. Bead incubation and washing on a droplet actuator
US9086345B2 (en) 2006-04-18 2015-07-21 Advanced Liquid Logic, Inc. Manipulation of beads in droplets and methods for manipulating droplets
US20080050834A1 (en) * 2006-04-18 2008-02-28 Pamula Vamsee K Protein Crystallization Droplet Actuator, System and Method
US7998436B2 (en) 2006-04-18 2011-08-16 Advanced Liquid Logic, Inc. Multiwell droplet actuator, system and method
US7727723B2 (en) 2006-04-18 2010-06-01 Advanced Liquid Logic, Inc. Droplet-based pyrosequencing
US7763471B2 (en) 2006-04-18 2010-07-27 Advanced Liquid Logic, Inc. Method of electrowetting droplet operations for protein crystallization
US9494498B2 (en) 2006-04-18 2016-11-15 Advanced Liquid Logic, Inc. Manipulation of beads in droplets and methods for manipulating droplets
US20100258441A1 (en) * 2006-04-18 2010-10-14 Advanced Liquid Logic, Inc. Manipulation of Beads in Droplets and Methods for Splitting Droplets
US9139865B2 (en) 2006-04-18 2015-09-22 Advanced Liquid Logic, Inc. Droplet-based nucleic acid amplification method and apparatus
US7816121B2 (en) 2006-04-18 2010-10-19 Advanced Liquid Logic, Inc. Droplet actuation system and method
US7901947B2 (en) 2006-04-18 2011-03-08 Advanced Liquid Logic, Inc. Droplet-based particle sorting
US9395361B2 (en) 2006-04-18 2016-07-19 Advanced Liquid Logic, Inc. Bead incubation and washing on a droplet actuator
US7851184B2 (en) 2006-04-18 2010-12-14 Advanced Liquid Logic, Inc. Droplet-based nucleic acid amplification method and apparatus
US9395329B2 (en) 2006-04-18 2016-07-19 Advanced Liquid Logic, Inc. Droplet-based particle sorting
US9377455B2 (en) 2006-04-18 2016-06-28 Advanced Liquid Logic, Inc Manipulation of beads in droplets and methods for manipulating droplets
US7815871B2 (en) 2006-04-18 2010-10-19 Advanced Liquid Logic, Inc. Droplet microactuator system
US9243282B2 (en) 2006-04-18 2016-01-26 Advanced Liquid Logic, Inc Droplet-based pyrosequencing
US9267131B2 (en) 2006-04-18 2016-02-23 Advanced Liquid Logic, Inc. Method of growing cells on a droplet actuator
US7822510B2 (en) 2006-05-09 2010-10-26 Advanced Liquid Logic, Inc. Systems, methods, and products for graphically illustrating and controlling a droplet actuator
US8041463B2 (en) 2006-05-09 2011-10-18 Advanced Liquid Logic, Inc. Modular droplet actuator drive
US20100143963A1 (en) * 2006-05-09 2010-06-10 Advanced Liquid Logic, Inc. Modular Droplet Actuator Drive
US7939021B2 (en) 2007-05-09 2011-05-10 Advanced Liquid Logic, Inc. Droplet actuator analyzer with cartridge
US8268246B2 (en) 2007-08-09 2012-09-18 Advanced Liquid Logic Inc PCB droplet actuator fabrication
US9492797B2 (en) 2008-09-23 2016-11-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US10512910B2 (en) 2008-09-23 2019-12-24 Bio-Rad Laboratories, Inc. Droplet-based analysis method
US11130128B2 (en) 2008-09-23 2021-09-28 Bio-Rad Laboratories, Inc. Detection method for a target nucleic acid
US11130134B2 (en) 2008-09-23 2021-09-28 Bio-Rad Laboratories, Inc. Method of performing droplet-based assays
US11612892B2 (en) 2008-09-23 2023-03-28 Bio-Rad Laboratories, Inc. Method of performing droplet-based assays
US9417190B2 (en) 2008-09-23 2016-08-16 Bio-Rad Laboratories, Inc. Calibrations and controls for droplet-based assays
US9156010B2 (en) 2008-09-23 2015-10-13 Bio-Rad Laboratories, Inc. Droplet-based assay system
US9132394B2 (en) 2008-09-23 2015-09-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US9126160B2 (en) 2008-09-23 2015-09-08 Bio-Rad Laboratories, Inc. System for forming an array of emulsions
US9243288B2 (en) 2008-09-23 2016-01-26 Bio-Rad Laboratories, Inc. Cartridge with lysis chamber and droplet generator
US9248417B2 (en) 2008-09-23 2016-02-02 Bio-Rad Laboratories, Inc. System for droplet-based assays using an array of emulsions
US9216392B2 (en) 2008-09-23 2015-12-22 Bio-Rad Laboratories, Inc. System for forming an array of emulsions
US10279350B2 (en) 2008-09-23 2019-05-07 Bio-Rad Laboratories, Inc. Method of generating droplets
US11633739B2 (en) 2008-09-23 2023-04-25 Bio-Rad Laboratories, Inc. Droplet-based assay system
US8633015B2 (en) 2008-09-23 2014-01-21 Bio-Rad Laboratories, Inc. Flow-based thermocycling system with thermoelectric cooler
US10258988B2 (en) 2008-09-23 2019-04-16 Bio-Rad Laboratories, Inc. Device for generating droplets
US9623384B2 (en) 2008-09-23 2017-04-18 Bio-Rad Laboratories, Inc. System for transporting emulsions from an array to a detector
US10258989B2 (en) 2008-09-23 2019-04-16 Bio-Rad Laboratories, Inc. Method of making a device for generating droplets
US9636682B2 (en) 2008-09-23 2017-05-02 Bio-Rad Laboratories, Inc. System for generating droplets—instruments and cassette
US9764322B2 (en) 2008-09-23 2017-09-19 Bio-Rad Laboratories, Inc. System for generating droplets with pressure monitoring
US9649635B2 (en) 2008-09-23 2017-05-16 Bio-Rad Laboratories, Inc. System for generating droplets with push-back to remove oil
US9656261B2 (en) 2009-06-04 2017-05-23 Leidos Innovations Technology, Inc. DNA analyzer
US9649631B2 (en) 2009-06-04 2017-05-16 Leidos Innovations Technology, Inc. Multiple-sample microfluidic chip for DNA analysis
US9067207B2 (en) 2009-06-04 2015-06-30 University Of Virginia Patent Foundation Optical approach for microfluidic DNA electrophoresis detection
US10677693B2 (en) 2009-09-02 2020-06-09 Bio-Rad Laboratories, Inc. System for mixing fluids by coalescence of multiple emulsions
US9194861B2 (en) 2009-09-02 2015-11-24 Bio-Rad Laboratories, Inc. Method of mixing fluids by coalescence of multiple emulsions
US10166522B2 (en) 2009-09-02 2019-01-01 Bio-Rad Laboratories, Inc. System for mixing fluids by coalescence of multiple emulsions
US9598725B2 (en) 2010-03-02 2017-03-21 Bio-Rad Laboratories, Inc. Emulsion chemistry for encapsulated droplets
US11866771B2 (en) 2010-03-02 2024-01-09 Bio-Rad Laboratories, Inc. Emulsion chemistry for encapsulated droplets
US8709762B2 (en) 2010-03-02 2014-04-29 Bio-Rad Laboratories, Inc. System for hot-start amplification via a multiple emulsion
US11060136B2 (en) 2010-03-02 2021-07-13 Bio-Rad Laboratories, Inc. Emulsion chemistry for encapsulated droplets
US10378048B2 (en) 2010-03-02 2019-08-13 Bio-Rad Laboratories, Inc. Emulsion chemistry for encapsulated droplets
US10744506B2 (en) 2010-03-25 2020-08-18 Bio-Rad Laboratories, Inc. Device for generating droplets
US9393560B2 (en) 2010-03-25 2016-07-19 Bio-Rad Laboratories, Inc. Droplet transport system for detection
US10099219B2 (en) 2010-03-25 2018-10-16 Bio-Rad Laboratories, Inc. Device for generating droplets
US8730479B2 (en) 2010-03-25 2014-05-20 Bio-Rad Laboratories, Inc. Detection system for droplet-based assays
US10272432B2 (en) 2010-03-25 2019-04-30 Bio-Rad Laboratories, Inc. Device for generating droplets
US9500664B2 (en) 2010-03-25 2016-11-22 Bio-Rad Laboratories, Inc. Droplet generation for droplet-based assays
US8961764B2 (en) 2010-10-15 2015-02-24 Lockheed Martin Corporation Micro fluidic optic design
US9089844B2 (en) 2010-11-01 2015-07-28 Bio-Rad Laboratories, Inc. System for forming emulsions
US9222128B2 (en) 2011-03-18 2015-12-29 Bio-Rad Laboratories, Inc. Multiplexed digital assays with combinatorial use of signals
US10190115B2 (en) 2011-04-25 2019-01-29 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis
US10760073B2 (en) 2011-04-25 2020-09-01 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis
US9347059B2 (en) 2011-04-25 2016-05-24 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis
US9885034B2 (en) 2011-04-25 2018-02-06 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis
US9513253B2 (en) 2011-07-11 2016-12-06 Advanced Liquid Logic, Inc. Droplet actuators and techniques for droplet-based enzymatic assays
US8951939B2 (en) 2011-07-12 2015-02-10 Bio-Rad Laboratories, Inc. Digital assays with multiplexed detection of two or more targets in the same optical channel
US8663920B2 (en) 2011-07-29 2014-03-04 Bio-Rad Laboratories, Inc. Library characterization by digital assay
US9988676B2 (en) 2012-02-22 2018-06-05 Leidos Innovations Technology, Inc. Microfluidic cartridge
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
US9399215B2 (en) 2012-04-13 2016-07-26 Bio-Rad Laboratories, Inc. Sample holder with a well having a wicking promoter
CN104884168A (en) * 2012-11-08 2015-09-02 瓦弗根公司 Extraction of restrained liquid from wells
US11369968B2 (en) 2017-04-21 2022-06-28 Essenlix Corporation Molecular manipulation and assay with controlled temperature (II)
WO2021219675A1 (en) 2020-04-30 2021-11-04 F. Hoffmann-La Roche Ag A method for detecting reaction volume deviations in a digital polymerase chain reaction

Also Published As

Publication number Publication date
WO1998047003A1 (en) 1998-10-22
US20080153091A1 (en) 2008-06-26
US20130143218A1 (en) 2013-06-06
US20120301884A1 (en) 2012-11-29
US7459315B2 (en) 2008-12-02
US20080171382A1 (en) 2008-07-17
US20140329305A1 (en) 2014-11-06
US20150010911A1 (en) 2015-01-08
US20080171326A1 (en) 2008-07-17
US20080171327A1 (en) 2008-07-17
US20110311979A1 (en) 2011-12-22
US8257925B2 (en) 2012-09-04
US20150017709A1 (en) 2015-01-15
US20120063972A1 (en) 2012-03-15
US20080213766A1 (en) 2008-09-04
US8067159B2 (en) 2011-11-29
US6391559B1 (en) 2002-05-21
US8859204B2 (en) 2014-10-14
US20080171325A1 (en) 2008-07-17
US20080169184A1 (en) 2008-07-17
US8822183B2 (en) 2014-09-02
AU7128998A (en) 1998-11-11
US6143496A (en) 2000-11-07
US20080171324A1 (en) 2008-07-17
US8278071B2 (en) 2012-10-02
US20040171055A1 (en) 2004-09-02
US20020164820A1 (en) 2002-11-07
US8551698B2 (en) 2013-10-08
US8563275B2 (en) 2013-10-22
US20080171380A1 (en) 2008-07-17
US20090035759A1 (en) 2009-02-05
US7972778B2 (en) 2011-07-05
US20080138815A1 (en) 2008-06-12
US9506105B2 (en) 2016-11-29

Similar Documents

Publication Publication Date Title
US9506105B2 (en) Device and method for amplifying target nucleic acid
CA2400644C (en) Apparatus and methods for parallel processing of micro-volume liquid reactions
US20120172252A1 (en) High Density Sequence Detection Methods
KR100774713B1 (en) Macroporous support for chemical amplification reactions
US20010006785A1 (en) Method and apparatus for analyzing nucleic acids
CA2244120A1 (en) A rapid method to detect duplex formation in sequencing by hybridization methods
EP1463796A1 (en) Microfluidic device and methods of using same

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN S

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SILVER, JONATHAN E.;REEL/FRAME:022421/0115

Effective date: 19971114

Owner name: CYTONIX CORPORATION, MARYLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BROWN, JAMES F.;REEL/FRAME:022421/0098

Effective date: 19971120

AS Assignment

Owner name: GENOMIC NANOSYSTEMS, LLC, MARYLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CYTONIX CORPORATION;REEL/FRAME:022427/0504

Effective date: 20071003

AS Assignment

Owner name: APPLIED BIOSYSTEMS, LLC,CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GENOMIC NANOSYSTEMS, LLC;REEL/FRAME:023950/0123

Effective date: 20100127

Owner name: APPLIED BIOSYSTEMS, LLC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GENOMIC NANOSYSTEMS, LLC;REEL/FRAME:023950/0123

Effective date: 20100127

AS Assignment

Owner name: GENOMIC NANOSYSTEMS CORPORATION,DELAWARE

Free format text: MERGER;ASSIGNOR:GENOMIC NANOSYSTEMS, LLC;REEL/FRAME:024508/0142

Effective date: 20100510

Owner name: GENOMIC NANOSYSTEMS CORPORATION, DELAWARE

Free format text: MERGER;ASSIGNOR:GENOMIC NANOSYSTEMS, LLC;REEL/FRAME:024508/0142

Effective date: 20100510

AS Assignment

Owner name: APPLIED BIOSYSTEMS, LLC,CALIFORNIA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NOS.; CONVEYING PARTY INTEREST; CONVEYING PARTY NAME/ADDRESS PER MERGER RECORDED 6/9/2010, REEL 024508, FRAME 0142. PREVIOUSLY RECORDED ON REEL 023950 FRAME 0123. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:GENOMIC NANOSYSTEMS CORPORATION;REEL/FRAME:024563/0930

Effective date: 20100615

Owner name: APPLIED BIOSYSTEMS, LLC, CALIFORNIA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NOS.; CONVEYING PARTY INTEREST; CONVEYING PARTY NAME/ADDRESS PER MERGER RECORDED 6/9/2010, REEL 024508, FRAME 0142. PREVIOUSLY RECORDED ON REEL 023950 FRAME 0123. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:GENOMIC NANOSYSTEMS CORPORATION;REEL/FRAME:024563/0930

Effective date: 20100615

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION